P-value | ln(P) | Term | GO Tree | GO ID | # of Genes in Term | # of Target Genes in Term | # of Total Genes | # of Target Genes | Common Genes |
1.332e-08 | -18.13 | plasma membrane | cellular component | GO:0005886 | 5538 | 33 | 19108 | 48 |
MYO1F,ARHGAP15,RAC2,SLCO2B1,GAS7,ELMO1,CTSB,NCF1,PLXND1,ITGB2,CD74,SH2B3,FYB1,NCAM2,RAPGEF6,PREX1,WDFY3,ZNRF2,CSF1R,PLEK,ITGAX,DAPP1,LPP,ENTPD1,CD68,SMPD4,ITM2B,RGS19,CMTM6,MARCO,P2RY6,NCKAP1L,HCK |
2.486e-08 | -17.51 | cell periphery | cellular component | GO:0071944 | 6020 | 34 | 19108 | 48 |
CTSB,PLXND1,NCF1,FYB1,SH2B3,CD74,ITGB2,WDFY3,PREX1,RAPGEF6,NCAM2,RAC2,ARHGAP15,MYO1F,SLCO2B1,ELMO1,GAS7,SMPD4,P2RY6,MARCO,CMTM6,ITM2B,RGS19,HCK,NCKAP1L,PLEK,CSF1R,ZNRF2,DAPP1,ITGAX,ENTPD1,MYO9B,LPP,CD68 |
8.817e-08 | -16.24 | membrane | cellular component | GO:0016020 | 9220 | 41 | 19108 | 48 |
GCH1,CD68,LPP,MYO9B,ENTPD1,ITGAX,DAPP1,ZNRF2,CSF1R,PLEK,HCK,NCKAP1L,RGS19,ITM2B,QSOX1,CMTM6,TFEB,MARCO,P2RY6,SMPD4,GAS7,ELMO1,ABR,UNC93B1,SLCO2B1,NDUFS2,MYO1F,ARHGAP15,RAC2,RAPGEF6,NCAM2,WDFY3,PREX1,CD74,ITGB2,SH2B3,MFNG,FYB1,NCF1,PLXND1,CTSB |
1.876e-07 | -15.49 | PH-like_dom_sf | interpro domains | IPR011993 | 431 | 10 | 18521 | 50 |
PREX1,GULP1,SH2B3,PLEK,WDFY3,GAB1,DAPP1,ABR,ARHGAP15,ELMO1 |
3.893e-07 | -14.76 | NHLRC2 (NHL repeat containing 2) | protein interactions | 374354 | 372 | 9 | 19454 | 50 |
PLEK,ITGAX,ARHGAP15,CTSB,TFEB,MYO1F,RAC2,NCKAP1L,MYO9B |
4.960e-07 | -14.52 | Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB) | gene3d domains | 2.30.29.30 | 431 | 10 | 14470 | 44 |
GULP1,GAB1,PLEK,WDFY3,SH2B3,DAPP1,ELMO1,ABR,ARHGAP15,PREX1 |
5.191e-07 | -14.47 | PH_domain | interpro domains | IPR001849 | 266 | 8 | 18521 | 50 |
ABR,ARHGAP15,ELMO1,GAB1,PREX1,SH2B3,DAPP1,PLEK |
1.906e-06 | -13.17 | immune system process | biological process | GO:0002376 | 1991 | 18 | 18204 | 49 |
GCH1,FYB1,ZFP36L1,SH2B3,HCK,CSF1R,TFEB,CD74,MARCO,NCF1,MFNG,RAC2,TNFAIP8L2,UNC93B1,NCKAP1L,ITGB2,CD68,PREX1 |
2.561e-06 | -12.88 | phagocytosis, engulfment | biological process | GO:0006911 | 36 | 4 | 18204 | 49 |
MARCO,ITGB2,GULP1,ELMO1 |
4.141e-06 | -12.39 | phagocytosis | biological process | GO:0006909 | 159 | 6 | 18204 | 49 |
ELMO1,GULP1,ITGB2,P2RY6,MARCO,HCK |
5.827e-06 | -12.05 | integrin-mediated signaling pathway | biological process | GO:0007229 | 96 | 5 | 18204 | 49 |
ITGB2,ITGAX,PLEK,HCK,FYB1 |
6.179e-06 | -11.99 | integrin alphaX-beta2 complex | cellular component | GO:0034689 | 2 | 2 | 19108 | 48 |
ITGAX,ITGB2 |
6.364e-06 | -11.96 | plasma membrane invagination | biological process | GO:0099024 | 45 | 4 | 18204 | 49 |
ELMO1,ITGB2,GULP1,MARCO |
6.821e-06 | -11.90 | vacuole | cellular component | GO:0005773 | 857 | 11 | 19108 | 48 |
TNFAIP8L2,TFEB,NCF1,CMTM6,ZNRF2,CTSB,WDFY3,CD68,HCK,UNC93B1,CD74 |
1.055e-05 | -11.46 | regulation of granulocyte chemotaxis | biological process | GO:0071622 | 51 | 4 | 18204 | 49 |
NCKAP1L,RAC2,CD74,CSF1R |
1.140e-05 | -11.38 | membrane invagination | biological process | GO:0010324 | 52 | 4 | 18204 | 49 |
MARCO,GULP1,ITGB2,ELMO1 |
1.186e-05 | -11.34 | regulation of catalytic activity | biological process | GO:0050790 | 1395 | 14 | 18204 | 49 |
CSF1R,ARHGAP15,CD74,NCF1,PLEK,NCKAP1L,ITGB2,PREX1,SPOCK3,ABR,RAPGEF6,GCH1,PLXND1,P2RY6 |
1.204e-05 | -11.33 | hemopoiesis | biological process | GO:0030097 | 688 | 10 | 18204 | 49 |
PREX1,RBM47,SH2B3,PLEK,NCKAP1L,RAC2,MFNG,ZFP36L1,CSF1R,CD74 |
1.354e-05 | -11.21 | response to stimulus | biological process | GO:0050896 | 7803 | 36 | 18204 | 49 |
GAB1,PREX1,DAPP1,SMPD4,RAC2,ARHGAP15,CSF1R,MARCO,CD74,ITGB2,CD68,TNFAIP8L2,NCKAP1L,HCK,RGS19,GCH1,FYB1,P2RY6,SLCO2B1,NDUFS2,RAPGEF6,MYO9B,ABR,ELMO1,ITGAX,MFNG,TFEB,NCF1,PLEK,UNC93B1,CTSB,ZFP36L1,ENTPD1,CPN1,SH2B3,PLXND1 |
1.585e-05 | -11.05 | lytic vacuole | cellular component | GO:0000323 | 762 | 10 | 19108 | 48 |
CMTM6,NCF1,TFEB,TNFAIP8L2,CTSB,ZNRF2,CD68,CD74,UNC93B1,HCK |
1.585e-05 | -11.05 | lysosome | cellular component | GO:0005764 | 762 | 10 | 19108 | 48 |
ZNRF2,CTSB,NCF1,CMTM6,TNFAIP8L2,TFEB,CD74,UNC93B1,HCK,CD68 |
1.927e-05 | -10.86 | response to external stimulus | biological process | GO:0009605 | 1882 | 16 | 18204 | 49 |
HCK,GCH1,ITGAX,PREX1,GAB1,UNC93B1,NCKAP1L,TNFAIP8L2,CD68,ITGB2,NCF1,CD74,MARCO,TFEB,CSF1R,RAC2 |
1.950e-05 | -10.85 | cytoplasmic vesicle | cellular component | GO:0031410 | 2521 | 18 | 19108 | 48 |
CTSB,CMTM6,QSOX1,ITM2B,NCF1,RGS19,MARCO,ITGB2,CD74,NCKAP1L,HCK,RAPGEF6,ZNRF2,ITGAX,RAC2,UNC93B1,GCH1,CD68 |
2.015e-05 | -10.81 | intracellular vesicle | cellular component | GO:0097708 | 2527 | 18 | 19108 | 48 |
ZNRF2,RAC2,ITGAX,UNC93B1,GCH1,CD68,CTSB,MARCO,CMTM6,QSOX1,ITM2B,NCF1,RGS19,HCK,NCKAP1L,CD74,ITGB2,RAPGEF6 |
2.560e-05 | -10.57 | PH | smart domains | SM00233 | 259 | 7 | 9717 | 34 |
ARHGAP15,PREX1,SH2B3,DAPP1,GAB1,PLEK,ABR |
3.515e-05 | -10.26 | regulation of cell shape | biological process | GO:0008360 | 139 | 5 | 18204 | 49 |
HCK,CSF1R,ARHGAP15,ITGB2,PLXND1 |
3.565e-05 | -10.24 | positive regulation of neutrophil chemotaxis | biological process | GO:0090023 | 24 | 3 | 18204 | 49 |
NCKAP1L,CD74,RAC2 |
3.565e-05 | -10.24 | respiratory burst | biological process | GO:0045730 | 24 | 3 | 18204 | 49 |
RAC2,HCK,NCF1 |
4.024e-05 | -10.12 | cellular response to stimulus | biological process | GO:0051716 | 6307 | 31 | 18204 | 49 |
PREX1,GAB1,ARHGAP15,CSF1R,CD74,MARCO,DAPP1,RAC2,SMPD4,NCKAP1L,ITGB2,CD68,HCK,RGS19,FYB1,P2RY6,SLCO2B1,NDUFS2,ITGAX,ELMO1,ABR,RAPGEF6,MYO9B,TFEB,NCF1,UNC93B1,PLEK,CTSB,ZFP36L1,PLXND1,SH2B3 |
4.562e-05 | -10.00 | positive regulation of granulocyte chemotaxis | biological process | GO:0071624 | 26 | 3 | 18204 | 49 |
RAC2,CD74,NCKAP1L |
5.420e-05 | -9.82 | SH3 Domains | gene3d domains | 2.30.30.40 | 223 | 6 | 14470 | 44 |
FYB1,GAS7,MYO1F,ELMO1,NCF1,HCK |
5.427e-05 | -9.82 | bounding membrane of organelle | cellular component | GO:0098588 | 2198 | 16 | 19108 | 48 |
MARCO,TFEB,QSOX1,CMTM6,ITM2B,SMPD4,WDFY3,NCKAP1L,MFNG,ITGB2,CD74,RAC2,ITGAX,ZNRF2,CD68,UNC93B1 |
6.099e-05 | -9.70 | phosphatidylinositol-3,4-bisphosphate binding | molecular function | GO:0043325 | 29 | 3 | 18094 | 48 |
NCF1,PLEK,DAPP1 |
6.416e-05 | -9.65 | small GTPase-mediated signal transduction | biological process | GO:0007264 | 258 | 6 | 18204 | 49 |
RGS19,RAC2,ELMO1,ABR,MYO9B,RAPGEF6 |
6.807e-05 | -9.59 | EIF2B5 (eukaryotic translation initiation factor 2B subunit epsilon) | protein interactions | 8893 | 167 | 5 | 19454 | 50 |
MYO9B,UNC93B1,P2RY6,CD74,CD68 |
8.704e-05 | -9.35 | positive regulation of catalytic activity | biological process | GO:0043085 | 868 | 10 | 18204 | 49 |
P2RY6,ITGB2,PLEK,GCH1,CSF1R,NCF1,CD74,RAPGEF6,ABR,PREX1 |
9.020e-05 | -9.31 | amyloid-beta binding | molecular function | GO:0001540 | 89 | 4 | 18094 | 48 |
CD74,ITGB2,ITM2B,MARCO |
9.447e-05 | -9.27 | positive regulation of neutrophil migration | biological process | GO:1902624 | 33 | 3 | 18204 | 49 |
NCKAP1L,RAC2,CD74 |
9.447e-05 | -9.27 | regulation of neutrophil chemotaxis | biological process | GO:0090022 | 33 | 3 | 18204 | 49 |
NCKAP1L,RAC2,CD74 |
9.493e-05 | -9.26 | cell-cell adhesion | biological process | GO:0098609 | 546 | 8 | 18204 | 49 |
NCAM2,LPP,ITGAX,RAC2,ZFP36L1,ENTPD1,PLEK,ITGB2 |
1.012e-04 | -9.20 | Rho_GTPase_activation_prot | interpro domains | IPR008936 | 90 | 4 | 18521 | 50 |
ABR,ARHGAP15,MYO9B,PLXND1 |
1.088e-04 | -9.13 | positive regulation of leukocyte chemotaxis | biological process | GO:0002690 | 92 | 4 | 18204 | 49 |
NCKAP1L,CD74,CSF1R,RAC2 |
1.112e-04 | -9.10 | defense response to symbiont | biological process | GO:0140546 | 894 | 10 | 18204 | 49 |
TNFAIP8L2,UNC93B1,GCH1,TFEB,CSF1R,NCF1,MARCO,CD74,ITGAX,HCK |
1.191e-04 | -9.04 | regulation of hydrolase activity | biological process | GO:0051336 | 726 | 9 | 18204 | 49 |
ARHGAP15,PLEK,NCKAP1L,PLXND1,P2RY6,PREX1,SPOCK3,ABR,RAPGEF6 |
1.390e-04 | -8.88 | innate immune response | biological process | GO:0045087 | 741 | 9 | 18204 | 49 |
TNFAIP8L2,UNC93B1,CSF1R,GCH1,TFEB,CD74,MARCO,NCF1,HCK |
1.442e-04 | -8.84 | PH | pfam domains | PF00169 | 187 | 5 | 17795 | 48 |
GAB1,PLEK,ARHGAP15,DAPP1,SH2B3 |
1.658e-04 | -8.70 | positive regulation of cell migration | biological process | GO:0030335 | 592 | 8 | 18204 | 49 |
P2RY6,NCKAP1L,RAC2,CD74,CSF1R,ITGAX,GAB1,PREX1 |
1.664e-04 | -8.70 | regulation of molecular function | biological process | GO:0065009 | 2005 | 15 | 18204 | 49 |
HCK,PLXND1,P2RY6,GCH1,ABR,SPOCK3,RAPGEF6,PREX1,NCKAP1L,PLEK,ITGB2,NCF1,CD74,ARHGAP15,CSF1R |
1.835e-04 | -8.60 | immune response | biological process | GO:0006955 | 1349 | 12 | 18204 | 49 |
FYB1,GCH1,HCK,CD68,UNC93B1,TNFAIP8L2,MFNG,CD74,MARCO,NCF1,TFEB,CSF1R |
1.845e-04 | -8.60 | Rho GTPase cycle | REACTOME pathways | R-HSA-194840 | 142 | 5 | 10285 | 39 |
PREX1,ABR,MYO9B,RAC2,ARHGAP15 |
2.081e-04 | -8.48 | regulation of immune system process | biological process | GO:0002682 | 1584 | 13 | 18204 | 49 |
RBM47,HCK,CSF1R,FYB1,NCF1,CD74,RAC2,ZFP36L1,TNFAIP8L2,NCKAP1L,UNC93B1,ITGB2,CD68 |
2.093e-04 | -8.47 | MTOR (mechanistic target of rapamycin kinase) | protein interactions | 2475 | 335 | 6 | 19454 | 50 |
ZNRF2,PREX1,UNC93B1,P2RY6,CD74,RAC2 |
2.097e-04 | -8.47 | erythrocyte development | biological process | GO:0048821 | 43 | 3 | 18204 | 49 |
RAC2,NCKAP1L,SH2B3 |
2.175e-04 | -8.43 | actin filament-based process | biological process | GO:0030029 | 616 | 8 | 18204 | 49 |
MYO9B,ELMO1,PREX1,GAS7,MYO1F,PLEK,NCKAP1L,RAC2 |
2.247e-04 | -8.40 | positive regulation of cell motility | biological process | GO:2000147 | 619 | 8 | 18204 | 49 |
CSF1R,CD74,RAC2,NCKAP1L,P2RY6,PREX1,GAB1,ITGAX |
2.285e-04 | -8.38 | endocytic vesicle | cellular component | GO:0030139 | 349 | 6 | 19108 | 48 |
UNC93B1,CD74,MARCO,RAC2,RAPGEF6,NCF1 |
2.325e-04 | -8.37 | actin filament | cellular component | GO:0005884 | 120 | 4 | 19108 | 48 |
MYO9B,HCK,GAS7,RAC2 |
2.363e-04 | -8.35 | PH_DOMAIN | prosite domains | PS50003 | 246 | 6 | 12186 | 44 |
PREX1,GAB1,PLEK,DAPP1,ABR,ARHGAP15 |
2.402e-04 | -8.33 | regulation of neutrophil migration | biological process | GO:1902622 | 45 | 3 | 18204 | 49 |
NCKAP1L,CD74,RAC2 |
2.402e-04 | -8.33 | regulation of leukocyte degranulation | biological process | GO:0043300 | 45 | 3 | 18204 | 49 |
RAC2,NCKAP1L,ITGB2 |
2.473e-04 | -8.31 | positive regulation of immune system process | biological process | GO:0002684 | 986 | 10 | 18204 | 49 |
RBM47,HCK,CSF1R,FYB1,CD74,RAC2,ZFP36L1,NCKAP1L,UNC93B1,ITGB2 |
2.612e-04 | -8.25 | SH3-like_dom_sf | interpro domains | IPR036028 | 212 | 5 | 18521 | 50 |
MYO1F,GAS7,FYB1,HCK,NCF1 |
2.615e-04 | -8.25 | positive regulation of locomotion | biological process | GO:0040017 | 633 | 8 | 18204 | 49 |
GAB1,PREX1,ITGAX,RAC2,CSF1R,CD74,P2RY6,NCKAP1L |
2.640e-04 | -8.24 | Immune System | REACTOME pathways | R-HSA-168256 | 2101 | 18 | 10285 | 39 |
CD68,CTSB,UNC93B1,HCK,GAB1,ELMO1,CMTM6,FYB1,ITGAX,NCKAP1L,DAPP1,ITGB2,QSOX1,CSF1R,ZNRF2,CD74,NCF1,MYO9B |
2.799e-04 | -8.18 | EIF2B3 (eukaryotic translation initiation factor 2B subunit gamma) | protein interactions | 8891 | 123 | 4 | 19454 | 50 |
GCH1,UNC93B1,P2RY6,CD74 |
2.875e-04 | -8.15 | FCER2 (Fc epsilon receptor II) | protein interactions | 2208 | 10 | 2 | 19454 | 50 |
ITGAX,ITGB2 |
2.887e-04 | -8.15 | TM9SF3 (transmembrane 9 superfamily member 3) | protein interactions | 56889 | 124 | 4 | 19454 | 50 |
P2RY6,UNC93B1,RBM47,RAC2 |
2.906e-04 | -8.14 | defense response to other organism | biological process | GO:0098542 | 1006 | 10 | 18204 | 49 |
HCK,ITGAX,TFEB,CSF1R,GCH1,CD74,MARCO,NCF1,TNFAIP8L2,UNC93B1 |
2.917e-04 | -8.14 | nucleoside-triphosphatase regulator activity | molecular function | GO:0060589 | 491 | 7 | 18094 | 48 |
ABR,MYO9B,RAPGEF6,ELMO1,ARHGAP15,PREX1,NCKAP1L |
2.917e-04 | -8.14 | GTPase regulator activity | molecular function | GO:0030695 | 491 | 7 | 18094 | 48 |
ARHGAP15,PREX1,NCKAP1L,ABR,ELMO1,MYO9B,RAPGEF6 |
2.972e-04 | -8.12 | actin cytoskeleton | cellular component | GO:0015629 | 520 | 7 | 19108 | 48 |
RAC2,MYO1F,HCK,FYB1,MYO9B,LPP,GAS7 |
2.998e-04 | -8.11 | Fcgamma receptor (FCGR) dependent phagocytosis | REACTOME pathways | R-HSA-2029480 | 86 | 4 | 10285 | 39 |
HCK,NCKAP1L,MYO9B,ELMO1 |
3.150e-04 | -8.06 | positive regulation of monocyte differentiation | biological process | GO:0045657 | 10 | 2 | 18204 | 49 |
CD74,ZFP36L1 |
3.177e-04 | -8.05 | defense response | biological process | GO:0006952 | 1431 | 12 | 18204 | 49 |
ITGB2,CD68,TNFAIP8L2,UNC93B1,TFEB,CSF1R,CD74,NCF1,MARCO,ITGAX,GCH1,HCK |
3.223e-04 | -8.04 | regulation of leukocyte chemotaxis | biological process | GO:0002688 | 122 | 4 | 18204 | 49 |
CD74,CSF1R,RAC2,NCKAP1L |
3.231e-04 | -8.04 | SH3_domain | interpro domains | IPR001452 | 222 | 5 | 18521 | 50 |
MYO1F,HCK,NCF1,GAS7,FYB1 |
3.312e-04 | -8.01 | signal transduction | biological process | GO:0007165 | 4637 | 24 | 18204 | 49 |
GAB1,PREX1,DAPP1,RAC2,CSF1R,ARHGAP15,CD74,MARCO,ITGB2,NCKAP1L,HCK,RGS19,FYB1,P2RY6,MYO9B,RAPGEF6,ITGAX,ELMO1,ABR,UNC93B1,PLEK,ZFP36L1,SH2B3,PLXND1 |
3.356e-04 | -8.00 | EIF2B4 (eukaryotic translation initiation factor 2B subunit delta) | protein interactions | 8890 | 129 | 4 | 19454 | 50 |
UNC93B1,P2RY6,CD74,MFNG |
3.534e-04 | -7.95 | endocytosis | biological process | GO:0006897 | 499 | 7 | 18204 | 49 |
P2RY6,ITGB2,MYO1F,GULP1,MARCO,ELMO1,HCK |
3.794e-04 | -7.88 | cellular response to chemical stimulus | biological process | GO:0070887 | 2411 | 16 | 18204 | 49 |
NCKAP1L,CD68,ITGB2,CD74,NCF1,CSF1R,SMPD4,PREX1,GAB1,NDUFS2,SLCO2B1,P2RY6,SH2B3,ZFP36L1,CTSB,HCK |
3.844e-04 | -7.86 | regulation of dendritic cell antigen processing and presentation | biological process | GO:0002604 | 11 | 2 | 18204 | 49 |
CD68,CD74 |
3.867e-04 | -7.86 | Nef and signal transduction | REACTOME pathways | R-HSA-164944 | 8 | 2 | 10285 | 39 |
ELMO1,HCK |
4.203e-04 | -7.77 | RWDD1 (RWD domain containing 1) | protein interactions | 51389 | 12 | 2 | 19454 | 50 |
CD74,P2RY6 |
4.277e-04 | -7.76 | Chemokine signaling pathway | KEGG pathways | hsa04062 | 182 | 5 | 7161 | 26 |
PREX1,NCF1,HCK,RAC2,ELMO1 |
4.277e-04 | -7.76 | Chemokine signaling pathway | KEGG pathways | ko04062 | 182 | 5 | 7161 | 26 |
RAC2,HCK,PREX1,NCF1,ELMO1 |
4.300e-04 | -7.75 | regulation of response to stimulus | biological process | GO:0048583 | 4104 | 22 | 18204 | 49 |
P2RY6,SH2B3,FYB1,RGS19,GCH1,HCK,RBM47,ITGB2,UNC93B1,NCKAP1L,PLEK,TNFAIP8L2,RAC2,MFNG,MARCO,NCF1,CD74,CSF1R,ARHGAP15,MYO9B,ABR,PREX1 |
4.357e-04 | -7.74 | neutrophil chemotaxis | biological process | GO:0030593 | 55 | 3 | 18204 | 49 |
ITGB2,NCKAP1L,PREX1 |
4.834e-04 | -7.63 | ficolin-1-rich granule membrane | cellular component | GO:0101003 | 61 | 3 | 19108 | 48 |
ITGAX,NCKAP1L,ITGB2 |
4.958e-04 | -7.61 | TMEM209 (transmembrane protein 209) | protein interactions | 84928 | 143 | 4 | 19454 | 50 |
RBM47,RAC2,P2RY6,UNC93B1 |
5.080e-04 | -7.58 | regulation of cell morphogenesis | biological process | GO:0022604 | 246 | 5 | 18204 | 49 |
CSF1R,ARHGAP15,HCK,PLXND1,ITGB2 |
5.576e-04 | -7.49 | positive regulation of chemotaxis | biological process | GO:0050921 | 141 | 4 | 18204 | 49 |
CSF1R,CD74,RAC2,NCKAP1L |
5.601e-04 | -7.49 | cell surface receptor signaling pathway | biological process | GO:0007166 | 1992 | 14 | 18204 | 49 |
CSF1R,CD74,MARCO,ITGB2,PLEK,NCKAP1L,GAB1,MYO9B,ITGAX,FYB1,P2RY6,SH2B3,PLXND1,HCK |
5.644e-04 | -7.48 | ATP1B1 (ATPase Na+/K+ transporting subunit beta 1) | protein interactions | 481 | 148 | 4 | 19454 | 50 |
RAC2,P2RY6,UNC93B1,GCH1 |
5.960e-04 | -7.43 | DGKE (diacylglycerol kinase epsilon) | protein interactions | 8526 | 64 | 3 | 19454 | 50 |
CD74,P2RY6,UNC93B1 |
5.978e-04 | -7.42 | Innate Immune System | REACTOME pathways | R-HSA-168249 | 1285 | 13 | 10285 | 39 |
MYO9B,NCF1,ITGB2,QSOX1,ELMO1,CMTM6,ITGAX,NCKAP1L,CD68,UNC93B1,CTSB,GAB1,HCK |
6.118e-04 | -7.40 | actin cytoskeleton organization | biological process | GO:0030036 | 547 | 7 | 18204 | 49 |
MYO1F,GAS7,PLEK,NCKAP1L,RAC2,ELMO1,PREX1 |
6.194e-04 | -7.39 | biological process involved in interspecies interaction between organisms | biological process | GO:0044419 | 1540 | 12 | 18204 | 49 |
HCK,CTSB,GCH1,ITGAX,CD68,UNC93B1,TNFAIP8L2,NCF1,CD74,MARCO,CSF1R,TFEB |
6.220e-04 | -7.38 | cytoplasm | cellular component | GO:0005737 | 12081 | 41 | 19108 | 48 |
NDUFS2,UNC93B1,GAS7,ABR,ELMO1,MYO1F,RAC2,ARHGAP15,ZFP36L1,CD74,ITGB2,FYB1,MFNG,GAB1,SH2B3,RAPGEF6,WDFY3,PREX1,CTSB,NOL4L,NCF1,MYO9B,LPP,GCH1,CD68,ZNRF2,PLEK,ITGAX,RBM47,DAPP1,NCKAP1L,HCK,GULP1,SMPD4,CMTM6,QSOX1,RGS19,ITM2B,TFEB,TNFAIP8L2,MARCO |
6.293e-04 | -7.37 | SH3 | smart domains | SM00326 | 202 | 5 | 9717 | 34 |
NCF1,MYO1F,HCK,FYB1,GAS7 |
6.460e-04 | -7.34 | cell activation | biological process | GO:0001775 | 725 | 8 | 18204 | 49 |
ITGB2,TNFAIP8L2,PLEK,ZFP36L1,ENTPD1,MFNG,CD74,PREX1 |
6.601e-04 | -7.32 | regulation of response to external stimulus | biological process | GO:0032101 | 1116 | 10 | 18204 | 49 |
TNFAIP8L2,UNC93B1,NCKAP1L,SH2B3,CSF1R,CD74,NCF1,RAC2,RBM47,HCK |
6.860e-04 | -7.28 | positive regulation of leukocyte migration | biological process | GO:0002687 | 149 | 4 | 18204 | 49 |
NCKAP1L,CD74,CSF1R,RAC2 |
6.883e-04 | -7.28 | regulation of cell motility | biological process | GO:2000145 | 1122 | 10 | 18204 | 49 |
PLXND1,NCKAP1L,P2RY6,CSF1R,CD74,RAC2,SPOCK3,ITGAX,PREX1,GAB1 |
6.971e-04 | -7.27 | HMOX2 (heme oxygenase 2) | protein interactions | 3163 | 276 | 5 | 19454 | 50 |
CD74,P2RY6,NDUFS2,UNC93B1,RAC2 |
7.044e-04 | -7.26 | PPP6R1 (protein phosphatase 6 regulatory subunit 1) | protein interactions | 22870 | 157 | 4 | 19454 | 50 |
UNC93B1,P2RY6,ZNRF2,CD74 |
7.154e-04 | -7.24 | RhoGAP | pfam domains | PF00620 | 65 | 3 | 17795 | 48 |
ARHGAP15,ABR,MYO9B |
7.188e-04 | -7.24 | RhoGAP_dom | interpro domains | IPR000198 | 65 | 3 | 18521 | 50 |
ARHGAP15,MYO9B,ABR |
7.288e-04 | -7.22 | regulation of inositol phosphate biosynthetic process | biological process | GO:0010919 | 15 | 2 | 18204 | 49 |
P2RY6,PLEK |
7.331e-04 | -7.22 | positive regulation of response to external stimulus | biological process | GO:0032103 | 564 | 7 | 18204 | 49 |
RBM47,HCK,CSF1R,CD74,RAC2,NCKAP1L,UNC93B1 |
7.392e-04 | -7.21 | regulation of actin polymerization or depolymerization | biological process | GO:0008064 | 152 | 4 | 18204 | 49 |
PLEK,NCKAP1L,PREX1,HCK |
7.444e-04 | -7.20 | neutrophil migration | biological process | GO:1990266 | 66 | 3 | 18204 | 49 |
ITGB2,NCKAP1L,PREX1 |
7.585e-04 | -7.18 | tertiary granule | cellular component | GO:0070820 | 164 | 4 | 19108 | 48 |
QSOX1,ITGAX,ITGB2,NCKAP1L |
7.595e-04 | -7.18 | GTPase activator activity | molecular function | GO:0005096 | 273 | 5 | 18094 | 48 |
ABR,ARHGAP15,PREX1,MYO9B,NCKAP1L |
7.747e-04 | -7.16 | INPP5D (inositol polyphosphate-5-phosphatase D) | protein interactions | 3635 | 70 | 3 | 19454 | 50 |
HCK,CSF1R,GAB1 |
7.952e-04 | -7.14 | regulation of actin filament length | biological process | GO:0030832 | 155 | 4 | 18204 | 49 |
PREX1,HCK,NCKAP1L,PLEK |
8.111e-04 | -7.12 | cell adhesion | biological process | GO:0007155 | 942 | 9 | 18204 | 49 |
ITGAX,LPP,NCAM2,HCK,PLEK,ITGB2,RAC2,ZFP36L1,ENTPD1 |
8.131e-04 | -7.11 | cytoplasmic vesicle membrane | cellular component | GO:0030659 | 1230 | 10 | 19108 | 48 |
CD68,NCKAP1L,ITGB2,CD74,RAC2,MARCO,CMTM6,ITM2B,ITGAX,ZNRF2 |
8.188e-04 | -7.11 | response to other organism | biological process | GO:0051707 | 1363 | 11 | 18204 | 49 |
TFEB,CSF1R,GCH1,NCF1,CD74,MARCO,CD68,TNFAIP8L2,UNC93B1,HCK,ITGAX |
8.224e-04 | -7.10 | Rap1 signaling pathway | KEGG pathways | ko04015 | 210 | 5 | 7161 | 26 |
RAC2,ITGB2,CSF1R,RAPGEF6,FYB1 |
8.224e-04 | -7.10 | Rap1 signaling pathway | KEGG pathways | hsa04015 | 210 | 5 | 7161 | 26 |
ITGB2,CSF1R,RAC2,RAPGEF6,FYB1 |
8.339e-04 | -7.09 | response to external biotic stimulus | biological process | GO:0043207 | 1366 | 11 | 18204 | 49 |
GCH1,HCK,CSF1R,TFEB,NCF1,MARCO,CD74,CD68,TNFAIP8L2,UNC93B1,ITGAX |
8.673e-04 | -7.05 | STT3A (STT3 oligosaccharyltransferase complex catalytic subunit A) | protein interactions | 3703 | 166 | 4 | 19454 | 50 |
RAC2,P2RY6,UNC93B1,TFEB |
8.822e-04 | -7.03 | regulation of GTPase activity | biological process | GO:0043087 | 278 | 5 | 18204 | 49 |
PREX1,ARHGAP15,RAPGEF6,PLXND1,ABR |
8.822e-04 | -7.03 | actin filament organization | biological process | GO:0007015 | 278 | 5 | 18204 | 49 |
RAC2,PREX1,MYO1F,GAS7,ELMO1 |
9.145e-04 | -7.00 | regulation of locomotion | biological process | GO:0040012 | 1164 | 10 | 18204 | 49 |
SPOCK3,ITGAX,GAB1,PREX1,P2RY6,PLXND1,NCKAP1L,RAC2,CSF1R,CD74 |
9.215e-04 | -6.99 | NADPH oxidase complex | cellular component | GO:0043020 | 18 | 2 | 19108 | 48 |
RAC2,NCF1 |
9.264e-04 | -6.98 | vesicle membrane | cellular component | GO:0012506 | 1251 | 10 | 19108 | 48 |
NCKAP1L,ITGB2,CD74,CD68,ZNRF2,RAC2,MARCO,CMTM6,ITM2B,ITGAX |
9.407e-04 | -6.97 | regulation of respiratory burst | biological process | GO:0060263 | 17 | 2 | 18204 | 49 |
RAC2,NCF1 |
9.442e-04 | -6.97 | Thyroglobulin_1 | pfam domains | PF00086 | 17 | 2 | 17795 | 48 |
CD74,SPOCK3 |
9.466e-04 | -6.96 | Thyroglobulin_1 | interpro domains | IPR000716 | 17 | 2 | 18521 | 50 |
CD74,SPOCK3 |
9.466e-04 | -6.96 | Thyroglobulin_1_sf | interpro domains | IPR036857 | 17 | 2 | 18521 | 50 |
CD74,SPOCK3 |
9.690e-04 | -6.94 | Signaling by Rho GTPases | REACTOME pathways | R-HSA-194315 | 426 | 7 | 10285 | 39 |
ARHGAP15,PREX1,RAC2,NCKAP1L,NCF1,ABR,MYO9B |
9.762e-04 | -6.93 | response to chemical | biological process | GO:0042221 | 3743 | 20 | 18204 | 49 |
GAB1,NDUFS2,PREX1,SMPD4,RAC2,NCF1,CD74,CSF1R,CD68,ITGB2,NCKAP1L,HCK,CTSB,ZFP36L1,CPN1,RGS19,GCH1,SLCO2B1,P2RY6,SH2B3 |
9.812e-04 | -6.93 | positive regulation of leukocyte proliferation | biological process | GO:0070665 | 164 | 4 | 18204 | 49 |
CSF1R,CD74,RAC2,NCKAP1L |
9.825e-04 | -6.93 | signaling | biological process | GO:0023052 | 4968 | 24 | 18204 | 49 |
PREX1,GAB1,ARHGAP15,CSF1R,MARCO,CD74,DAPP1,RAC2,NCKAP1L,ITGB2,HCK,RGS19,FYB1,P2RY6,ELMO1,ABR,ITGAX,RAPGEF6,MYO9B,UNC93B1,PLEK,ZFP36L1,PLXND1,SH2B3 |
1.050e-03 | -6.86 | Rho GTPase activation protein | gene3d domains | 1.10.555.10 | 66 | 3 | 14470 | 44 |
MYO9B,ABR,ARHGAP15 |
1.064e-03 | -6.85 | RHO GTPases Activate NADPH Oxidases | REACTOME pathways | R-HSA-5668599 | 13 | 2 | 10285 | 39 |
RAC2,NCF1 |
1.071e-03 | -6.84 | response to biotic stimulus | biological process | GO:0009607 | 1408 | 11 | 18204 | 49 |
TNFAIP8L2,UNC93B1,CD68,GCH1,CSF1R,TFEB,MARCO,CD74,NCF1,ITGAX,HCK |
1.091e-03 | -6.82 | plasma membrane region | cellular component | GO:0098590 | 1278 | 10 | 19108 | 48 |
PLEK,CTSB,ZNRF2,P2RY6,PLXND1,HCK,ENTPD1,SLCO2B1,ITGB2,RAPGEF6 |
1.097e-03 | -6.82 | positive regulation of molecular function | biological process | GO:0044093 | 1192 | 10 | 18204 | 49 |
PREX1,ABR,RAPGEF6,CSF1R,GCH1,NCF1,CD74,PLEK,ITGB2,P2RY6 |
1.118e-03 | -6.80 | cell communication | biological process | GO:0007154 | 5010 | 24 | 18204 | 49 |
SH2B3,PLXND1,ZFP36L1,UNC93B1,PLEK,RAPGEF6,MYO9B,ELMO1,ITGAX,ABR,P2RY6,RGS19,FYB1,HCK,ITGB2,NCKAP1L,DAPP1,RAC2,ARHGAP15,CSF1R,MARCO,CD74,GAB1,PREX1 |
1.162e-03 | -6.76 | secretory granule membrane | cellular component | GO:0030667 | 317 | 5 | 19108 | 48 |
ITGB2,NCKAP1L,CD68,CMTM6,ITGAX |
1.168e-03 | -6.75 | SH3 | prosite domains | PS50002 | 222 | 5 | 12186 | 44 |
GAS7,MYO1F,HCK,NCF1,FYB1 |
1.184e-03 | -6.74 | DMWD (DM1 locus, WD repeat containing) | protein interactions | 1762 | 81 | 3 | 19454 | 50 |
CTSB,NDUFS2,WDFY3 |
1.187e-03 | -6.74 | ficolin-1-rich granule | cellular component | GO:0101002 | 185 | 4 | 19108 | 48 |
ITGAX,NCKAP1L,ITGB2,CTSB |
1.194e-03 | -6.73 | Thyroglobulin type-1 | gene3d domains | 4.10.800.10 | 17 | 2 | 14470 | 44 |
SPOCK3,CD74 |
1.194e-03 | -6.73 | RARRES1 (retinoic acid receptor responder 1) | protein interactions | 5918 | 20 | 2 | 19454 | 50 |
RAPGEF6,DAPP1 |
1.194e-03 | -6.73 | CREB3L2 (cAMP responsive element binding protein 3 like 2) | protein interactions | 64764 | 20 | 2 | 19454 | 50 |
GULP1,GAS7 |
1.195e-03 | -6.73 | SCAMP3 (secretory carrier membrane protein 3) | protein interactions | 10067 | 181 | 4 | 19454 | 50 |
RBM47,RAC2,UNC93B1,P2RY6 |
1.239e-03 | -6.69 | Trafficking and processing of endosomal TLR | REACTOME pathways | R-HSA-1679131 | 14 | 2 | 10285 | 39 |
CTSB,UNC93B1 |
1.255e-03 | -6.68 | myeloid cell development | biological process | GO:0061515 | 79 | 3 | 18204 | 49 |
SH2B3,NCKAP1L,RAC2 |
1.270e-03 | -6.67 | SAAL1 (serum amyloid A like 1) | protein interactions | 113174 | 184 | 4 | 19454 | 50 |
CD68,P2RY6,UNC93B1,QSOX1 |
1.293e-03 | -6.65 | regulation of cell adhesion | biological process | GO:0030155 | 807 | 8 | 18204 | 49 |
PREX1,RAC2,CD74,ITGB2,SH2B3,TNFAIP8L2,PLXND1,NCKAP1L |
1.307e-03 | -6.64 | regulation of monocyte differentiation | biological process | GO:0045655 | 20 | 2 | 18204 | 49 |
ZFP36L1,CD74 |
1.307e-03 | -6.64 | regulation of antigen processing and presentation | biological process | GO:0002577 | 20 | 2 | 18204 | 49 |
CD68,CD74 |
1.358e-03 | -6.60 | vacuolar membrane | cellular component | GO:0005774 | 490 | 6 | 19108 | 48 |
CMTM6,TFEB,ZNRF2,CD68,WDFY3,CD74 |
1.396e-03 | -6.57 | regulation of cell activation | biological process | GO:0050865 | 630 | 7 | 18204 | 49 |
CD74,RAC2,ZFP36L1,PLEK,NCKAP1L,TNFAIP8L2,SH2B3 |
1.398e-03 | -6.57 | granulocyte chemotaxis | biological process | GO:0071621 | 82 | 3 | 18204 | 49 |
PREX1,ITGB2,NCKAP1L |
1.401e-03 | -6.57 | GTP-dependent protein binding | molecular function | GO:0030742 | 21 | 2 | 18094 | 48 |
RAPGEF6,GCH1 |
1.407e-03 | -6.57 | WAS (WASP actin nucleation promoting factor) | protein interactions | 7454 | 86 | 3 | 19454 | 50 |
GAS7,FYB1,HCK |
1.410e-03 | -6.56 | RhoGAP | smart domains | SM00324 | 64 | 3 | 9717 | 34 |
ABR,MYO9B,ARHGAP15 |
1.448e-03 | -6.54 | DEP | pfam domains | PF00610 | 21 | 2 | 17795 | 48 |
PLEK,PREX1 |
1.452e-03 | -6.54 | GDS_CDC24_CS | interpro domains | IPR001331 | 21 | 2 | 18521 | 50 |
ABR,PREX1 |
1.455e-03 | -6.53 | PLCG2 (phospholipase C gamma 2) | protein interactions | 5336 | 87 | 3 | 19454 | 50 |
HCK,DAPP1,GAB1 |
1.484e-03 | -6.51 | SH2DOMAIN | prints domains | PR00401 | 72 | 3 | 5227 | 17 |
SH2B3,HCK,DAPP1 |
1.508e-03 | -6.50 | basal_(triple-negative)_carcinoma | COSMIC cancer mutations | basal_(triple-negative)_carcinoma | 2981 | 17 | 16828 | 46 |
LPP,NDUFS2,RAC2,ZNRF2,PLXND1,GAS7,MFNG,WDFY3,CSF1R,GAB1,TFEB,ELMO1,NCAM2,RAPGEF6,P2RY6,SPOCK3,RBM47 |
1.508e-03 | -6.50 | breast-carcinoma-basal_(triple-negative)_carcinoma | COSMIC cancer mutations | breast-carcinoma-basal_(triple-negative)_carcinoma | 2981 | 17 | 16828 | 46 |
ZNRF2,RAC2,GAS7,PLXND1,LPP,NDUFS2,SPOCK3,RAPGEF6,P2RY6,RBM47,MFNG,ELMO1,TFEB,GAB1,NCAM2,WDFY3,CSF1R |
1.528e-03 | -6.48 | positive regulation of immune response | biological process | GO:0050778 | 640 | 7 | 18204 | 49 |
NCKAP1L,UNC93B1,ITGB2,CD74,FYB1,RBM47,HCK |
1.543e-03 | -6.47 | CNPY3 (canopy FGF signaling regulator 3) | protein interactions | 10695 | 194 | 4 | 19454 | 50 |
CD74,HCK,CTSB,RGS19 |
1.558e-03 | -6.46 | Regulation of actin dynamics for phagocytic cup formation | REACTOME pathways | R-HSA-2029482 | 61 | 3 | 10285 | 39 |
ELMO1,NCKAP1L,MYO9B |
1.564e-03 | -6.46 | TY | smart domains | SM00211 | 17 | 2 | 9717 | 34 |
SPOCK3,CD74 |
1.594e-03 | -6.44 | DEP_dom | interpro domains | IPR000591 | 22 | 2 | 18521 | 50 |
PREX1,PLEK |
1.604e-03 | -6.44 | IPO13 (importin 13) | protein interactions | 9670 | 90 | 3 | 19454 | 50 |
CD74,UNC93B1,P2RY6 |
1.640e-03 | -6.41 | lymph_node | COSMIC cancer mutations | lymph_node | 1703 | 12 | 16828 | 46 |
NDUFS2,HCK,CPN1,CD74,NCAM2,ELMO1,ZFP36L1,CSF1R,WDFY3,DAPP1,GULP1,SPOCK3 |
1.641e-03 | -6.41 | RHOGAP | prosite domains | PS50238 | 65 | 3 | 12186 | 44 |
MYO9B,ARHGAP15,ABR |
1.655e-03 | -6.40 | SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1) | protein interactions | 6654 | 91 | 3 | 19454 | 50 |
GAB1,HCK,CSF1R |
1.674e-03 | -6.39 | THYROGLOBULIN_1_1 | prosite domains | PS00484 | 17 | 2 | 12186 | 44 |
SPOCK3,CD74 |
1.674e-03 | -6.39 | THYROGLOBULIN_1_2 | prosite domains | PS51162 | 17 | 2 | 12186 | 44 |
CD74,SPOCK3 |
1.723e-03 | -6.36 | ARHGAP42 (Rho GTPase activating protein 42) | protein interactions | 143872 | 24 | 2 | 19454 | 50 |
RAC2,GCH1 |
1.723e-03 | -6.36 | GSTCD (glutathione S-transferase C-terminal domain containing) | protein interactions | 79807 | 24 | 2 | 19454 | 50 |
CSF1R,DAPP1 |
1.732e-03 | -6.36 | amyloid-beta clearance | biological process | GO:0097242 | 23 | 2 | 18204 | 49 |
MARCO,ITGB2 |
1.752e-03 | -6.35 | response to organic substance | biological process | GO:0010033 | 2498 | 15 | 18204 | 49 |
SH2B3,P2RY6,ZFP36L1,RGS19,GCH1,CPN1,HCK,CTSB,ITGB2,CD68,SMPD4,CSF1R,NCF1,CD74,GAB1 |
1.758e-03 | -6.34 | cell development | biological process | GO:0048468 | 2236 | 14 | 18204 | 49 |
NCAM2,RBM47,SH2B3,GAS7,PLXND1,ZFP36L1,RAPGEF6,PREX1,NCKAP1L,PLEK,RAC2,MFNG,CSF1R,CD74 |
1.762e-03 | -6.34 | MAIP1 (matrix AAA peptidase interacting protein 1) | protein interactions | 79568 | 93 | 3 | 19454 | 50 |
UNC93B1,NDUFS2,P2RY6 |
1.762e-03 | -6.34 | C19orf25 (chromosome 19 open reading frame 25) | protein interactions | 148223 | 93 | 3 | 19454 | 50 |
UNC93B1,P2RY6,MFNG |
1.838e-03 | -6.30 | intracellular signal transduction | biological process | GO:0035556 | 1505 | 11 | 18204 | 49 |
HCK,ZFP36L1,RGS19,SH2B3,PREX1,RAPGEF6,MYO9B,ABR,ELMO1,RAC2,PLEK |
1.866e-03 | -6.28 | regulation of cell migration | biological process | GO:0030334 | 1061 | 9 | 18204 | 49 |
P2RY6,NCKAP1L,PLXND1,RAC2,CD74,CSF1R,ITGAX,GAB1,PREX1 |
1.888e-03 | -6.27 | ARCN1 (archain 1) | protein interactions | 372 | 205 | 4 | 19454 | 50 |
P2RY6,UNC93B1,NCF1,CD74 |
1.911e-03 | -6.26 | cell differentiation | biological process | GO:0030154 | 3645 | 19 | 18204 | 49 |
PLXND1,LRMDA,SH2B3,GAS7,ZFP36L1,CTSB,RBM47,HCK,NCAM2,NCKAP1L,PLEK,ITGB2,CSF1R,CD74,MFNG,RAC2,RAPGEF6,PREX1,NDUFS2 |
1.913e-03 | -6.26 | human chr3q27.3-q28 | chromosome location | human chr3q27.3-q28 | 1 | 1 | 26134 | 50 |
LPP |
1.913e-03 | -6.26 | human chr7p14.2-p14.1 | chromosome location | human chr7p14.2-p14.1 | 1 | 1 | 26134 | 50 |
ELMO1 |
1.913e-03 | -6.26 | human chr2q22.2-q22.3 | chromosome location | human chr2q22.2-q22.3 | 1 | 1 | 26134 | 50 |
ARHGAP15 |
1.913e-03 | -6.26 | human chr12q13.13-q13.2 | chromosome location | human chr12q13.13-q13.2 | 1 | 1 | 26134 | 50 |
NCKAP1L |
1.913e-03 | -6.26 | human chr2q32.1-q32.2 | chromosome location | human chr2q32.1-q32.2 | 1 | 1 | 26134 | 50 |
GULP1 |
1.913e-03 | -6.26 | human chr10q22.2-q22.3 | chromosome location | human chr10q22.2-q22.3 | 1 | 1 | 26134 | 50 |
LRMDA |
1.925e-03 | -6.25 | enzyme regulator activity | molecular function | GO:0030234 | 1305 | 10 | 18094 | 48 |
ARHGAP15,RAC2,NCKAP1L,SPOCK3,PREX1,ABR,RAPGEF6,MYO9B,ELMO1,NCF1 |
1.929e-03 | -6.25 | LMAN2 (lectin, mannose binding 2) | protein interactions | 10960 | 96 | 3 | 19454 | 50 |
UNC93B1,NDUFS2,P2RY6 |
1.931e-03 | -6.25 | cellular developmental process | biological process | GO:0048869 | 3648 | 19 | 18204 | 49 |
ZFP36L1,GAS7,SH2B3,LRMDA,PLXND1,NCAM2,HCK,RBM47,CTSB,RAC2,MFNG,CD74,CSF1R,ITGB2,PLEK,NCKAP1L,NDUFS2,PREX1,RAPGEF6 |
1.956e-03 | -6.24 | OPALIN (oligodendrocytic myelin paranodal and inner loop protein) | protein interactions | 93377 | 207 | 4 | 19454 | 50 |
UNC93B1,CMTM6,SMPD4,WDFY3 |
1.999e-03 | -6.22 | positive regulation of ERK1 and ERK2 cascade | biological process | GO:0070374 | 199 | 4 | 18204 | 49 |
CSF1R,CD74,MARCO,P2RY6 |
2.000e-03 | -6.21 | anatomical structure development | biological process | GO:0048856 | 5207 | 24 | 18204 | 49 |
ITM2B,ITGB2,UNC93B1,PLEK,NCKAP1L,MFNG,RAC2,TFEB,CSF1R,CD74,RAPGEF6,MYO9B,ITGAX,NDUFS2,GAB1,PREX1,SH2B3,GAS7,PLXND1,ZFP36L1,HCK,NCAM2,CTSB,RBM47 |
2.059e-03 | -6.19 | Integrin_dom_sf | interpro domains | IPR032695 | 25 | 2 | 18521 | 50 |
ITGAX,ITGB2 |
2.061e-03 | -6.18 | ABI1 (abl interactor 1) | protein interactions | 10006 | 210 | 4 | 19454 | 50 |
GAS7,RAC2,NCKAP1L,NCF1 |
2.101e-03 | -6.17 | Neutrophil degranulation | REACTOME pathways | R-HSA-6798695 | 487 | 7 | 10285 | 39 |
CMTM6,CTSB,ITGB2,CD68,QSOX1,ITGAX,NCKAP1L |
2.197e-03 | -6.12 | granulocyte migration | biological process | GO:0097530 | 96 | 3 | 18204 | 49 |
ITGB2,NCKAP1L,PREX1 |
2.201e-03 | -6.12 | regulation of actin cytoskeleton organization | biological process | GO:0032956 | 342 | 5 | 18204 | 49 |
CSF1R,PREX1,HCK,PLEK,NCKAP1L |
2.214e-03 | -6.11 | ruffle organization | biological process | GO:0031529 | 26 | 2 | 18204 | 49 |
PLEK,CSF1R |
2.217e-03 | -6.11 | YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta) | protein interactions | 7534 | 1138 | 9 | 19454 | 50 |
SH2B3,RAPGEF6,CD74,GAB1,ZFP36L1,ITGB2,GCH1,NCAM2,TFEB |
2.283e-03 | -6.08 | HACD3 (3-hydroxyacyl-CoA dehydratase 3) | protein interactions | 51495 | 216 | 4 | 19454 | 50 |
ARHGAP15,RAC2,UNC93B1,P2RY6 |
2.286e-03 | -6.08 | import into cell | biological process | GO:0098657 | 687 | 7 | 18204 | 49 |
HCK,ELMO1,MARCO,GULP1,MYO1F,ITGB2,P2RY6 |
2.286e-03 | -6.08 | chemotaxis | biological process | GO:0006935 | 345 | 5 | 18204 | 49 |
PREX1,GAB1,RAC2,NCKAP1L,ITGB2 |
2.294e-03 | -6.08 | FASLG (Fas ligand) | protein interactions | 356 | 102 | 3 | 19454 | 50 |
NCF1,HCK,FYB1 |
2.344e-03 | -6.06 | taxis | biological process | GO:0042330 | 347 | 5 | 18204 | 49 |
GAB1,RAC2,PREX1,ITGB2,NCKAP1L |
2.379e-03 | -6.04 | Regulation of RAC1 activity | Pathway Interaction DB | rac1_reg_pathway | 39 | 3 | 2226 | 16 |
ELMO1,PREX1,ABR |
2.387e-03 | -6.04 | positive regulation of protein tyrosine kinase activity | biological process | GO:0061098 | 27 | 2 | 18204 | 49 |
NCF1,CSF1R |
2.388e-03 | -6.04 | regulation of chemotaxis | biological process | GO:0050920 | 209 | 4 | 18204 | 49 |
CD74,CSF1R,RAC2,NCKAP1L |
2.394e-03 | -6.03 | DEP | smart domains | SM00049 | 21 | 2 | 9717 | 34 |
PREX1,PLEK |
2.419e-03 | -6.02 | enzyme binding | molecular function | GO:0019899 | 2086 | 13 | 18094 | 48 |
NDUFS2,SH2B3,RAPGEF6,CSF1R,RBM47,PREX1,ITGAX,ITGB2,CD74,MYO9B,GCH1,PLEK,TFEB |
2.467e-03 | -6.00 | hematopoietic progenitor cell differentiation | biological process | GO:0002244 | 100 | 3 | 18204 | 49 |
PLEK,SH2B3,RBM47 |
2.479e-03 | -6.00 | SH2 | pfam domains | PF00017 | 100 | 3 | 17795 | 48 |
SH2B3,DAPP1,HCK |
2.479e-03 | -6.00 | positive regulation of phosphate metabolic process | biological process | GO:0045937 | 697 | 7 | 18204 | 49 |
NCKAP1L,PLEK,P2RY6,CSF1R,CD74,NCF1,MARCO |
2.479e-03 | -6.00 | positive regulation of phosphorus metabolic process | biological process | GO:0010562 | 697 | 7 | 18204 | 49 |
P2RY6,NCKAP1L,PLEK,CSF1R,NCF1,MARCO,CD74 |
2.512e-03 | -5.99 | NOS2-CD74 complex | cellular component | GO:0035693 | 1 | 1 | 19108 | 48 |
CD74 |
2.514e-03 | -5.99 | NCF2 (neutrophil cytosolic factor 2) | protein interactions | 4688 | 29 | 2 | 19454 | 50 |
RAC2,NCF1 |
2.559e-03 | -5.97 | SGCA (sarcoglycan alpha) | protein interactions | 6442 | 106 | 3 | 19454 | 50 |
ITM2B,SMPD4,CMTM6 |
2.562e-03 | -5.97 | DEP | prosite domains | PS50186 | 21 | 2 | 12186 | 44 |
PREX1,PLEK |
2.562e-03 | -5.97 | DH_1 | prosite domains | PS00741 | 21 | 2 | 12186 | 44 |
PREX1,ABR |
2.570e-03 | -5.96 | Alox12 (arachidonate 12-lipoxygenase, 12S type) | protein interactions | 287454 | 1 | 1 | 19454 | 50 |
NCF1 |
2.570e-03 | -5.96 | SCGB3A2 (secretoglobin family 3A member 2) | protein interactions | 117156 | 1 | 1 | 19454 | 50 |
MARCO |
2.653e-03 | -5.93 | ITPase activity | molecular function | GO:0103023 | 1 | 1 | 18094 | 48 |
ENTPD1 |
2.653e-03 | -5.93 | GTP cyclohydrolase I activity | molecular function | GO:0003934 | 1 | 1 | 18094 | 48 |
GCH1 |
2.653e-03 | -5.93 | GTP cyclohydrolase activity | molecular function | GO:0003933 | 1 | 1 | 18094 | 48 |
GCH1 |
2.653e-03 | -5.93 | sphingomyelin phosphodiesterase D activity | molecular function | GO:0050290 | 1 | 1 | 18094 | 48 |
SMPD4 |
2.653e-03 | -5.93 | MHC class II protein binding, via antigen binding groove | molecular function | GO:0042658 | 1 | 1 | 18094 | 48 |
CD74 |
2.683e-03 | -5.92 | erythrocyte differentiation | biological process | GO:0030218 | 103 | 3 | 18204 | 49 |
SH2B3,NCKAP1L,RAC2 |
2.688e-03 | -5.92 | PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2) | protein interactions | 5296 | 226 | 4 | 19454 | 50 |
CSF1R,RAC2,HCK,GAB1 |
2.690e-03 | -5.92 | cell chemotaxis | biological process | GO:0060326 | 216 | 4 | 18204 | 49 |
PREX1,GAB1,NCKAP1L,ITGB2 |
2.692e-03 | -5.92 | phospholipase C-inhibiting G protein-coupled receptor signaling pathway | biological process | GO:0030845 | 1 | 1 | 18204 | 49 |
PLEK |
2.692e-03 | -5.92 | response to pyrimidine ribonucleotide | biological process | GO:1905834 | 1 | 1 | 18204 | 49 |
P2RY6 |
2.692e-03 | -5.92 | cellular response to pyrimidine ribonucleotide | biological process | GO:1905835 | 1 | 1 | 18204 | 49 |
P2RY6 |
2.692e-03 | -5.92 | positive regulation of endothelial tube morphogenesis | biological process | GO:1905956 | 1 | 1 | 18204 | 49 |
ITGAX |
2.692e-03 | -5.92 | regulation of cell diameter | biological process | GO:0060305 | 1 | 1 | 18204 | 49 |
PLEK |
2.692e-03 | -5.92 | protein secretion by platelet | biological process | GO:0070560 | 1 | 1 | 18204 | 49 |
PLEK |
2.692e-03 | -5.92 | macrophage migration inhibitory factor signaling pathway | biological process | GO:0035691 | 1 | 1 | 18204 | 49 |
CD74 |
2.692e-03 | -5.92 | ARF protein signal transduction | biological process | GO:0032011 | 1 | 1 | 18204 | 49 |
MYO9B |
2.692e-03 | -5.92 | regulation of inositol-polyphosphate 5-phosphatase activity | biological process | GO:0010924 | 1 | 1 | 18204 | 49 |
PLEK |
2.692e-03 | -5.92 | positive regulation of inositol-polyphosphate 5-phosphatase activity | biological process | GO:0010925 | 1 | 1 | 18204 | 49 |
PLEK |
2.697e-03 | -5.92 | p47_phox_C | pfam domains | PF08944 | 1 | 1 | 17795 | 48 |
NCF1 |
2.697e-03 | -5.92 | MHC2-interact | pfam domains | PF09307 | 1 | 1 | 17795 | 48 |
CD74 |
2.697e-03 | -5.92 | Propeptide_C1 | pfam domains | PF08127 | 1 | 1 | 17795 | 48 |
CTSB |
2.697e-03 | -5.92 | NCF1_PBR_AIR | pfam domains | PF16621 | 1 | 1 | 17795 | 48 |
NCF1 |
2.697e-03 | -5.92 | MHCassoc_trimer | pfam domains | PF08831 | 1 | 1 | 17795 | 48 |
CD74 |
2.697e-03 | -5.92 | mit_SMPDase | pfam domains | PF14724 | 1 | 1 | 17795 | 48 |
SMPD4 |
2.697e-03 | -5.92 | WW_FCH_linker | pfam domains | PF16623 | 1 | 1 | 17795 | 48 |
GAS7 |
2.697e-03 | -5.92 | GTP_cyclohydroI | pfam domains | PF01227 | 1 | 1 | 17795 | 48 |
GCH1 |
2.697e-03 | -5.92 | Complex1_49kDa | pfam domains | PF00346 | 1 | 1 | 17795 | 48 |
NDUFS2 |
2.698e-03 | -5.92 | SLC39A14 (solute carrier family 39 member 14) | protein interactions | 23516 | 108 | 3 | 19454 | 50 |
RAC2,UNC93B1,P2RY6 |
2.700e-03 | -5.91 | NCF1_PBR/AIR | interpro domains | IPR032136 | 1 | 1 | 18521 | 50 |
NCF1 |
2.700e-03 | -5.91 | NCF1_C | interpro domains | IPR015039 | 1 | 1 | 18521 | 50 |
NCF1 |
2.700e-03 | -5.91 | Plexin-D1_Sema | interpro domains | IPR042719 | 1 | 1 | 18521 | 50 |
PLXND1 |
2.700e-03 | -5.91 | Integrin_b-2_sf | interpro domains | IPR015439 | 1 | 1 | 18521 | 50 |
ITGB2 |
2.700e-03 | -5.91 | NCF1_SH3_1 | interpro domains | IPR035756 | 1 | 1 | 18521 | 50 |
NCF1 |
2.700e-03 | -5.91 | CD74_antigen | interpro domains | IPR043530 | 1 | 1 | 18521 | 50 |
CD74 |
2.700e-03 | -5.91 | GTP_CycHdrlase_I_dom | interpro domains | IPR020602 | 1 | 1 | 18521 | 50 |
GCH1 |
2.700e-03 | -5.91 | MHC_II-assoc_invar_chain | interpro domains | IPR022339 | 1 | 1 | 18521 | 50 |
CD74 |
2.700e-03 | -5.91 | RBM47_RRM3 | interpro domains | IPR034445 | 1 | 1 | 18521 | 50 |
RBM47 |
2.700e-03 | -5.91 | RBM47_RRM1 | interpro domains | IPR047044 | 1 | 1 | 18521 | 50 |
RBM47 |
2.700e-03 | -5.91 | GTP-CH-I_C/QueF | interpro domains | IPR043133 | 1 | 1 | 18521 | 50 |
GCH1 |
2.700e-03 | -5.91 | MHC_II-assoc_invariant_trimer | interpro domains | IPR011988 | 1 | 1 | 18521 | 50 |
CD74 |
2.700e-03 | -5.91 | NADH_UbQ_OxRdtase_49kDa_CS | interpro domains | IPR014029 | 1 | 1 | 18521 | 50 |
NDUFS2 |
2.700e-03 | -5.91 | GTP_CycHdrlase_I_CS | interpro domains | IPR018234 | 1 | 1 | 18521 | 50 |
GCH1 |
2.700e-03 | -5.91 | PX_p47phox | interpro domains | IPR034909 | 1 | 1 | 18521 | 50 |
NCF1 |
2.700e-03 | -5.91 | NDH1_su_D/H | interpro domains | IPR022885 | 1 | 1 | 18521 | 50 |
NDUFS2 |
2.700e-03 | -5.91 | PLEK_DEP | interpro domains | IPR037371 | 1 | 1 | 18521 | 50 |
PLEK |
2.700e-03 | -5.91 | M14_CPN | interpro domains | IPR033814 | 1 | 1 | 18521 | 50 |
CPN1 |
2.700e-03 | -5.91 | bHLHzip_TFEB | interpro domains | IPR024098 | 1 | 1 | 18521 | 50 |
TFEB |
2.700e-03 | -5.91 | Sphingomy_SMPD4 | interpro domains | IPR024129 | 1 | 1 | 18521 | 50 |
SMPD4 |
2.700e-03 | -5.91 | CSF-1_receptor | interpro domains | IPR030658 | 1 | 1 | 18521 | 50 |
CSF1R |
2.700e-03 | -5.91 | MHCII_invariant_trimer_sf | interpro domains | IPR036613 | 1 | 1 | 18521 | 50 |
CD74 |
2.700e-03 | -5.91 | MHC_II-assoc_invar/CLIP_MHC-bd | interpro domains | IPR015386 | 1 | 1 | 18521 | 50 |
CD74 |
2.700e-03 | -5.91 | GTP-CH-I_N | interpro domains | IPR043134 | 1 | 1 | 18521 | 50 |
GCH1 |
2.700e-03 | -5.91 | RhoGAP_myosin_IXB | interpro domains | IPR028557 | 1 | 1 | 18521 | 50 |
MYO9B |
2.700e-03 | -5.91 | DAPP1_SH2 | interpro domains | IPR035843 | 1 | 1 | 18521 | 50 |
DAPP1 |
2.700e-03 | -5.91 | LRMDA | interpro domains | IPR043313 | 1 | 1 | 18521 | 50 |
LRMDA |
2.700e-03 | -5.91 | SH2B3_SH2 | interpro domains | IPR035059 | 1 | 1 | 18521 | 50 |
SH2B3 |
2.700e-03 | -5.91 | NiFe-Hase_large | interpro domains | IPR029014 | 1 | 1 | 18521 | 50 |
NDUFS2 |
2.700e-03 | -5.91 | P2Y6_rcpt | interpro domains | IPR001973 | 1 | 1 | 18521 | 50 |
P2RY6 |
2.700e-03 | -5.91 | Propeptide_C1A | interpro domains | IPR012599 | 1 | 1 | 18521 | 50 |
CTSB |
2.700e-03 | -5.91 | NCF1_SH3_2 | interpro domains | IPR035757 | 1 | 1 | 18521 | 50 |
NCF1 |
2.700e-03 | -5.91 | UNC93B1 | interpro domains | IPR043268 | 1 | 1 | 18521 | 50 |
UNC93B1 |
2.700e-03 | -5.91 | RA_Myosin-IXb | interpro domains | IPR046989 | 1 | 1 | 18521 | 50 |
MYO9B |
2.700e-03 | -5.91 | NADH_Q_OxRdtase_suD | interpro domains | IPR001135 | 1 | 1 | 18521 | 50 |
NDUFS2 |
2.700e-03 | -5.91 | P47PHOX | interpro domains | IPR001655 | 1 | 1 | 18521 | 50 |
NCF1 |
2.700e-03 | -5.91 | RBM47_RRM2 | interpro domains | IPR034440 | 1 | 1 | 18521 | 50 |
RBM47 |
2.700e-03 | -5.91 | GTP_CycHdrlase_I | interpro domains | IPR001474 | 1 | 1 | 18521 | 50 |
GCH1 |
2.700e-03 | -5.91 | GAS7_F-BAR | interpro domains | IPR037957 | 1 | 1 | 18521 | 50 |
GAS7 |
2.700e-03 | -5.91 | ABR_PH | interpro domains | IPR037865 | 1 | 1 | 18521 | 50 |
ABR |
2.700e-03 | -5.91 | HCK_SH2 | interpro domains | IPR035851 | 1 | 1 | 18521 | 50 |
HCK |
2.700e-03 | -5.91 | FYB_hSH3 | interpro domains | IPR035540 | 1 | 1 | 18521 | 50 |
FYB1 |
2.743e-03 | -5.90 | integrin complex | cellular component | GO:0008305 | 31 | 2 | 19108 | 48 |
ITGAX,ITGB2 |
2.751e-03 | -5.90 | Class I PI3K signaling events | Pathway Interaction DB | pi3kcipathway | 41 | 3 | 2226 | 16 |
HCK,DAPP1,PREX1 |
2.775e-03 | -5.89 | TNPO3 (transportin 3) | protein interactions | 23534 | 228 | 4 | 19454 | 50 |
MFNG,GCH1,P2RY6,UNC93B1 |
2.795e-03 | -5.88 | regulation of intracellular signal transduction | biological process | GO:1902531 | 1832 | 12 | 18204 | 49 |
ARHGAP15,CSF1R,MARCO,CD74,NCF1,P2RY6,SH2B3,NCKAP1L,PLEK,PREX1,MYO9B,ABR |
2.804e-03 | -5.88 | ntegrin, alpha v. Chain A, domain 3 | gene3d domains | 2.60.40.1510 | 26 | 2 | 14470 | 44 |
ITGAX,ITGB2 |
2.834e-03 | -5.87 | positive regulation of myeloid cell differentiation | biological process | GO:0045639 | 105 | 3 | 18204 | 49 |
NCKAP1L,CD74,ZFP36L1 |
2.834e-03 | -5.87 | response to type II interferon | biological process | GO:0034341 | 105 | 3 | 18204 | 49 |
CD74,GCH1,HCK |
2.842e-03 | -5.86 | KIT (KIT proto-oncogene, receptor tyrosine kinase) | protein interactions | 3815 | 110 | 3 | 19454 | 50 |
CSF1R,HCK,SH2B3 |
2.874e-03 | -5.85 | regulation of peptidyl-tyrosine phosphorylation | biological process | GO:0050730 | 220 | 4 | 18204 | 49 |
ITGB2,NCF1,CD74,CSF1R |
2.882e-03 | -5.85 | mononuclear cell differentiation | biological process | GO:1903131 | 364 | 5 | 18204 | 49 |
CD74,CSF1R,PREX1,MFNG,ZFP36L1 |
2.925e-03 | -5.83 | SH3_1 | pfam domains | PF00018 | 106 | 3 | 17795 | 48 |
NCF1,HCK,MYO1F |
2.942e-03 | -5.83 | plasma membrane raft | cellular component | GO:0044853 | 114 | 3 | 19108 | 48 |
HCK,ENTPD1,ITGB2 |
2.942e-03 | -5.83 | regulation of superoxide metabolic process | biological process | GO:0090322 | 30 | 2 | 18204 | 49 |
GCH1,ITGB2 |
2.954e-03 | -5.82 | HLA-B (major histocompatibility complex, class I, B) | protein interactions | 3106 | 232 | 4 | 19454 | 50 |
RAC2,SMPD4,ITM2B,WDFY3 |
2.968e-03 | -5.82 | organelle membrane | cellular component | GO:0031090 | 3742 | 18 | 19108 | 48 |
NDUFS2,UNC93B1,CD68,GCH1,ZNRF2,ITGAX,RAC2,ITGB2,CD74,NCKAP1L,MFNG,WDFY3,SMPD4,CMTM6,QSOX1,ITM2B,TFEB,MARCO |
2.985e-03 | -5.81 | locomotion | biological process | GO:0040011 | 367 | 5 | 18204 | 49 |
PREX1,GAB1,RAC2,NCKAP1L,ITGB2 |
2.993e-03 | -5.81 | YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta) | protein interactions | 7529 | 965 | 8 | 19454 | 50 |
TFEB,NCAM2,P2RY6,ITGB2,GAB1,ZFP36L1,CD74,RAPGEF6 |
3.041e-03 | -5.80 | - | gene3d domains | 1.10.286.10 | 1 | 1 | 14470 | 44 |
GCH1 |
3.041e-03 | -5.80 | Cytochrome-c3 Hydrogenase, chain B | gene3d domains | 1.10.645.10 | 1 | 1 | 14470 | 44 |
NDUFS2 |
3.041e-03 | -5.80 | MHC class II-associated invariant chain, trimerisation domain | gene3d domains | 1.10.870.10 | 1 | 1 | 14470 | 44 |
CD74 |
3.041e-03 | -5.80 | - | gene3d domains | 6.20.50.10 | 1 | 1 | 14470 | 44 |
ITGB2 |
3.041e-03 | -5.80 | - | gene3d domains | 3.30.1130.10 | 1 | 1 | 14470 | 44 |
GCH1 |
3.057e-03 | -5.79 | RASA3 (RAS p21 protein activator 3) | protein interactions | 22821 | 32 | 2 | 19454 | 50 |
HCK,RAC2 |
3.095e-03 | -5.78 | guanyl-nucleotide exchange factor activity | molecular function | GO:0005085 | 228 | 4 | 18094 | 48 |
ABR,ELMO1,RAPGEF6,PREX1 |
3.140e-03 | -5.76 | antigen processing and presentation of exogenous peptide antigen via MHC class II | biological process | GO:0019886 | 31 | 2 | 18204 | 49 |
CD74,UNC93B1 |
3.144e-03 | -5.76 | ATP5MF (ATP synthase membrane subunit f) | protein interactions | 9551 | 114 | 3 | 19454 | 50 |
P2RY6,UNC93B1,LPP |
3.179e-03 | -5.75 | SH2 | interpro domains | IPR000980 | 109 | 3 | 18521 | 50 |
DAPP1,HCK,SH2B3 |
3.180e-03 | -5.75 | skin-scalp-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-scalp-carcinoma-squamous_cell_carcinoma | 1596 | 11 | 16828 | 46 |
RBM47,P2RY6,ITGAX,NCF1,CSF1R,ITGB2,MYO1F,NCAM2,ELMO1,PREX1,SLCO2B1 |
3.249e-03 | -5.73 | HS6ST1 (heparan sulfate 6-O-sulfotransferase 1) | protein interactions | 9394 | 33 | 2 | 19454 | 50 |
ITM2B,MFNG |
3.249e-03 | -5.73 | ELMO3 (engulfment and cell motility 3) | protein interactions | 79767 | 33 | 2 | 19454 | 50 |
ELMO1,RAC2 |
3.252e-03 | -5.73 | P2Y6PRNOCPTR | prints domains | PR01068 | 1 | 1 | 5227 | 17 |
P2RY6 |
3.252e-03 | -5.73 | P47PHOX | prints domains | PR00498 | 1 | 1 | 5227 | 17 |
NCF1 |
3.252e-03 | -5.73 | CD74ANTIGEN | prints domains | PR01990 | 1 | 1 | 5227 | 17 |
CD74 |
3.270e-03 | -5.72 | developmental process | biological process | GO:0032502 | 5716 | 25 | 18204 | 49 |
CTSB,NCAM2,ZFP36L1,LRMDA,PLXND1,GAS7,SH2B3,NDUFS2,ITGAX,MYO9B,RAPGEF6,TFEB,MFNG,PLEK,UNC93B1,RBM47,HCK,PREX1,GAB1,CD74,CSF1R,RAC2,NCKAP1L,ITGB2,ITM2B |
3.286e-03 | -5.72 | RCN1 (reticulocalbin 1) | protein interactions | 5954 | 239 | 4 | 19454 | 50 |
MYO9B,CTSB,CD74,P2RY6 |
3.302e-03 | -5.71 | THEM6 (thioesterase superfamily member 6) | protein interactions | 51337 | 116 | 3 | 19454 | 50 |
UNC93B1,P2RY6,RAC2 |
3.381e-03 | -5.69 | scalp | COSMIC cancer mutations | scalp | 2110 | 13 | 16828 | 46 |
SLCO2B1,ITGB2,MYO1F,CSF1R,NCKAP1L,ELMO1,NCAM2,P2RY6,MARCO,RBM47,PREX1,NCF1,ITGAX |
3.400e-03 | -5.68 | erythrocyte homeostasis | biological process | GO:0034101 | 112 | 3 | 18204 | 49 |
SH2B3,NCKAP1L,RAC2 |
3.423e-03 | -5.68 | regulation of leukocyte migration | biological process | GO:0002685 | 231 | 4 | 18204 | 49 |
CSF1R,CD74,RAC2,NCKAP1L |
3.436e-03 | -5.67 | STT3B (STT3 oligosaccharyltransferase complex catalytic subunit B) | protein interactions | 201595 | 242 | 4 | 19454 | 50 |
RAC2,CTSB,UNC93B1,P2RY6 |
3.447e-03 | -5.67 | regulation of immune response | biological process | GO:0050776 | 944 | 8 | 18204 | 49 |
CD74,FYB1,NCF1,ITGB2,NCKAP1L,UNC93B1,HCK,RBM47 |
3.465e-03 | -5.67 | GID8 (GID complex subunit 8 homolog) | protein interactions | 54994 | 118 | 3 | 19454 | 50 |
PREX1,GCH1,CTSB |
3.481e-03 | -5.66 | oxidoreductase complex | cellular component | GO:1990204 | 121 | 3 | 19108 | 48 |
RAC2,NCF1,NDUFS2 |
3.486e-03 | -5.66 | regulation of regulated secretory pathway | biological process | GO:1903305 | 113 | 3 | 18204 | 49 |
NCKAP1L,ITGB2,RAC2 |
3.519e-03 | -5.65 | SH2_dom_sf | interpro domains | IPR036860 | 113 | 3 | 18521 | 50 |
HCK,DAPP1,SH2B3 |
3.525e-03 | -5.65 | receptor complex | cellular component | GO:0043235 | 409 | 5 | 19108 | 48 |
PLXND1,ITGAX,CSF1R,CD74,ITGB2 |
3.548e-03 | -5.64 | HLA-DPA1 (major histocompatibility complex, class II, DP alpha 1) | protein interactions | 3113 | 119 | 3 | 19454 | 50 |
CD74,MYO9B,QSOX1 |
3.553e-03 | -5.64 | antigen processing and presentation of peptide antigen via MHC class II | biological process | GO:0002495 | 33 | 2 | 18204 | 49 |
CD74,UNC93B1 |
3.600e-03 | -5.63 | cytosol | cellular component | GO:0005829 | 5475 | 23 | 19108 | 48 |
DAPP1,PLEK,ZNRF2,GCH1,LPP,MYO9B,TFEB,NCKAP1L,HCK,ARHGAP15,ZFP36L1,RAC2,MYO1F,ELMO1,ABR,NCF1,NOL4L,WDFY3,PREX1,RAPGEF6,SH2B3,GAB1,FYB1 |
3.611e-03 | -5.62 | COMPLEX1_49K | prosite domains | PS00535 | 1 | 1 | 12186 | 44 |
NDUFS2 |
3.611e-03 | -5.62 | GTP_CYCLOHYDROL_1_2 | prosite domains | PS00860 | 1 | 1 | 12186 | 44 |
GCH1 |
3.611e-03 | -5.62 | GTP_CYCLOHYDROL_1_1 | prosite domains | PS00859 | 1 | 1 | 12186 | 44 |
GCH1 |
3.623e-03 | -5.62 | regulation of actin filament-based process | biological process | GO:0032970 | 384 | 5 | 18204 | 49 |
NCKAP1L,PLEK,HCK,PREX1,CSF1R |
3.632e-03 | -5.62 | PJA1 (praja ring finger ubiquitin ligase 1) | protein interactions | 64219 | 120 | 3 | 19454 | 50 |
ENTPD1,MYO9B,ABR |
3.649e-03 | -5.61 | GAS7 (growth arrest specific 7) | protein interactions | 8522 | 35 | 2 | 19454 | 50 |
NCKAP1L,GAS7 |
3.649e-03 | -5.61 | C5 (complement C5) | protein interactions | 727 | 35 | 2 | 19454 | 50 |
CPN1,CTSB |
3.649e-03 | -5.61 | Mbp (myelin basic protein) | protein interactions | 17196 | 35 | 2 | 19454 | 50 |
FYB1,HCK |
3.649e-03 | -5.61 | JAG1 (jagged canonical Notch ligand 1) | protein interactions | 182 | 35 | 2 | 19454 | 50 |
MFNG,RAC2 |
3.740e-03 | -5.59 | vesicle | cellular component | GO:0031982 | 4141 | 19 | 19108 | 48 |
RAPGEF6,HCK,NCKAP1L,CD74,ITGB2,MARCO,ITM2B,NCF1,RGS19,CMTM6,QSOX1,CTSB,CD68,GCH1,ENTPD1,UNC93B1,RAC2,ITGAX,ZNRF2 |
3.749e-03 | -5.59 | MET (MET proto-oncogene, receptor tyrosine kinase) | protein interactions | 4233 | 248 | 4 | 19454 | 50 |
ITM2B,SH2B3,GAB1,HCK |
3.769e-03 | -5.58 | regulation of B cell differentiation | biological process | GO:0045577 | 34 | 2 | 18204 | 49 |
ZFP36L1,NCKAP1L |
3.769e-03 | -5.58 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | biological process | GO:0002504 | 34 | 2 | 18204 | 49 |
UNC93B1,CD74 |
3.783e-03 | -5.58 | RA | pfam domains | PF00788 | 34 | 2 | 17795 | 48 |
RAPGEF6,MYO9B |
3.794e-03 | -5.57 | breast-carcinoma-ER-PR-positive_carcinoma | COSMIC cancer mutations | breast-carcinoma-ER-PR-positive_carcinoma | 1881 | 12 | 16828 | 46 |
CSF1R,ELMO1,GAB1,TFEB,MFNG,RAPGEF6,P2RY6,LPP,GAS7,ITGAX,RAC2,ZNRF2 |
3.794e-03 | -5.57 | ER-PR-positive_carcinoma | COSMIC cancer mutations | ER-PR-positive_carcinoma | 1881 | 12 | 16828 | 46 |
RAPGEF6,P2RY6,MFNG,CSF1R,TFEB,ELMO1,GAB1,ITGAX,ZNRF2,RAC2,GAS7,LPP |
3.869e-03 | -5.55 | regulation of immune effector process | biological process | GO:0002697 | 390 | 5 | 18204 | 49 |
ITGB2,NCKAP1L,RAC2,NCF1,CD74 |
4.049e-03 | -5.51 | Fc gamma R-mediated phagocytosis | KEGG pathways | hsa04666 | 90 | 3 | 7161 | 26 |
NCF1,HCK,RAC2 |
4.049e-03 | -5.51 | Fc gamma R-mediated phagocytosis | KEGG pathways | ko04666 | 90 | 3 | 7161 | 26 |
RAC2,HCK,NCF1 |
4.083e-03 | -5.50 | lung-carcinoma-undifferentiated_carcinoma | COSMIC cancer mutations | lung-carcinoma-undifferentiated_carcinoma | 1408 | 10 | 16828 | 46 |
LPP,MFNG,TFEB,GAB1,CSF1R,ZNRF2,RAC2,P2RY6,RAPGEF6,GAS7 |
4.200e-03 | -5.47 | nef (Nef) | protein interactions | 156110 | 802 | 7 | 19454 | 50 |
TFEB,CSF1R,RAC2,HCK,CD74,ITGAX,ELMO1 |
4.220e-03 | -5.47 | leukocyte migration | biological process | GO:0050900 | 245 | 4 | 18204 | 49 |
ITGB2,NCKAP1L,HCK,PREX1 |
4.295e-03 | -5.45 | undifferentiated_carcinoma | COSMIC cancer mutations | undifferentiated_carcinoma | 1418 | 10 | 16828 | 46 |
RAPGEF6,P2RY6,ZNRF2,RAC2,GAS7,LPP,MFNG,TFEB,GAB1,CSF1R |
4.314e-03 | -5.45 | PLCG1 (phospholipase C gamma 1) | protein interactions | 5335 | 258 | 4 | 19454 | 50 |
SH2B3,GAB1,HCK,DAPP1 |
4.326e-03 | -5.44 | microfilament motor activity | molecular function | GO:0000146 | 37 | 2 | 18094 | 48 |
MYO9B,MYO1F |
4.352e-03 | -5.44 | BTK (Bruton tyrosine kinase) | protein interactions | 695 | 128 | 3 | 19454 | 50 |
GAB1,DAPP1,HCK |
4.429e-03 | -5.42 | G alpha (12/13) signalling events | REACTOME pathways | R-HSA-416482 | 88 | 3 | 10285 | 39 |
RAC2,PREX1,ABR |
4.429e-03 | -5.42 | Focal Adhesion | WikiPathways | WP306 | 195 | 4 | 5310 | 19 |
HCK,ITGB2,RAC2,ITGAX |
4.451e-03 | -5.41 | response to lipoprotein particle | biological process | GO:0055094 | 37 | 2 | 18204 | 49 |
CD68,ITGB2 |
4.451e-03 | -5.41 | cellular response to low-density lipoprotein particle stimulus | biological process | GO:0071404 | 37 | 2 | 18204 | 49 |
CD68,ITGB2 |
4.545e-03 | -5.39 | YIPF5 (Yip1 domain family member 5) | protein interactions | 81555 | 130 | 3 | 19454 | 50 |
P2RY6,UNC93B1,RAC2 |
4.545e-03 | -5.39 | HM13 (histocompatibility minor 13) | protein interactions | 81502 | 130 | 3 | 19454 | 50 |
CMTM6,UNC93B1,RAC2 |
4.547e-03 | -5.39 | amide binding | molecular function | GO:0033218 | 254 | 4 | 18094 | 48 |
ITGB2,CD74,MARCO,ITM2B |
4.548e-03 | -5.39 | RA | smart domains | SM00314 | 29 | 2 | 9717 | 34 |
MYO9B,RAPGEF6 |
4.566e-03 | -5.39 | positive regulation of multicellular organismal process | biological process | GO:0051240 | 1691 | 11 | 18204 | 49 |
GAB1,RBM47,ITGAX,ZFP36L1,GCH1,CSF1R,CD74,PLXND1,NCKAP1L,UNC93B1,PLEK |
4.629e-03 | -5.38 | SH2 domain | gene3d domains | 3.30.505.10 | 111 | 3 | 14470 | 44 |
SH2B3,HCK,DAPP1 |
4.645e-03 | -5.37 | human chr20q11.21 | chromosome location | human chr20q11.21 | 53 | 2 | 26134 | 50 |
HCK,NOL4L |
4.691e-03 | -5.36 | actin filament polymerization | biological process | GO:0030041 | 38 | 2 | 18204 | 49 |
GAS7,PREX1 |
4.691e-03 | -5.36 | heterotypic cell-cell adhesion | biological process | GO:0034113 | 38 | 2 | 18204 | 49 |
ITGAX,ITGB2 |
4.708e-03 | -5.36 | Myosin_head | pfam domains | PF00063 | 38 | 2 | 17795 | 48 |
MYO1F,MYO9B |
4.719e-03 | -5.36 | Myosin_head_motor_dom | interpro domains | IPR001609 | 38 | 2 | 18521 | 50 |
MYO1F,MYO9B |
4.742e-03 | -5.35 | OSBPL8 (oxysterol binding protein like 8) | protein interactions | 114882 | 265 | 4 | 19454 | 50 |
P2RY6,UNC93B1,CD74,RAC2 |
4.766e-03 | -5.35 | B Cell Receptor Signaling Pathway | WikiPathways | WP23 | 98 | 3 | 5310 | 19 |
RAC2,GAB1,DAPP1 |
4.805e-03 | -5.34 | peptide binding | molecular function | GO:0042277 | 258 | 4 | 18094 | 48 |
CD74,ITGB2,MARCO,ITM2B |
4.805e-03 | -5.34 | COPB1 (COPI coat complex subunit beta 1) | protein interactions | 1315 | 266 | 4 | 19454 | 50 |
NCF1,CD74,UNC93B1,P2RY6 |
4.834e-03 | -5.33 | enzyme activator activity | molecular function | GO:0008047 | 599 | 6 | 18094 | 48 |
ABR,ARHGAP15,PREX1,MYO9B,NCKAP1L,NCF1 |
4.839e-03 | -5.33 | endometrium-carcinoma-serous_carcinoma | COSMIC cancer mutations | endometrium-carcinoma-serous_carcinoma | 1442 | 10 | 16828 | 46 |
GAS7,PLEK,SPOCK3,ENTPD1,RAPGEF6,ELMO1,GCH1,SMPD4,WDFY3,HCK |
4.942e-03 | -5.31 | regulation of B cell activation | biological process | GO:0050864 | 128 | 3 | 18204 | 49 |
CD74,ZFP36L1,NCKAP1L |
4.966e-03 | -5.31 | RA_dom | interpro domains | IPR000159 | 39 | 2 | 18521 | 50 |
RAPGEF6,MYO9B |
4.980e-03 | -5.30 | ATP8 (ATP synthase F0 subunit 8) | protein interactions | 4509 | 41 | 2 | 19454 | 50 |
P2RY6,UNC93B1 |
5.018e-03 | -5.29 | macrophage migration inhibitory factor receptor complex | cellular component | GO:0035692 | 2 | 1 | 19108 | 48 |
CD74 |
5.018e-03 | -5.29 | integrin alphaL-beta2 complex | cellular component | GO:0034687 | 2 | 1 | 19108 | 48 |
ITGB2 |
5.018e-03 | -5.29 | integrin alphaM-beta2 complex | cellular component | GO:0034688 | 2 | 1 | 19108 | 48 |
ITGB2 |
5.018e-03 | -5.29 | CSF1-CSF1R complex | cellular component | GO:1990682 | 2 | 1 | 19108 | 48 |
CSF1R |
5.049e-03 | -5.29 | SEL1L (SEL1L adaptor subunit of SYVN1 ubiquitin ligase) | protein interactions | 6400 | 135 | 3 | 19454 | 50 |
P2RY6,UNC93B1,CTSB |
5.083e-03 | -5.28 | lytic vacuole membrane | cellular component | GO:0098852 | 446 | 5 | 19108 | 48 |
TFEB,CD68,CMTM6,CD74,ZNRF2 |
5.083e-03 | -5.28 | lysosomal membrane | cellular component | GO:0005765 | 446 | 5 | 19108 | 48 |
TFEB,CMTM6,CD68,CD74,ZNRF2 |
5.094e-03 | -5.28 | cell projection | cellular component | GO:0042995 | 2398 | 13 | 19108 | 48 |
HCK,PREX1,WDFY3,NCAM2,PLXND1,NCF1,MYO9B,ABR,GCH1,PLEK,ZNRF2,RAC2,MYO1F |
5.104e-03 | -5.28 | cellular response to organic substance | biological process | GO:0071310 | 1716 | 11 | 18204 | 49 |
CSF1R,CD74,NCF1,SMPD4,CD68,GAB1,ZFP36L1,SH2B3,P2RY6,CTSB,HCK |
5.134e-03 | -5.27 | SYNGR4 (synaptogyrin 4) | protein interactions | 23546 | 2 | 1 | 19454 | 50 |
GULP1 |
5.187e-03 | -5.26 | cellular response to lipoprotein particle stimulus | biological process | GO:0071402 | 40 | 2 | 18204 | 49 |
ITGB2,CD68 |
5.204e-03 | -5.26 | leukocyte activation | biological process | GO:0045321 | 599 | 6 | 18204 | 49 |
ZFP36L1,MFNG,CD74,ITGB2,TNFAIP8L2,PREX1 |
5.220e-03 | -5.26 | NFE2L1 (NFE2 like bZIP transcription factor 1) | protein interactions | 4779 | 42 | 2 | 19454 | 50 |
WDFY3,NCF1 |
5.220e-03 | -5.26 | DYNC2I1 (dynein 2 intermediate chain 1) | protein interactions | 55112 | 42 | 2 | 19454 | 50 |
ENTPD1,WDFY3 |
5.259e-03 | -5.25 | C3 (complement C3) | protein interactions | 718 | 137 | 3 | 19454 | 50 |
ITGAX,CPN1,ITGB2 |
5.299e-03 | -5.24 | macrophage colony-stimulating factor receptor activity | molecular function | GO:0005011 | 2 | 1 | 18094 | 48 |
CSF1R |
5.299e-03 | -5.24 | G protein-coupled UDP receptor activity | molecular function | GO:0045029 | 2 | 1 | 18094 | 48 |
P2RY6 |
5.299e-03 | -5.24 | macrophage migration inhibitory factor binding | molecular function | GO:0035718 | 2 | 1 | 18094 | 48 |
CD74 |
5.332e-03 | -5.23 | The role of Nef in HIV-1 replication and disease pathogenesis | REACTOME pathways | R-HSA-164952 | 29 | 2 | 10285 | 39 |
ELMO1,HCK |
5.337e-03 | -5.23 | phagocytic vesicle | cellular component | GO:0045335 | 141 | 3 | 19108 | 48 |
NCF1,RAC2,UNC93B1 |
5.366e-03 | -5.23 | ATP5MG (ATP synthase membrane subunit g) | protein interactions | 10632 | 138 | 3 | 19454 | 50 |
RBM47,UNC93B1,P2RY6 |
5.376e-03 | -5.23 | regulation of prostaglandin-E synthase activity | biological process | GO:2000361 | 2 | 1 | 18204 | 49 |
ITGB2 |
5.376e-03 | -5.23 | dihydrobiopterin metabolic process | biological process | GO:0051066 | 2 | 1 | 18204 | 49 |
GCH1 |
5.376e-03 | -5.23 | positive regulation of prostaglandin-E synthase activity | biological process | GO:2000363 | 2 | 1 | 18204 | 49 |
ITGB2 |
5.376e-03 | -5.23 | negative regulation of inositol phosphate biosynthetic process | biological process | GO:0010920 | 2 | 1 | 18204 | 49 |
PLEK |
5.376e-03 | -5.23 | negative regulation of dopamine metabolic process | biological process | GO:0045963 | 2 | 1 | 18204 | 49 |
ITGB2 |
5.376e-03 | -5.23 | positive regulation of macrophage migration inhibitory factor signaling pathway | biological process | GO:2000448 | 2 | 1 | 18204 | 49 |
CD74 |
5.376e-03 | -5.23 | synaptic target recognition | biological process | GO:0008039 | 2 | 1 | 18204 | 49 |
PLXND1 |
5.376e-03 | -5.23 | negative regulation of catecholamine metabolic process | biological process | GO:0045914 | 2 | 1 | 18204 | 49 |
ITGB2 |
5.376e-03 | -5.23 | negative regulation of Kit signaling pathway | biological process | GO:1900235 | 2 | 1 | 18204 | 49 |
SH2B3 |
5.376e-03 | -5.23 | regulation of Kit signaling pathway | biological process | GO:1900234 | 2 | 1 | 18204 | 49 |
SH2B3 |
5.388e-03 | -5.22 | QSOX_Trx1 | pfam domains | PF18108 | 2 | 1 | 17795 | 48 |
QSOX1 |
5.388e-03 | -5.22 | FAD_SOX | pfam domains | PF18371 | 2 | 1 | 17795 | 48 |
QSOX1 |
5.388e-03 | -5.22 | Bcr-Abl_Oligo | pfam domains | PF09036 | 2 | 1 | 17795 | 48 |
ABR |
5.388e-03 | -5.22 | Nckap1 | pfam domains | PF09735 | 2 | 1 | 17795 | 48 |
NCKAP1L |
5.388e-03 | -5.22 | Tis11B_N | pfam domains | PF04553 | 2 | 1 | 17795 | 48 |
ZFP36L1 |
5.392e-03 | -5.22 | Bcr-Abl_oncoprot_oligo_sf | interpro domains | IPR036481 | 2 | 1 | 18521 | 50 |
ABR |
5.392e-03 | -5.22 | Sulfhydryl_oxidase | interpro domains | IPR039798 | 2 | 1 | 18521 | 50 |
QSOX1 |
5.392e-03 | -5.22 | Ie/If_SH3 | interpro domains | IPR035507 | 2 | 1 | 18521 | 50 |
MYO1F |
5.392e-03 | -5.22 | MYSc_Myo9 | interpro domains | IPR036023 | 2 | 1 | 18521 | 50 |
MYO9B |
5.392e-03 | -5.22 | QSOX_FAD-bd_dom | interpro domains | IPR040986 | 2 | 1 | 18521 | 50 |
QSOX1 |
5.392e-03 | -5.22 | Nck-associated_protein-1 | interpro domains | IPR019137 | 2 | 1 | 18521 | 50 |
NCKAP1L |
5.392e-03 | -5.22 | NOL4/NOL4L | interpro domains | IPR039788 | 2 | 1 | 18521 | 50 |
NOL4L |
5.392e-03 | -5.22 | Pleckstrin | interpro domains | IPR037370 | 2 | 1 | 18521 | 50 |
PLEK |
5.392e-03 | -5.22 | Abr/Bcr | interpro domains | IPR037769 | 2 | 1 | 18521 | 50 |
ABR |
5.392e-03 | -5.22 | QSOX_Trx1 | interpro domains | IPR041269 | 2 | 1 | 18521 | 50 |
QSOX1 |
5.392e-03 | -5.22 | QSOX_FAD-bd_sf | interpro domains | IPR042568 | 2 | 1 | 18521 | 50 |
QSOX1 |
5.392e-03 | -5.22 | Tis11B_N | interpro domains | IPR007635 | 2 | 1 | 18521 | 50 |
ZFP36L1 |
5.392e-03 | -5.22 | Neural_cell_adh | interpro domains | IPR009138 | 2 | 1 | 18521 | 50 |
NCAM2 |
5.392e-03 | -5.22 | Myo9 | interpro domains | IPR046987 | 2 | 1 | 18521 | 50 |
MYO9B |
5.392e-03 | -5.22 | Bcr-Abl_oncoprot_oligo | interpro domains | IPR015123 | 2 | 1 | 18521 | 50 |
ABR |
5.443e-03 | -5.21 | antigen processing and presentation of exogenous peptide antigen | biological process | GO:0002478 | 41 | 2 | 18204 | 49 |
CD74,UNC93B1 |
5.443e-03 | -5.21 | cortical actin cytoskeleton organization | biological process | GO:0030866 | 41 | 2 | 18204 | 49 |
PLEK,NCKAP1L |
5.443e-03 | -5.21 | cell adhesion mediated by integrin | biological process | GO:0033627 | 41 | 2 | 18204 | 49 |
ITGAX,ITGB2 |
5.453e-03 | -5.21 | SH2 | smart domains | SM00252 | 103 | 3 | 9717 | 34 |
DAPP1,SH2B3,HCK |
5.480e-03 | -5.21 | Integrin-mediated Cell Adhesion | WikiPathways | WP185 | 103 | 3 | 5310 | 19 |
RAC2,ITGB2,ITGAX |
5.556e-03 | -5.19 | leukocyte differentiation | biological process | GO:0002521 | 425 | 5 | 18204 | 49 |
ZFP36L1,MFNG,PREX1,CSF1R,CD74 |
5.612e-03 | -5.18 | regulation of actin filament polymerization | biological process | GO:0030833 | 134 | 3 | 18204 | 49 |
NCKAP1L,PREX1,HCK |
5.696e-03 | -5.17 | NCAPD3 (non-SMC condensin II complex subunit D3) | protein interactions | 23310 | 141 | 3 | 19454 | 50 |
CD74,UNC93B1,P2RY6 |
5.696e-03 | -5.17 | WASF2 (WASP family member 2) | protein interactions | 10163 | 141 | 3 | 19454 | 50 |
GAS7,NCKAP1L,RAC2 |
5.714e-03 | -5.16 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | 7307 | 29 | 16828 | 46 |
GAS7,RAC2,ITGAX,ABR,GCH1,QSOX1,CTSB,SH2B3,MARCO,PLEK,WDFY3,ARHGAP15,CSF1R,NCKAP1L,TFEB,GAB1,NCAM2,MFNG,PLXND1,ZNRF2,CPN1,PREX1,CMTM6,ITGB2,MYO1F,ZFP36L1,ELMO1,GULP1,SLCO2B1 |
5.739e-03 | -5.16 | positive regulation of response to stimulus | biological process | GO:0048584 | 2266 | 13 | 18204 | 49 |
UNC93B1,NCKAP1L,ITGB2,CSF1R,MARCO,CD74,NCF1,RAC2,MFNG,P2RY6,FYB1,RBM47,HCK |
5.740e-03 | -5.16 | PSI | interpro domains | IPR016201 | 42 | 2 | 18521 | 50 |
ITGB2,PLXND1 |
5.788e-03 | -5.15 | regulation of leukocyte proliferation | biological process | GO:0070663 | 268 | 4 | 18204 | 49 |
NCKAP1L,RAC2,CD74,CSF1R |
5.864e-03 | -5.14 | regulation of actin filament organization | biological process | GO:0110053 | 269 | 4 | 18204 | 49 |
PLEK,NCKAP1L,PREX1,HCK |
5.922e-03 | -5.13 | DCAF8 (DDB1 and CUL4 associated factor 8) | protein interactions | 50717 | 143 | 3 | 19454 | 50 |
UNC93B1,P2RY6,MYO9B |
5.922e-03 | -5.13 | ATP13A3 (ATPase 13A3) | protein interactions | 79572 | 143 | 3 | 19454 | 50 |
RAC2,P2RY6,UNC93B1 |
5.926e-03 | -5.13 | - | gene3d domains | 1.10.10.820 | 38 | 2 | 14470 | 44 |
MYO1F,MYO9B |
5.926e-03 | -5.13 | - | gene3d domains | 1.20.58.530 | 38 | 2 | 14470 | 44 |
MYO9B,MYO1F |
5.926e-03 | -5.13 | Myosin VI head, motor domain, U50 subdomain | gene3d domains | 1.20.120.720 | 38 | 2 | 14470 | 44 |
MYO9B,MYO1F |
5.967e-03 | -5.12 | myeloid leukocyte migration | biological process | GO:0097529 | 137 | 3 | 18204 | 49 |
ITGB2,NCKAP1L,PREX1 |
5.973e-03 | -5.12 | SKAP2 (src kinase associated phosphoprotein 2) | protein interactions | 8935 | 45 | 2 | 19454 | 50 |
FYB1,HCK |
6.001e-03 | -5.12 | YWHAH (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta) | protein interactions | 7533 | 1083 | 8 | 19454 | 50 |
ZNRF2,GAB1,ZFP36L1,RAPGEF6,LPP,P2RY6,TFEB,NCAM2 |
6.037e-03 | -5.11 | COPG2 (COPI coat complex subunit gamma 2) | protein interactions | 26958 | 144 | 3 | 19454 | 50 |
CD74,UNC93B1,P2RY6 |
6.053e-03 | -5.11 | GPR182 (G protein-coupled receptor 182) | protein interactions | 11318 | 454 | 5 | 19454 | 50 |
SMPD4,CMTM6,UNC93B1,WDFY3,MYO9B |
6.073e-03 | -5.10 | Bcr-Abl oncoprotein oligomerisation domain | gene3d domains | 4.10.280.30 | 2 | 1 | 14470 | 44 |
ABR |
6.073e-03 | -5.10 | QSOX sulfhydryl oxidase domain | gene3d domains | 1.20.120.1960 | 2 | 1 | 14470 | 44 |
QSOX1 |
6.104e-03 | -5.10 | lymphoid_neoplasm | COSMIC cancer mutations | lymphoid_neoplasm | 12233 | 41 | 16828 | 46 |
PREX1,NDUFS2,HCK,CMTM6,PLXND1,CPN1,ENTPD1,ZNRF2,NCF1,CD74,ZFP36L1,ELMO1,MYO1F,ITGB2,ITM2B,SLCO2B1,GULP1,RAPGEF6,TNFAIP8L2,QSOX1,GCH1,GAS7,ABR,RAC2,ITGAX,NCAM2,NCKAP1L,TFEB,GAB1,SMPD4,WDFY3,CSF1R,ARHGAP15,MFNG,RBM47,MYO9B,CTSB,SPOCK3,PLEK,MARCO,SH2B3 |
6.234e-03 | -5.08 | ANKRD44 (ankyrin repeat domain 44) | protein interactions | 91526 | 46 | 2 | 19454 | 50 |
ENTPD1,ZNRF2 |
6.234e-03 | -5.08 | TM4SF18 (transmembrane 4 L six family member 18) | protein interactions | 116441 | 46 | 2 | 19454 | 50 |
UNC93B1,ITGB2 |
6.335e-03 | -5.06 | myeloid cell homeostasis | biological process | GO:0002262 | 140 | 3 | 18204 | 49 |
RAC2,NCKAP1L,SH2B3 |
6.391e-03 | -5.05 | PIP5K1A (phosphatidylinositol-4-phosphate 5-kinase type 1 alpha) | protein interactions | 8394 | 147 | 3 | 19454 | 50 |
GCH1,PREX1,RAC2 |
6.495e-03 | -5.04 | NCAMFAMILY | prints domains | PR01838 | 2 | 1 | 5227 | 17 |
NCAM2 |
6.527e-03 | -5.03 | superoxide metabolic process | biological process | GO:0006801 | 45 | 2 | 18204 | 49 |
PREX1,NCF1 |
6.527e-03 | -5.03 | positive regulation of B cell proliferation | biological process | GO:0030890 | 45 | 2 | 18204 | 49 |
NCKAP1L,CD74 |
6.532e-03 | -5.03 | oesophagus-lower_third-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-adenocarcinoma | 6302 | 26 | 16828 | 46 |
GAS7,ITGAX,RAC2,CTSB,MYO9B,P2RY6,MARCO,RGS19,SH2B3,SPOCK3,WDFY3,NCAM2,TFEB,NCKAP1L,PLXND1,NCF1,CPN1,PREX1,NDUFS2,RAPGEF6,TNFAIP8L2,ITGB2,MYO1F,ELMO1,SLCO2B1,ITM2B |
6.534e-03 | -5.03 | MYOSINHEAVY | prints domains | PR00193 | 38 | 2 | 5227 | 17 |
MYO1F,MYO9B |
6.581e-03 | -5.02 | Regulation of actin cytoskeleton | KEGG pathways | hsa04810 | 211 | 4 | 7161 | 26 |
RAC2,NCKAP1L,ITGB2,ITGAX |
6.581e-03 | -5.02 | Regulation of actin cytoskeleton | KEGG pathways | ko04810 | 211 | 4 | 7161 | 26 |
ITGAX,NCKAP1L,RAC2,ITGB2 |
6.602e-03 | -5.02 | vesicle-mediated transport | biological process | GO:0016192 | 1283 | 9 | 18204 | 49 |
ELMO1,HCK,P2RY6,ITGB2,GULP1,MYO1F,CMTM6,PLEK,MARCO |
6.620e-03 | -5.02 | response to cytokine | biological process | GO:0034097 | 834 | 7 | 18204 | 49 |
HCK,GCH1,CSF1R,CD74,ZFP36L1,SMPD4,SH2B3 |
6.624e-03 | -5.02 | MCAM (melanoma cell adhesion molecule) | protein interactions | 4162 | 464 | 5 | 19454 | 50 |
RAC2,GAS7,GULP1,GAB1,LRMDA |
6.645e-03 | -5.01 | UTP and CTP dephosphorylation I | BIOCYC pathways | META_PWY-7185 | 3 | 1 | 902 | 2 |
ENTPD1 |
6.645e-03 | -5.01 | UTP and CTP dephosphorylation II | BIOCYC pathways | META_PWY-7177 | 3 | 1 | 902 | 2 |
ENTPD1 |
6.645e-03 | -5.01 | tetrahydrobiopterin de novo biosynthesis | BIOCYC pathways | HUMAN_PWY-5663 | 3 | 1 | 902 | 2 |
GCH1 |
6.645e-03 | -5.01 | tetrahydrobiopterin biosynthesis I | BIOCYC pathways | META_PWY-5663 | 3 | 1 | 902 | 2 |
GCH1 |
6.645e-03 | -5.01 | tetrahydrobiopterin biosynthesis II | BIOCYC pathways | META_PWY-5664 | 3 | 1 | 902 | 2 |
GCH1 |
6.696e-03 | -5.01 | Neurotrophic factor-mediated Trk receptor signaling | Pathway Interaction DB | trkrpathway | 56 | 3 | 2226 | 16 |
RGS19,GAB1,ELMO1 |
6.713e-03 | -5.00 | SH2 | prosite domains | PS50001 | 107 | 3 | 12186 | 44 |
HCK,SH2B3,DAPP1 |
6.726e-03 | -5.00 | secretory granule | cellular component | GO:0030141 | 897 | 7 | 19108 | 48 |
ITGB2,CTSB,NCKAP1L,ITGAX,CD68,CMTM6,QSOX1 |
6.748e-03 | -5.00 | intracellular signaling cassette | biological process | GO:0141124 | 837 | 7 | 18204 | 49 |
ABR,ELMO1,MYO9B,RAPGEF6,RGS19,RAC2,ZFP36L1 |
6.812e-03 | -4.99 | neuron recognition | biological process | GO:0008038 | 46 | 2 | 18204 | 49 |
PLXND1,NCAM2 |
6.840e-03 | -4.98 | nodular | COSMIC cancer mutations | nodular | 1515 | 10 | 16828 | 46 |
RBM47,TNFAIP8L2,PLEK,SPOCK3,ITGB2,ARHGAP15,WDFY3,NCKAP1L,TFEB,SLCO2B1 |
6.881e-03 | -4.98 | IPO11 (importin 11) | protein interactions | 51194 | 151 | 3 | 19454 | 50 |
UNC93B1,P2RY6,LPP |
6.881e-03 | -4.98 | CYFIP2 (cytoplasmic FMR1 interacting protein 2) | protein interactions | 26999 | 151 | 3 | 19454 | 50 |
GAS7,RAC2,NCKAP1L |
6.890e-03 | -4.98 | HER-positive_carcinoma | COSMIC cancer mutations | HER-positive_carcinoma | 2025 | 12 | 16828 | 46 |
SLCO2B1,MFNG,LPP,WDFY3,CSF1R,GAB1,TFEB,ZNRF2,RAC2,RAPGEF6,P2RY6,GAS7 |
6.890e-03 | -4.98 | breast-carcinoma-HER-positive_carcinoma | COSMIC cancer mutations | breast-carcinoma-HER-positive_carcinoma | 2025 | 12 | 16828 | 46 |
RAPGEF6,P2RY6,GAB1,TFEB,WDFY3,CSF1R,SLCO2B1,MFNG,GAS7,RAC2,ZNRF2,LPP |
6.982e-03 | -4.96 | Golgi membrane | cellular component | GO:0000139 | 683 | 6 | 19108 | 48 |
UNC93B1,CD74,MFNG,SMPD4,ITM2B,QSOX1 |
7.049e-03 | -4.95 | MCRIP1 (MAPK regulated corepressor interacting protein 1) | protein interactions | 348262 | 49 | 2 | 19454 | 50 |
RBM47,P2RY6 |
7.049e-03 | -4.95 | GPR173 (G protein-coupled receptor 173) | protein interactions | 54328 | 49 | 2 | 19454 | 50 |
UNC93B1,CMTM6 |
7.103e-03 | -4.95 | regulation of erythrocyte differentiation | biological process | GO:0045646 | 47 | 2 | 18204 | 49 |
NCKAP1L,ZFP36L1 |
7.147e-03 | -4.94 | UBR4 (ubiquitin protein ligase E3 component n-recognin 4) | protein interactions | 23352 | 298 | 4 | 19454 | 50 |
UNC93B1,P2RY6,CD74,CTSB |
7.147e-03 | -4.94 | GPR45 (G protein-coupled receptor 45) | protein interactions | 11250 | 298 | 4 | 19454 | 50 |
WDFY3,SMPD4,CMTM6,NDUFS2 |
7.224e-03 | -4.93 | lipid binding | molecular function | GO:0008289 | 861 | 7 | 18094 | 48 |
WDFY3,HCK,DAPP1,NCF1,FYB1,RAPGEF6,PREX1 |
7.246e-03 | -4.93 | leukocyte chemotaxis | biological process | GO:0030595 | 147 | 3 | 18204 | 49 |
PREX1,NCKAP1L,ITGB2 |
7.330e-03 | -4.92 | DOK1 (docking protein 1) | protein interactions | 1796 | 50 | 2 | 19454 | 50 |
HCK,ITGB2 |
7.382e-03 | -4.91 | regulation of reactive oxygen species metabolic process | biological process | GO:2000377 | 148 | 3 | 18204 | 49 |
RAC2,GCH1,ITGB2 |
7.443e-03 | -4.90 | Kazal_dom | interpro domains | IPR002350 | 48 | 2 | 18521 | 50 |
SLCO2B1,SPOCK3 |
7.564e-03 | -4.88 | specific granule | cellular component | GO:0042581 | 160 | 3 | 19108 | 48 |
ITGB2,CMTM6,QSOX1 |
7.569e-03 | -4.88 | kidney-carcinoma-papillary_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-papillary_renal_cell_carcinoma | 6364 | 26 | 16828 | 46 |
WDFY3,ARHGAP15,CSF1R,SMPD4,NCAM2,NCKAP1L,P2RY6,SH2B3,SPOCK3,CTSB,RBM47,MYO9B,GCH1,RAC2,ITGAX,ABR,GAS7,SLCO2B1,ITM2B,DAPP1,ITGB2,MYO1F,ELMO1,HCK,PREX1,PLXND1 |
7.569e-03 | -4.88 | papillary_renal_cell_carcinoma | COSMIC cancer mutations | papillary_renal_cell_carcinoma | 6364 | 26 | 16828 | 46 |
NCKAP1L,NCAM2,CSF1R,ARHGAP15,SMPD4,WDFY3,SPOCK3,SH2B3,P2RY6,MYO9B,RBM47,CTSB,GCH1,ABR,ITGAX,RAC2,GAS7,DAPP1,ITM2B,SLCO2B1,ELMO1,ITGB2,MYO1F,HCK,PREX1,PLXND1 |
7.615e-03 | -4.88 | lymphocyte differentiation | biological process | GO:0030098 | 290 | 4 | 18204 | 49 |
CD74,PREX1,MFNG,ZFP36L1 |
7.627e-03 | -4.88 | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 6023 | 25 | 16828 | 46 |
RAPGEF6,ZFP36L1,ELMO1,MYO1F,DAPP1,SLCO2B1,PLXND1,CPN1,ENTPD1,NDUFS2,PREX1,HCK,MYO9B,MARCO,P2RY6,GAB1,NCKAP1L,WDFY3,CSF1R,ARHGAP15,MFNG,CD68,GAS7,ABR,ITGAX |
7.658e-03 | -4.87 | placenta development | biological process | GO:0001890 | 150 | 3 | 18204 | 49 |
CTSB,TFEB,ZFP36L1 |
7.691e-03 | -4.87 | SRPX2 (sushi repeat containing protein X-linked 2) | protein interactions | 27286 | 3 | 1 | 19454 | 50 |
CTSB |
7.691e-03 | -4.87 | Sestd1 (SEC14 and spectrin domains 1) | protein interactions | 228071 | 3 | 1 | 19454 | 50 |
LPP |
7.700e-03 | -4.87 | platelet aggregation | biological process | GO:0070527 | 49 | 2 | 18204 | 49 |
ENTPD1,PLEK |
7.721e-03 | -4.86 | MYSc | smart domains | SM00242 | 38 | 2 | 9717 | 34 |
MYO9B,MYO1F |
7.825e-03 | -4.85 | Leukocyte transendothelial migration | KEGG pathways | hsa04670 | 114 | 3 | 7161 | 26 |
ITGB2,NCF1,RAC2 |
7.825e-03 | -4.85 | Leukocyte transendothelial migration | KEGG pathways | ko04670 | 114 | 3 | 7161 | 26 |
NCF1,ITGB2,RAC2 |
7.832e-03 | -4.85 | RA | prosite domains | PS50200 | 37 | 2 | 12186 | 44 |
RAPGEF6,MYO9B |
7.885e-03 | -4.84 | response to lipid | biological process | GO:0033993 | 862 | 7 | 18204 | 49 |
HCK,ZFP36L1,CPN1,NCF1,GCH1,CD68,P2RY6 |
7.909e-03 | -4.84 | EVI5 (ecotropic viral integration site 5) | protein interactions | 7813 | 52 | 2 | 19454 | 50 |
UNC93B1,P2RY6 |
7.909e-03 | -4.84 | ATP5F1E (ATP synthase F1 subunit epsilon) | protein interactions | 514 | 52 | 2 | 19454 | 50 |
P2RY6,UNC93B1 |
7.928e-03 | -4.84 | STYK1 (serine/threonine/tyrosine kinase 1) | protein interactions | 55359 | 159 | 3 | 19454 | 50 |
GAB1,MYO1F,SMPD4 |
7.928e-03 | -4.84 | COG6 (component of oligomeric golgi complex 6) | protein interactions | 57511 | 159 | 3 | 19454 | 50 |
UNC93B1,P2RY6,CD68 |
7.938e-03 | -4.84 | ICAM-3 receptor activity | molecular function | GO:0030369 | 3 | 1 | 18094 | 48 |
ITGB2 |
7.938e-03 | -4.84 | G protein-coupled ADP receptor activity | molecular function | GO:0001621 | 3 | 1 | 18094 | 48 |
P2RY6 |
7.938e-03 | -4.84 | flavin-dependent sulfhydryl oxidase activity | molecular function | GO:0016971 | 3 | 1 | 18094 | 48 |
QSOX1 |
7.938e-03 | -4.84 | G protein-coupled UTP receptor activity | molecular function | GO:0045030 | 3 | 1 | 18094 | 48 |
P2RY6 |
7.938e-03 | -4.84 | apyrase activity | molecular function | GO:0004050 | 3 | 1 | 18094 | 48 |
ENTPD1 |
7.938e-03 | -4.84 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity | molecular function | GO:0033829 | 3 | 1 | 18094 | 48 |
MFNG |
8.007e-03 | -4.83 | cortical cytoskeleton organization | biological process | GO:0030865 | 50 | 2 | 18204 | 49 |
NCKAP1L,PLEK |
8.007e-03 | -4.83 | antigen processing and presentation of exogenous antigen | biological process | GO:0019884 | 50 | 2 | 18204 | 49 |
CD74,UNC93B1 |
8.054e-03 | -4.82 | monocyte homeostasis | biological process | GO:0035702 | 3 | 1 | 18204 | 49 |
SH2B3 |
8.054e-03 | -4.82 | negative regulation of cytotoxic T cell degranulation | biological process | GO:0043318 | 3 | 1 | 18204 | 49 |
NCKAP1L |
8.054e-03 | -4.82 | septum transversum development | biological process | GO:0003343 | 3 | 1 | 18204 | 49 |
ZFP36L1 |
8.054e-03 | -4.82 | positive regulation of intracellular mRNA localization | biological process | GO:1904582 | 3 | 1 | 18204 | 49 |
ZFP36L1 |
8.054e-03 | -4.82 | regulation of macrophage migration inhibitory factor signaling pathway | biological process | GO:2000446 | 3 | 1 | 18204 | 49 |
CD74 |
8.054e-03 | -4.82 | leukocyte migration involved in immune response | biological process | GO:0002522 | 3 | 1 | 18204 | 49 |
HCK |
8.054e-03 | -4.82 | cellular response to raffinose | biological process | GO:0097403 | 3 | 1 | 18204 | 49 |
ZFP36L1 |
8.054e-03 | -4.82 | regulation of cytotoxic T cell degranulation | biological process | GO:0043317 | 3 | 1 | 18204 | 49 |
NCKAP1L |
8.054e-03 | -4.82 | response to raffinose | biological process | GO:1901545 | 3 | 1 | 18204 | 49 |
ZFP36L1 |
8.054e-03 | -4.82 | proepicardium development | biological process | GO:0003342 | 3 | 1 | 18204 | 49 |
ZFP36L1 |
8.071e-03 | -4.82 | MITF_TFEB_C_3_N | pfam domains | PF15951 | 3 | 1 | 17795 | 48 |
TFEB |
8.071e-03 | -4.82 | ELMO_ARM | pfam domains | PF11841 | 3 | 1 | 17795 | 48 |
ELMO1 |
8.071e-03 | -4.82 | Phe_ZIP | pfam domains | PF08916 | 3 | 1 | 17795 | 48 |
SH2B3 |
8.071e-03 | -4.82 | hSH3 | pfam domains | PF14603 | 3 | 1 | 17795 | 48 |
FYB1 |
8.071e-03 | -4.82 | ITGAX-like_Ig_3 | pfam domains | PF21520 | 3 | 1 | 17795 | 48 |
ITGAX |
8.071e-03 | -4.82 | Evr1_Alr | pfam domains | PF04777 | 3 | 1 | 17795 | 48 |
QSOX1 |
8.077e-03 | -4.82 | myeloid cell differentiation | biological process | GO:0030099 | 295 | 4 | 18204 | 49 |
CSF1R,RAC2,NCKAP1L,SH2B3 |
8.077e-03 | -4.82 | regulation of ERK1 and ERK2 cascade | biological process | GO:0070372 | 295 | 4 | 18204 | 49 |
P2RY6,CD74,MARCO,CSF1R |
8.078e-03 | -4.82 | ELMO_ARM | interpro domains | IPR024574 | 3 | 1 | 18521 | 50 |
ELMO1 |
8.078e-03 | -4.82 | ZFP36-like | interpro domains | IPR045877 | 3 | 1 | 18521 | 50 |
ZFP36L1 |
8.078e-03 | -4.82 | ERV/ALR_sulphydryl_oxidase | interpro domains | IPR017905 | 3 | 1 | 18521 | 50 |
QSOX1 |
8.078e-03 | -4.82 | LAMP_CS | interpro domains | IPR018134 | 3 | 1 | 18521 | 50 |
CD68 |
8.078e-03 | -4.82 | Fringe | interpro domains | IPR017374 | 3 | 1 | 18521 | 50 |
MFNG |
8.078e-03 | -4.82 | ITGAX-like_Ig_3 | interpro domains | IPR048633 | 3 | 1 | 18521 | 50 |
ITGAX |
8.078e-03 | -4.82 | ERV/ALR_sulphydryl_oxid_sf | interpro domains | IPR036774 | 3 | 1 | 18521 | 50 |
QSOX1 |
8.078e-03 | -4.82 | FYB1/2-like | interpro domains | IPR043443 | 3 | 1 | 18521 | 50 |
FYB1 |
8.078e-03 | -4.82 | SH2B | interpro domains | IPR030523 | 3 | 1 | 18521 | 50 |
SH2B3 |
8.078e-03 | -4.82 | ITM2 | interpro domains | IPR040145 | 3 | 1 | 18521 | 50 |
ITM2B |
8.078e-03 | -4.82 | hSH3 | interpro domains | IPR029294 | 3 | 1 | 18521 | 50 |
FYB1 |
8.078e-03 | -4.82 | Phe_ZIP | interpro domains | IPR015012 | 3 | 1 | 18521 | 50 |
SH2B3 |
8.078e-03 | -4.82 | Phe_ZIP_sf | interpro domains | IPR036290 | 3 | 1 | 18521 | 50 |
SH2B3 |
8.078e-03 | -4.82 | MiT/TFE_N | interpro domains | IPR031867 | 3 | 1 | 18521 | 50 |
TFEB |
8.129e-03 | -4.81 | positive regulation of hydrolase activity | biological process | GO:0051345 | 466 | 5 | 18204 | 49 |
PREX1,P2RY6,RAPGEF6,PLEK,ABR |
8.206e-03 | -4.80 | ELMO2 (engulfment and cell motility 2) | protein interactions | 63916 | 53 | 2 | 19454 | 50 |
ELMO1,RAC2 |
8.248e-03 | -4.80 | MYOSIN_MOTOR | prosite domains | PS51456 | 38 | 2 | 12186 | 44 |
MYO1F,MYO9B |
8.320e-03 | -4.79 | regulation of protein tyrosine kinase activity | biological process | GO:0061097 | 51 | 2 | 18204 | 49 |
NCF1,CSF1R |
8.390e-03 | -4.78 | regulation of biological quality | biological process | GO:0065008 | 2936 | 15 | 18204 | 49 |
PREX1,ARHGAP15,CSF1R,ITGB2,CMTM6,PLEK,NCKAP1L,HCK,CTSB,RBM47,ZFP36L1,ENTPD1,GCH1,SH2B3,PLXND1 |
8.461e-03 | -4.77 | anion binding | molecular function | GO:0043168 | 2412 | 13 | 18094 | 48 |
CSF1R,NCF1,RAPGEF6,HCK,DAPP1,RAC2,MYO1F,ENTPD1,MYO9B,QSOX1,ITM2B,PLEK,GCH1 |
8.484e-03 | -4.77 | DNAJB12 (DnaJ heat shock protein family (Hsp40) member B12) | protein interactions | 54788 | 163 | 3 | 19454 | 50 |
CD74,UNC93B1,P2RY6 |
8.484e-03 | -4.77 | GRAMD1A (GRAM domain containing 1A) | protein interactions | 57655 | 163 | 3 | 19454 | 50 |
CD74,P2RY6,UNC93B1 |
8.507e-03 | -4.77 | LCP2 (lymphocyte cytosolic protein 2) | protein interactions | 3937 | 54 | 2 | 19454 | 50 |
HCK,FYB1 |
8.638e-03 | -4.75 | positive regulation of actin filament polymerization | biological process | GO:0030838 | 52 | 2 | 18204 | 49 |
HCK,NCKAP1L |
8.639e-03 | -4.75 | positive regulation of MAPK cascade | biological process | GO:0043410 | 473 | 5 | 18204 | 49 |
P2RY6,CSF1R,CD74,MARCO,NCF1 |
8.660e-03 | -4.75 | side of membrane | cellular component | GO:0098552 | 715 | 6 | 19108 | 48 |
CD74,ITGB2,HCK,NCF1,ITGAX,CTSB |
8.729e-03 | -4.74 | myosin complex | cellular component | GO:0016459 | 56 | 2 | 19108 | 48 |
MYO9B,MYO1F |
8.755e-03 | -4.74 | immune response-activating signaling pathway | biological process | GO:0002757 | 302 | 4 | 18204 | 49 |
HCK,FYB1,NCKAP1L,UNC93B1 |
8.771e-03 | -4.74 | RASA1 (RAS p21 protein activator 1) | protein interactions | 5921 | 165 | 3 | 19454 | 50 |
GAB1,CSF1R,HCK |
8.789e-03 | -4.73 | regulation of MAPK cascade | biological process | GO:0043408 | 669 | 6 | 18204 | 49 |
CD74,MARCO,NCF1,CSF1R,P2RY6,SH2B3 |
8.791e-03 | -4.73 | Hemostasis | REACTOME pathways | R-HSA-109582 | 632 | 7 | 10285 | 39 |
QSOX1,PLEK,ITGB2,RAC2,CD74,ITGAX,SH2B3 |
8.814e-03 | -4.73 | DOCK1 (dedicator of cytokinesis 1) | protein interactions | 1793 | 55 | 2 | 19454 | 50 |
RAC2,ELMO1 |
8.843e-03 | -4.73 | LGALS1 (galectin 1) | protein interactions | 3956 | 317 | 4 | 19454 | 50 |
PLXND1,CD68,RAC2,HCK |
8.854e-03 | -4.73 | UTP and CTP dephosphorylation II | BIOCYC pathways | HUMAN_PWY-7177 | 4 | 1 | 902 | 2 |
ENTPD1 |
8.864e-03 | -4.73 | lymphocyte activation | biological process | GO:0046649 | 476 | 5 | 18204 | 49 |
TNFAIP8L2,PREX1,CD74,MFNG,ZFP36L1 |
8.917e-03 | -4.72 | TBL2 (transducin beta like 2) | protein interactions | 26608 | 166 | 3 | 19454 | 50 |
RAC2,P2RY6,UNC93B1 |
8.917e-03 | -4.72 | CPD (carboxypeptidase D) | protein interactions | 1362 | 166 | 3 | 19454 | 50 |
CPN1,CSF1R,RAC2 |
8.939e-03 | -4.72 | RHOT2 (ras homolog family member T2) | protein interactions | 89941 | 318 | 4 | 19454 | 50 |
P2RY6,SMPD4,WDFY3,CD74 |
8.962e-03 | -4.71 | regulation of platelet activation | biological process | GO:0010543 | 53 | 2 | 18204 | 49 |
PLEK,SH2B3 |
9.032e-03 | -4.71 | protein complex involved in cell adhesion | cellular component | GO:0098636 | 57 | 2 | 19108 | 48 |
ITGB2,ITGAX |
9.063e-03 | -4.70 | MACO1 (macoilin 1) | protein interactions | 55219 | 167 | 3 | 19454 | 50 |
UNC93B1,P2RY6,RAC2 |
9.063e-03 | -4.70 | CIP2A (cellular inhibitor of PP2A) | protein interactions | 57650 | 167 | 3 | 19454 | 50 |
MFNG,UNC93B1,P2RY6 |
9.095e-03 | -4.70 | ERV/ALR sulfhydryl oxidase domain | gene3d domains | 1.20.120.310 | 3 | 1 | 14470 | 44 |
QSOX1 |
9.095e-03 | -4.70 | - | gene3d domains | 6.10.250.810 | 3 | 1 | 14470 | 44 |
ELMO1 |
9.095e-03 | -4.70 | - | gene3d domains | 6.10.140.110 | 3 | 1 | 14470 | 44 |
SH2B3 |
9.159e-03 | -4.69 | regulation of small GTPase mediated signal transduction | biological process | GO:0051056 | 306 | 4 | 18204 | 49 |
ABR,MYO9B,ARHGAP15,PREX1 |
9.177e-03 | -4.69 | acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_B_cell_leukaemia | 3828 | 18 | 16828 | 46 |
NDUFS2,QSOX1,CMTM6,GAS7,PLXND1,GAB1,NCKAP1L,ELMO1,NCAM2,ITGB2,WDFY3,ARHGAP15,CSF1R,SLCO2B1,MYO9B,SH2B3,MARCO,RAPGEF6 |
9.177e-03 | -4.69 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | 3828 | 18 | 16828 | 46 |
QSOX1,NDUFS2,CMTM6,PLXND1,GAS7,CSF1R,WDFY3,ARHGAP15,ITGB2,NCAM2,GAB1,ELMO1,NCKAP1L,SLCO2B1,MYO9B,MARCO,RAPGEF6,SH2B3 |
9.212e-03 | -4.69 | KLK10 (kallikrein related peptidase 10) | protein interactions | 5655 | 168 | 3 | 19454 | 50 |
RAC2,ITGB2,MYO1F |
9.290e-03 | -4.68 | positive regulation of peptidyl-tyrosine phosphorylation | biological process | GO:0050731 | 161 | 3 | 18204 | 49 |
CSF1R,CD74,NCF1 |
9.290e-03 | -4.68 | regulation of alcohol biosynthetic process | biological process | GO:1902930 | 54 | 2 | 18204 | 49 |
P2RY6,PLEK |
9.300e-03 | -4.68 | phospholipid binding | molecular function | GO:0005543 | 489 | 5 | 18094 | 48 |
PREX1,NCF1,RAPGEF6,DAPP1,WDFY3 |
9.361e-03 | -4.67 | NUP210 (nucleoporin 210) | protein interactions | 23225 | 169 | 3 | 19454 | 50 |
UNC93B1,P2RY6,CTSB |
9.374e-03 | -4.67 | PSI | smart domains | SM00423 | 42 | 2 | 9717 | 34 |
ITGB2,PLXND1 |
9.442e-03 | -4.66 | EVI5L (ecotropic viral integration site 5 like) | protein interactions | 115704 | 57 | 2 | 19454 | 50 |
UNC93B1,P2RY6 |
9.442e-03 | -4.66 | KNG1 (kininogen 1) | protein interactions | 3827 | 57 | 2 | 19454 | 50 |
ITGB2,CPN1 |
9.442e-03 | -4.66 | FXN (frataxin) | protein interactions | 2395 | 57 | 2 | 19454 | 50 |
CTSB,DAPP1 |
9.442e-03 | -4.66 | ICAM2 (intercellular adhesion molecule 2) | protein interactions | 3384 | 57 | 2 | 19454 | 50 |
ITGB2,ITM2B |
9.513e-03 | -4.66 | PIK3C2A (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha) | protein interactions | 5286 | 170 | 3 | 19454 | 50 |
P2RY6,RBM47,RAC2 |
9.513e-03 | -4.66 | BZW1 (basic leucine zipper and W2 domains 1) | protein interactions | 9689 | 170 | 3 | 19454 | 50 |
PREX1,P2RY6,UNC93B1 |
9.544e-03 | -4.65 | regulation of anatomical structure morphogenesis | biological process | GO:0022603 | 894 | 7 | 18204 | 49 |
PLXND1,ITGAX,ITGB2,CSF1R,ARHGAP15,HCK,GAB1 |
9.575e-03 | -4.65 | negative regulation of cell adhesion | biological process | GO:0007162 | 310 | 4 | 18204 | 49 |
CD74,SH2B3,TNFAIP8L2,PLXND1 |
9.579e-03 | -4.65 | human chr11q13.4 | chromosome location | human chr11q13.4 | 77 | 2 | 26134 | 50 |
SLCO2B1,P2RY6 |
9.652e-03 | -4.64 | azurophil granule membrane | cellular component | GO:0035577 | 59 | 2 | 19108 | 48 |
CMTM6,CD68 |
9.763e-03 | -4.63 | SELENOF (selenoprotein F) | protein interactions | 9403 | 58 | 2 | 19454 | 50 |
P2RY6,UNC93B1 |
9.819e-03 | -4.62 | Adaptive Immune System | REACTOME pathways | R-HSA-1280218 | 810 | 8 | 10285 | 39 |
DAPP1,CTSB,ITGB2,GAB1,ZNRF2,FYB1,CD74,NCF1 |
9.964e-03 | -4.61 | leukocyte cell-cell adhesion | biological process | GO:0007159 | 56 | 2 | 18204 | 49 |
ITGB2,RAC2 |
1.004e-02 | -4.60 | IL-6 signaling pathway | WikiPathways | WP364 | 43 | 2 | 5310 | 19 |
HCK,GAB1 |
1.009e-02 | -4.60 | CNNM4 (cyclin and CBS domain divalent metal cation transport mediator 4) | protein interactions | 26504 | 59 | 2 | 19454 | 50 |
UNC93B1,P2RY6 |
1.011e-02 | -4.59 | T cell activation | biological process | GO:0042110 | 315 | 4 | 18204 | 49 |
ZFP36L1,PREX1,CD74,TNFAIP8L2 |
1.024e-02 | -4.58 | Map6 (microtubule-associated protein 6) | protein interactions | 29457 | 4 | 1 | 19454 | 50 |
PLXND1 |
1.024e-02 | -4.58 | UBC1 (E2 ubiquitin-conjugating protein UBC1) | protein interactions | 851757 | 4 | 1 | 19454 | 50 |
ZNRF2 |
1.031e-02 | -4.57 | regulation of myeloid leukocyte mediated immunity | biological process | GO:0002886 | 57 | 2 | 18204 | 49 |
RAC2,ITGB2 |
1.035e-02 | -4.57 | SEC63 (SEC63 homolog, protein translocation regulator) | protein interactions | 11231 | 332 | 4 | 19454 | 50 |
SMPD4,P2RY6,UNC93B1,RBM47 |
1.042e-02 | -4.56 | DOCK2 (dedicator of cytokinesis 2) | protein interactions | 1794 | 60 | 2 | 19454 | 50 |
RAC2,ELMO1 |
1.057e-02 | -4.55 | stem cell factor receptor binding | molecular function | GO:0005173 | 4 | 1 | 18094 | 48 |
SH2B3 |
1.057e-02 | -4.55 | CDP phosphatase activity | molecular function | GO:0036384 | 4 | 1 | 18094 | 48 |
ENTPD1 |
1.057e-02 | -4.55 | IDP phosphatase activity | molecular function | GO:1990003 | 4 | 1 | 18094 | 48 |
ENTPD1 |
1.057e-02 | -4.55 | G protein-coupled pyrimidinergic nucleotide receptor activity | molecular function | GO:0071553 | 4 | 1 | 18094 | 48 |
P2RY6 |
1.064e-02 | -4.54 | regulation of anatomical structure size | biological process | GO:0090066 | 498 | 5 | 18204 | 49 |
NCKAP1L,PLEK,PREX1,GCH1,HCK |
1.066e-02 | -4.54 | regulation of phosphatase activity | biological process | GO:0010921 | 58 | 2 | 18204 | 49 |
PLEK,NCKAP1L |
1.072e-02 | -4.54 | macrophage colony-stimulating factor signaling pathway | biological process | GO:0038145 | 4 | 1 | 18204 | 49 |
CSF1R |
1.072e-02 | -4.54 | regulation of inositol trisphosphate biosynthetic process | biological process | GO:0032960 | 4 | 1 | 18204 | 49 |
P2RY6 |
1.072e-02 | -4.54 | erythrocyte enucleation | biological process | GO:0043131 | 4 | 1 | 18204 | 49 |
RAC2 |
1.072e-02 | -4.54 | negative regulation of mature B cell apoptotic process | biological process | GO:0002906 | 4 | 1 | 18204 | 49 |
CD74 |
1.072e-02 | -4.54 | positive regulation of TORC2 signaling | biological process | GO:1904515 | 4 | 1 | 18204 | 49 |
NCKAP1L |
1.072e-02 | -4.54 | positive regulation of mast cell proliferation | biological process | GO:0070668 | 4 | 1 | 18204 | 49 |
RAC2 |
1.072e-02 | -4.54 | enucleate erythrocyte maturation | biological process | GO:0043354 | 4 | 1 | 18204 | 49 |
RAC2 |
1.072e-02 | -4.54 | mast cell proliferation | biological process | GO:0070662 | 4 | 1 | 18204 | 49 |
RAC2 |
1.072e-02 | -4.54 | respiratory burst after phagocytosis | biological process | GO:0045728 | 4 | 1 | 18204 | 49 |
HCK |
1.072e-02 | -4.54 | positive regulation of neutrophil degranulation | biological process | GO:0043315 | 4 | 1 | 18204 | 49 |
ITGB2 |
1.072e-02 | -4.54 | regulation of mature B cell apoptotic process | biological process | GO:0002905 | 4 | 1 | 18204 | 49 |
CD74 |
1.072e-02 | -4.54 | enucleation | biological process | GO:0090601 | 4 | 1 | 18204 | 49 |
RAC2 |
1.072e-02 | -4.54 | regulation of intracellular mRNA localization | biological process | GO:1904580 | 4 | 1 | 18204 | 49 |
ZFP36L1 |
1.072e-02 | -4.54 | positive regulation of inositol trisphosphate biosynthetic process | biological process | GO:0032962 | 4 | 1 | 18204 | 49 |
P2RY6 |
1.072e-02 | -4.54 | dichotomous subdivision of terminal units involved in salivary gland branching | biological process | GO:0060666 | 4 | 1 | 18204 | 49 |
PLXND1 |
1.072e-02 | -4.54 | negative regulation of dendritic cell antigen processing and presentation | biological process | GO:0002605 | 4 | 1 | 18204 | 49 |
CD68 |
1.072e-02 | -4.54 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity | biological process | GO:0031587 | 4 | 1 | 18204 | 49 |
P2RY6 |
1.072e-02 | -4.54 | positive regulation of epidermal growth factor-activated receptor activity | biological process | GO:0045741 | 4 | 1 | 18204 | 49 |
NCF1 |
1.075e-02 | -4.53 | DUF758 | pfam domains | PF05527 | 4 | 1 | 17795 | 48 |
TNFAIP8L2 |
1.075e-02 | -4.53 | DUF3371 | pfam domains | PF11851 | 4 | 1 | 17795 | 48 |
TFEB |
1.076e-02 | -4.53 | TNFAIP8-like | interpro domains | IPR008477 | 4 | 1 | 18521 | 50 |
TNFAIP8L2 |
1.076e-02 | -4.53 | Gab1-4-like | interpro domains | IPR046355 | 4 | 1 | 18521 | 50 |
GAB1 |
1.076e-02 | -4.53 | MiT/TFE_C | interpro domains | IPR021802 | 4 | 1 | 18521 | 50 |
TFEB |
1.076e-02 | -4.53 | TNFAIP8_sf | interpro domains | IPR038355 | 4 | 1 | 18521 | 50 |
TNFAIP8L2 |
1.076e-02 | -4.53 | VPS8 (VPS8 subunit of CORVET complex) | protein interactions | 23355 | 61 | 2 | 19454 | 50 |
UNC93B1,P2RY6 |
1.076e-02 | -4.53 | PTPN18 (protein tyrosine phosphatase non-receptor type 18) | protein interactions | 26469 | 61 | 2 | 19454 | 50 |
CTSB,GAB1 |
1.079e-02 | -4.53 | ERV_ALR | prosite domains | PS51324 | 3 | 1 | 12186 | 44 |
QSOX1 |
1.079e-02 | -4.53 | LAMP_2 | prosite domains | PS00311 | 3 | 1 | 12186 | 44 |
CD68 |
1.080e-02 | -4.53 | GTPase activity | molecular function | GO:0003924 | 326 | 4 | 18094 | 48 |
RGS19,ENTPD1,RAC2,GCH1 |
1.081e-02 | -4.53 | human chr22q13.1 | chromosome location | human chr22q13.1 | 82 | 2 | 26134 | 50 |
RAC2,MFNG |
1.082e-02 | -4.53 | regulation of cell-cell adhesion | biological process | GO:0022407 | 500 | 5 | 18204 | 49 |
CD74,ITGB2,SH2B3,NCKAP1L,TNFAIP8L2 |
1.089e-02 | -4.52 | haematopoietic_and_lymphoid_tissue-other-idiopathic_erythrocytosis | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-other-idiopathic_erythrocytosis | 4 | 1 | 16828 | 46 |
SH2B3 |
1.089e-02 | -4.52 | idiopathic_erythrocytosis | COSMIC cancer mutations | idiopathic_erythrocytosis | 4 | 1 | 16828 | 46 |
SH2B3 |
1.094e-02 | -4.52 | regulation of exocytosis | biological process | GO:0017157 | 171 | 3 | 18204 | 49 |
RAC2,ITGB2,NCKAP1L |
1.094e-02 | -4.52 | NDUFAF4 (NADH:ubiquinone oxidoreductase complex assembly factor 4) | protein interactions | 29078 | 179 | 3 | 19454 | 50 |
P2RY6,NDUFS2,UNC93B1 |
1.110e-02 | -4.50 | IL1R2 (interleukin 1 receptor type 2) | protein interactions | 7850 | 62 | 2 | 19454 | 50 |
QSOX1,ITM2B |
1.110e-02 | -4.50 | GCH1 (GTP cyclohydrolase 1) | protein interactions | 2643 | 62 | 2 | 19454 | 50 |
GCH1,RGS19 |
1.110e-02 | -4.50 | SLC39A7 (solute carrier family 39 member 7) | protein interactions | 7922 | 180 | 3 | 19454 | 50 |
RGS19,RAC2,P2RY6 |
1.110e-02 | -4.50 | CYFIP1 (cytoplasmic FMR1 interacting protein 1) | protein interactions | 23191 | 180 | 3 | 19454 | 50 |
NCKAP1L,RAC2,GAS7 |
1.126e-02 | -4.49 | regulation of lymphocyte activation | biological process | GO:0051249 | 505 | 5 | 18204 | 49 |
CD74,RAC2,ZFP36L1,TNFAIP8L2,NCKAP1L |
1.126e-02 | -4.49 | regulation of phosphate metabolic process | biological process | GO:0019220 | 1154 | 8 | 18204 | 49 |
NCF1,CD74,MARCO,CSF1R,P2RY6,ITGB2,PLEK,NCKAP1L |
1.131e-02 | -4.48 | regulation of phosphorus metabolic process | biological process | GO:0051174 | 1155 | 8 | 18204 | 49 |
CSF1R,NCF1,CD74,MARCO,PLEK,NCKAP1L,ITGB2,P2RY6 |
1.133e-02 | -4.48 | pancreas-carcinoid-endocrine_tumour | COSMIC cancer mutations | pancreas-carcinoid-endocrine_tumour | 7250 | 28 | 16828 | 46 |
ITM2B,GULP1,ELMO1,ZFP36L1,MYO1F,CPN1,ZNRF2,PLXND1,PREX1,PLEK,SPOCK3,SH2B3,MARCO,CTSB,MFNG,NCKAP1L,GAB1,NCAM2,ARHGAP15,CSF1R,WDFY3,SMPD4,ABR,ITGAX,RAC2,GAS7,GCH1,QSOX1 |
1.137e-02 | -4.48 | positive regulation of cytokine-mediated signaling pathway | biological process | GO:0001961 | 60 | 2 | 18204 | 49 |
CD74,RBM47 |
1.144e-02 | -4.47 | NOXA1 (NADPH oxidase activator 1) | protein interactions | 10811 | 63 | 2 | 19454 | 50 |
NCF1,RAC2 |
1.144e-02 | -4.47 | RAB32 (RAB32, member RAS oncogene family) | protein interactions | 10981 | 63 | 2 | 19454 | 50 |
RAC2,LRMDA |
1.145e-02 | -4.47 | TOP3B (DNA topoisomerase III beta) | protein interactions | 8940 | 1465 | 9 | 19454 | 50 |
ABR,MYO9B,RBM47,TFEB,WDFY3,RAPGEF6,SH2B3,PREX1,PLXND1 |
1.145e-02 | -4.47 | YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma) | protein interactions | 7532 | 1211 | 8 | 19454 | 50 |
RAPGEF6,GAB1,ZFP36L1,ZNRF2,NCAM2,TFEB,P2RY6,RAC2 |
1.161e-02 | -4.46 | HCK (HCK proto-oncogene, Src family tyrosine kinase) | protein interactions | 3055 | 183 | 3 | 19454 | 50 |
HCK,ELMO1,GAB1 |
1.164e-02 | -4.45 | regulation of interleukin-6 production | biological process | GO:0032675 | 175 | 3 | 18204 | 49 |
UNC93B1,NCKAP1L,CD74 |
1.164e-02 | -4.45 | positive regulation of supramolecular fiber organization | biological process | GO:1902905 | 175 | 3 | 18204 | 49 |
HCK,PLEK,NCKAP1L |
1.164e-02 | -4.45 | ATP1A1 (ATPase Na+/K+ transporting subunit alpha 1) | protein interactions | 476 | 533 | 5 | 19454 | 50 |
RAC2,ZNRF2,UNC93B1,P2RY6,NDUFS2 |
1.166e-02 | -4.45 | ion binding | molecular function | GO:0043167 | 6007 | 24 | 18094 | 48 |
GCH1,PLEK,ITGB2,ZNRF2,MYO9B,LPP,MYO1F,RAC2,DAPP1,SPOCK3,CPN1,NDUFS2,HCK,WDFY3,RAPGEF6,ITM2B,QSOX1,ITGAX,MFNG,ENTPD1,SMPD4,NCF1,CSF1R,ZFP36L1 |
1.166e-02 | -4.45 | DOPA-Responsive Dystonia | SMPDB pathways | SMP0000486 | 8 | 1 | 1369 | 2 |
GCH1 |
1.166e-02 | -4.45 | Hyperphenylalaninemia Due to DHPR-Deficiency | SMPDB pathways | SMP0000489 | 8 | 1 | 1369 | 2 |
GCH1 |
1.166e-02 | -4.45 | Hyperphenylalaninemia Due to 6-Pyruvoyltetrahydropterin Synthase Deficiency (ptps) | SMPDB pathways | SMP0000488 | 8 | 1 | 1369 | 2 |
GCH1 |
1.166e-02 | -4.45 | Hyperphenylalaninemia Due to Guanosine Triphosphate Cyclohydrolase Deficiency | SMPDB pathways | SMP0000487 | 8 | 1 | 1369 | 2 |
GCH1 |
1.166e-02 | -4.45 | Sepiapterin Reductase Deficiency | SMPDB pathways | SMP0000491 | 8 | 1 | 1369 | 2 |
GCH1 |
1.166e-02 | -4.45 | Pterine Biosynthesis | SMPDB pathways | SMP0000005 | 8 | 1 | 1369 | 2 |
GCH1 |
1.166e-02 | -4.45 | Segawa Syndrome | SMPDB pathways | SMP0000490 | 8 | 1 | 1369 | 2 |
GCH1 |
1.174e-02 | -4.44 | negative regulation of G protein-coupled receptor signaling pathway | biological process | GO:0045744 | 61 | 2 | 18204 | 49 |
PLEK,SH2B3 |
1.179e-02 | -4.44 | AGPAT2 (1-acylglycerol-3-phosphate O-acyltransferase 2) | protein interactions | 10555 | 64 | 2 | 19454 | 50 |
UNC93B1,P2RY6 |
1.195e-02 | -4.43 | NPLOC4 (NPL4 homolog, ubiquitin recognition factor) | protein interactions | 55666 | 185 | 3 | 19454 | 50 |
LPP,NDUFS2,P2RY6 |
1.211e-02 | -4.41 | Tumor necrosis factor alpha-induced protein 8-like | gene3d domains | 1.20.1440.160 | 4 | 1 | 14470 | 44 |
TNFAIP8L2 |
1.211e-02 | -4.41 | positive regulation of myeloid leukocyte differentiation | biological process | GO:0002763 | 62 | 2 | 18204 | 49 |
ZFP36L1,CD74 |
1.215e-02 | -4.41 | COG5 (component of oligomeric golgi complex 5) | protein interactions | 10466 | 65 | 2 | 19454 | 50 |
P2RY6,UNC93B1 |
1.226e-02 | -4.40 | HLA-C (major histocompatibility complex, class I, C) | protein interactions | 3107 | 349 | 4 | 19454 | 50 |
ITM2B,QSOX1,CTSB,RAC2 |
1.238e-02 | -4.39 | EPHA2 (EPH receptor A2) | protein interactions | 1969 | 350 | 4 | 19454 | 50 |
CSF1R,RAC2,HCK,GAB1 |
1.250e-02 | -4.38 | apolipoprotein B mRNA editing enzyme complex | cellular component | GO:0030895 | 5 | 1 | 19108 | 48 |
RBM47 |
1.250e-02 | -4.38 | endolysosome lumen | cellular component | GO:0036021 | 5 | 1 | 19108 | 48 |
CTSB |
1.250e-02 | -4.38 | HLA-DRB3 (major histocompatibility complex, class II, DR beta 3) | protein interactions | 3125 | 66 | 2 | 19454 | 50 |
ITM2B,CD74 |
1.274e-02 | -4.36 | ESYT2 (extended synaptotagmin 2) | protein interactions | 57488 | 353 | 4 | 19454 | 50 |
SMPD4,UNC93B1,P2RY6,RAC2 |
1.275e-02 | -4.36 | regulation of cytoskeleton organization | biological process | GO:0051493 | 521 | 5 | 18204 | 49 |
NCKAP1L,PLEK,HCK,PREX1,CSF1R |
1.279e-02 | -4.36 | SAMD8 (sterile alpha motif domain containing 8) | protein interactions | 142891 | 5 | 1 | 19454 | 50 |
MFNG |
1.279e-02 | -4.36 | CPN2 (carboxypeptidase N subunit 2) | protein interactions | 1370 | 5 | 1 | 19454 | 50 |
CPN1 |
1.284e-02 | -4.36 | RMND1 (required for meiotic nuclear division 1 homolog) | protein interactions | 55005 | 190 | 3 | 19454 | 50 |
MFNG,CTSB,NDUFS2 |
1.287e-02 | -4.35 | actin polymerization or depolymerization | biological process | GO:0008154 | 64 | 2 | 18204 | 49 |
PREX1,GAS7 |
1.287e-02 | -4.35 | regulation of B cell proliferation | biological process | GO:0030888 | 64 | 2 | 18204 | 49 |
CD74,NCKAP1L |
1.293e-02 | -4.35 | T cell differentiation | biological process | GO:0030217 | 182 | 3 | 18204 | 49 |
PREX1,CD74,ZFP36L1 |
1.293e-02 | -4.35 | regulation of cytokine-mediated signaling pathway | biological process | GO:0001959 | 182 | 3 | 18204 | 49 |
RBM47,CD74,SH2B3 |
1.294e-02 | -4.35 | KAZAL_2 | prosite domains | PS51465 | 48 | 2 | 12186 | 44 |
SLCO2B1,SPOCK3 |
1.295e-02 | -4.35 | LYSASSOCTDMP | prints domains | PR00336 | 4 | 1 | 5227 | 17 |
CD68 |
1.302e-02 | -4.34 | UGGT1 (UDP-glucose glycoprotein glucosyltransferase 1) | protein interactions | 56886 | 191 | 3 | 19454 | 50 |
CTSB,UNC93B1,P2RY6 |
1.311e-02 | -4.33 | DNAJC1 (DnaJ heat shock protein family (Hsp40) member C1) | protein interactions | 64215 | 356 | 4 | 19454 | 50 |
P2RY6,UNC93B1,SMPD4,RAC2 |
1.312e-02 | -4.33 | response to tumor necrosis factor | biological process | GO:0034612 | 183 | 3 | 18204 | 49 |
GCH1,SMPD4,ZFP36L1 |
1.320e-02 | -4.33 | cyclohydrolase activity | molecular function | GO:0019238 | 5 | 1 | 18094 | 48 |
GCH1 |
1.320e-02 | -4.33 | oxygen sensor activity | molecular function | GO:0019826 | 5 | 1 | 18094 | 48 |
NDUFS2 |
1.320e-02 | -4.33 | TORC2 complex binding | molecular function | GO:1904841 | 5 | 1 | 18094 | 48 |
NCKAP1L |
1.320e-02 | -4.33 | UBE3C (ubiquitin protein ligase E3C) | protein interactions | 9690 | 192 | 3 | 19454 | 50 |
P2RY6,UNC93B1,CD74 |
1.324e-02 | -4.32 | CA6 (carbonic anhydrase 6) | protein interactions | 765 | 68 | 2 | 19454 | 50 |
MYO9B,QSOX1 |
1.324e-02 | -4.32 | GEMIN6 (gem nuclear organelle associated protein 6) | protein interactions | 79833 | 68 | 2 | 19454 | 50 |
P2RY6,UNC93B1 |
1.325e-02 | -4.32 | T cell differentiation in thymus | biological process | GO:0033077 | 65 | 2 | 18204 | 49 |
ZFP36L1,CD74 |
1.327e-02 | -4.32 | response to stress | biological process | GO:0006950 | 3388 | 16 | 18204 | 49 |
ENTPD1,ZFP36L1,GCH1,HCK,CD68,ITGB2,PLEK,UNC93B1,TNFAIP8L2,MARCO,CD74,NCF1,TFEB,CSF1R,ITGAX,NDUFS2 |
1.328e-02 | -4.32 | env (Envelope surface glycoprotein gp160, precursor) | protein interactions | 155971 | 1501 | 9 | 19454 | 50 |
HCK,ABR,SMPD4,ITM2B,CTSB,ITGB2,GULP1,CD74,ITGAX |
1.331e-02 | -4.32 | positive regulation of cytoskeleton organization | biological process | GO:0051495 | 184 | 3 | 18204 | 49 |
PLEK,NCKAP1L,HCK |
1.335e-02 | -4.32 | PGRMC1 (progesterone receptor membrane component 1) | protein interactions | 10857 | 358 | 4 | 19454 | 50 |
CD74,P2RY6,UNC93B1,ARHGAP15 |
1.339e-02 | -4.31 | LTN1 (listerin E3 ubiquitin protein ligase 1) | protein interactions | 26046 | 193 | 3 | 19454 | 50 |
CD74,UNC93B1,P2RY6 |
1.339e-02 | -4.31 | toll-like receptor 7 signaling pathway | biological process | GO:0034154 | 5 | 1 | 18204 | 49 |
UNC93B1 |
1.339e-02 | -4.31 | Roundabout signaling pathway | biological process | GO:0035385 | 5 | 1 | 18204 | 49 |
MYO9B |
1.339e-02 | -4.31 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity | biological process | GO:0031585 | 5 | 1 | 18204 | 49 |
P2RY6 |
1.339e-02 | -4.31 | T cell antigen processing and presentation | biological process | GO:0002457 | 5 | 1 | 18204 | 49 |
UNC93B1 |
1.339e-02 | -4.31 | regulation of lung blood pressure | biological process | GO:0014916 | 5 | 1 | 18204 | 49 |
GCH1 |
1.339e-02 | -4.31 | positive regulation of CD8-positive, alpha-beta T cell differentiation | biological process | GO:0043378 | 5 | 1 | 18204 | 49 |
NCKAP1L |
1.339e-02 | -4.31 | thrombopoietin-mediated signaling pathway | biological process | GO:0038163 | 5 | 1 | 18204 | 49 |
SH2B3 |
1.339e-02 | -4.31 | negative regulation of myosin-light-chain-phosphatase activity | biological process | GO:0035509 | 5 | 1 | 18204 | 49 |
NCKAP1L |
1.339e-02 | -4.31 | lymphocyte aggregation | biological process | GO:0071593 | 5 | 1 | 18204 | 49 |
RAC2 |
1.342e-02 | -4.31 | Fringe | pfam domains | PF02434 | 5 | 1 | 17795 | 48 |
MFNG |
1.342e-02 | -4.31 | PH_19 | pfam domains | PF19057 | 5 | 1 | 17795 | 48 |
ABR |
1.342e-02 | -4.31 | Lamp | pfam domains | PF01299 | 5 | 1 | 17795 | 48 |
CD68 |
1.343e-02 | -4.31 | Lysosome-assoc_membr_glycop | interpro domains | IPR002000 | 5 | 1 | 18521 | 50 |
CD68 |
1.343e-02 | -4.31 | Lamp2-like_luminal | interpro domains | IPR048528 | 5 | 1 | 18521 | 50 |
CD68 |
1.343e-02 | -4.31 | Fringe-like_glycosylTrfase | interpro domains | IPR003378 | 5 | 1 | 18521 | 50 |
MFNG |
1.343e-02 | -4.31 | HnRNP_R/Q_splicing_fac | interpro domains | IPR006535 | 5 | 1 | 18521 | 50 |
RBM47 |
1.347e-02 | -4.31 | cellular response to cytokine stimulus | biological process | GO:0071345 | 734 | 6 | 18204 | 49 |
CSF1R,CD74,HCK,ZFP36L1,SMPD4,SH2B3 |
1.348e-02 | -4.31 | ST7 (suppression of tumorigenicity 7) | protein interactions | 7982 | 359 | 4 | 19454 | 50 |
SMPD4,P2RY6,UNC93B1,CTSB |
1.355e-02 | -4.30 | negative regulation of immune system process | biological process | GO:0002683 | 529 | 5 | 18204 | 49 |
HCK,CD74,CD68,NCKAP1L,TNFAIP8L2 |
1.357e-02 | -4.30 | ATP5PF (ATP synthase peripheral stalk subunit F6) | protein interactions | 522 | 194 | 3 | 19454 | 50 |
P2RY6,UNC93B1,TFEB |
1.361e-02 | -4.30 | EVL (Enah/Vasp-like) | protein interactions | 51466 | 69 | 2 | 19454 | 50 |
FYB1,HCK |
1.361e-02 | -4.30 | YIF1B (Yip1 interacting factor homolog B, membrane trafficking protein) | protein interactions | 90522 | 69 | 2 | 19454 | 50 |
P2RY6,UNC93B1 |
1.364e-02 | -4.29 | peptidyl-tyrosine phosphorylation | biological process | GO:0018108 | 66 | 2 | 18204 | 49 |
CSF1R,HCK |
1.364e-02 | -4.29 | homotypic cell-cell adhesion | biological process | GO:0034109 | 66 | 2 | 18204 | 49 |
PLEK,ENTPD1 |
1.373e-02 | -4.29 | DDOST (dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit) | protein interactions | 1650 | 361 | 4 | 19454 | 50 |
P2RY6,UNC93B1,RAC2,CTSB |
1.376e-02 | -4.29 | RPUSD3 (RNA pseudouridine synthase D3) | protein interactions | 285367 | 195 | 3 | 19454 | 50 |
NDUFS2,RBM47,RAC2 |
1.376e-02 | -4.29 | SGPL1 (sphingosine-1-phosphate lyase 1) | protein interactions | 8879 | 195 | 3 | 19454 | 50 |
P2RY6,UNC93B1,CD74 |
1.395e-02 | -4.27 | CALM2 (calmodulin 2) | protein interactions | 805 | 196 | 3 | 19454 | 50 |
RAC2,CTSB,MYO9B |
1.399e-02 | -4.27 | IL6ST (interleukin 6 cytokine family signal transducer) | protein interactions | 3572 | 70 | 2 | 19454 | 50 |
HCK,RAC2 |
1.403e-02 | -4.27 | cell projection organization | biological process | GO:0030030 | 1200 | 8 | 18204 | 49 |
MYO9B,RAPGEF6,NCAM2,GAS7,NCKAP1L,PLEK,RAC2,CSF1R |
1.404e-02 | -4.27 | positive regulation of response to cytokine stimulus | biological process | GO:0060760 | 67 | 2 | 18204 | 49 |
CD74,RBM47 |
1.406e-02 | -4.26 | cellular response to lipid | biological process | GO:0071396 | 534 | 5 | 18204 | 49 |
CD68,P2RY6,NCF1,ZFP36L1,HCK |
1.412e-02 | -4.26 | YES1 (YES proto-oncogene 1, Src family tyrosine kinase) | protein interactions | 7525 | 364 | 4 | 19454 | 50 |
CSF1R,RAC2,HCK,GAB1 |
1.414e-02 | -4.26 | TMEM237 (transmembrane protein 237) | protein interactions | 65062 | 197 | 3 | 19454 | 50 |
RAC2,UNC93B1,CMTM6 |
1.414e-02 | -4.26 | PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3) | protein interactions | 8503 | 197 | 3 | 19454 | 50 |
HCK,WDFY3,GAB1 |
1.421e-02 | -4.25 | regulation of multicellular organismal process | biological process | GO:0051239 | 3113 | 15 | 18204 | 49 |
TNFAIP8L2,NCKAP1L,PLEK,UNC93B1,CSF1R,CD74,NCF1,RAC2,ITGAX,GAB1,PLXND1,SH2B3,GCH1,ZFP36L1,RBM47 |
1.425e-02 | -4.25 | regulation of signal transduction | biological process | GO:0009966 | 3114 | 15 | 18204 | 49 |
RBM47,RGS19,SH2B3,P2RY6,PREX1,MYO9B,ABR,MFNG,ARHGAP15,CSF1R,CD74,NCF1,MARCO,PLEK,NCKAP1L |
1.433e-02 | -4.25 | NDC1 (NDC1 transmembrane nucleoporin) | protein interactions | 55706 | 198 | 3 | 19454 | 50 |
UNC93B1,P2RY6,RAC2 |
1.437e-02 | -4.24 | LAMP_3 | prosite domains | PS51407 | 4 | 1 | 12186 | 44 |
CD68 |
1.437e-02 | -4.24 | HIGD1A (HIG1 hypoxia inducible domain family member 1A) | protein interactions | 25994 | 71 | 2 | 19454 | 50 |
UNC93B1,P2RY6 |
1.439e-02 | -4.24 | lamellipodium | cellular component | GO:0030027 | 203 | 3 | 19108 | 48 |
MYO9B,PLXND1,RAC2 |
1.439e-02 | -4.24 | endocytic vesicle membrane | cellular component | GO:0030666 | 203 | 3 | 19108 | 48 |
CD74,MARCO,RAC2 |
1.444e-02 | -4.24 | peptidyl-tyrosine modification | biological process | GO:0018212 | 68 | 2 | 18204 | 49 |
HCK,CSF1R |
1.450e-02 | -4.23 | tertiary granule membrane | cellular component | GO:0070821 | 73 | 2 | 19108 | 48 |
ITGAX,ITGB2 |
1.461e-02 | -4.23 | Cell surface interactions at the vascular wall | REACTOME pathways | R-HSA-202733 | 136 | 3 | 10285 | 39 |
ITGB2,CD74,ITGAX |
1.470e-02 | -4.22 | regulation of cellular component size | biological process | GO:0032535 | 352 | 4 | 18204 | 49 |
PLEK,NCKAP1L,HCK,PREX1 |
1.476e-02 | -4.22 | ITGB2 (integrin subunit beta 2) | protein interactions | 3689 | 72 | 2 | 19454 | 50 |
ITGB2,ITGAX |
1.476e-02 | -4.22 | FAM234B (family with sequence similarity 234 member B) | protein interactions | 57613 | 72 | 2 | 19454 | 50 |
ITM2B,RAC2 |
1.492e-02 | -4.21 | PTDSS1 (phosphatidylserine synthase 1) | protein interactions | 9791 | 201 | 3 | 19454 | 50 |
RAC2,CTSB,RBM47 |
1.498e-02 | -4.20 | Atg12-Atg5-Atg16 complex | cellular component | GO:0034274 | 6 | 1 | 19108 | 48 |
WDFY3 |
1.498e-02 | -4.20 | mRNA editing complex | cellular component | GO:0045293 | 6 | 1 | 19108 | 48 |
RBM47 |
1.512e-02 | -4.19 | positive regulation of leukocyte differentiation | biological process | GO:1902107 | 193 | 3 | 18204 | 49 |
NCKAP1L,ZFP36L1,CD74 |
1.512e-02 | -4.19 | positive regulation of hemopoiesis | biological process | GO:1903708 | 193 | 3 | 18204 | 49 |
CD74,ZFP36L1,NCKAP1L |
1.518e-02 | -4.19 | carcinoid-endocrine_tumour | COSMIC cancer mutations | carcinoid-endocrine_tumour | 7752 | 29 | 16828 | 46 |
NCKAP1L,GAB1,NCAM2,ARHGAP15,SMPD4,CSF1R,WDFY3,MFNG,CTSB,PLEK,SPOCK3,SH2B3,MARCO,GCH1,QSOX1,GAS7,ABR,ITGAX,RAC2,ZFP36L1,ELMO1,MYO1F,ITM2B,GULP1,PREX1,HCK,PLXND1,CPN1,ZNRF2 |
1.526e-02 | -4.18 | antigen processing and presentation of peptide antigen | biological process | GO:0048002 | 70 | 2 | 18204 | 49 |
UNC93B1,CD74 |
1.530e-02 | -4.18 | CKAP4 (cytoskeleton associated protein 4) | protein interactions | 10970 | 571 | 5 | 19454 | 50 |
UNC93B1,P2RY6,SMPD4,RAC2,CTSB |
1.531e-02 | -4.18 | RhoGEF | pfam domains | PF00621 | 70 | 2 | 17795 | 48 |
ABR,PREX1 |
1.531e-02 | -4.18 | CERS2 (ceramide synthase 2) | protein interactions | 29956 | 203 | 3 | 19454 | 50 |
UNC93B1,P2RY6,RAC2 |
1.532e-02 | -4.18 | CGB1 (chorionic gonadotropin subunit beta 1) | protein interactions | 114335 | 6 | 1 | 19454 | 50 |
ZNRF2 |
1.532e-02 | -4.18 | ITGAX (integrin subunit alpha X) | protein interactions | 3687 | 6 | 1 | 19454 | 50 |
ITGB2 |
1.533e-02 | -4.18 | regulation of response to cytokine stimulus | biological process | GO:0060759 | 194 | 3 | 18204 | 49 |
SH2B3,CD74,RBM47 |
1.535e-02 | -4.18 | DH-domain | interpro domains | IPR000219 | 70 | 2 | 18521 | 50 |
ABR,PREX1 |
1.538e-02 | -4.17 | signaling receptor binding | molecular function | GO:0005102 | 1493 | 9 | 18094 | 48 |
MARCO,FYB1,UNC93B1,MYO9B,SH2B3,CD74,ITGB2,ITGAX,HCK |
1.554e-02 | -4.16 | KCNK1 (potassium two pore domain channel subfamily K member 1) | protein interactions | 3775 | 74 | 2 | 19454 | 50 |
UNC93B1,CMTM6 |
1.554e-02 | -4.16 | COG1 (component of oligomeric golgi complex 1) | protein interactions | 9382 | 74 | 2 | 19454 | 50 |
UNC93B1,P2RY6 |
1.554e-02 | -4.16 | COG7 (component of oligomeric golgi complex 7) | protein interactions | 91949 | 74 | 2 | 19454 | 50 |
UNC93B1,P2RY6 |
1.557e-02 | -4.16 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 748 | 6 | 16828 | 46 |
WDFY3,ELMO1,ZFP36L1,CD74,CPN1,HCK |
1.568e-02 | -4.16 | localization within membrane | biological process | GO:0051668 | 549 | 5 | 18204 | 49 |
ITGB2,RAPGEF6,CMTM6,FYB1,NCF1 |
1.573e-02 | -4.15 | CALR (calreticulin) | protein interactions | 811 | 376 | 4 | 19454 | 50 |
NDUFS2,P2RY6,CTSB,LPP |
1.576e-02 | -4.15 | DBL_dom_sf | interpro domains | IPR035899 | 71 | 2 | 18521 | 50 |
PREX1,ABR |
1.581e-02 | -4.15 | CTPase activity | molecular function | GO:0043273 | 6 | 1 | 18094 | 48 |
ENTPD1 |
1.581e-02 | -4.15 | ADP phosphatase activity | molecular function | GO:0043262 | 6 | 1 | 18094 | 48 |
ENTPD1 |
1.581e-02 | -4.15 | thiol oxidase activity | molecular function | GO:0016972 | 6 | 1 | 18094 | 48 |
QSOX1 |
1.592e-02 | -4.14 | CDKAL1 (CDK5 regulatory subunit associated protein 1 like 1) | protein interactions | 54901 | 206 | 3 | 19454 | 50 |
RAC2,UNC93B1,P2RY6 |
1.594e-02 | -4.14 | CHP1 (calcineurin like EF-hand protein 1) | protein interactions | 11261 | 75 | 2 | 19454 | 50 |
UNC93B1,P2RY6 |
1.594e-02 | -4.14 | SPTLC2 (serine palmitoyltransferase long chain base subunit 2) | protein interactions | 9517 | 75 | 2 | 19454 | 50 |
UNC93B1,P2RY6 |
1.604e-02 | -4.13 | positive regulation of macrophage proliferation | biological process | GO:0120041 | 6 | 1 | 18204 | 49 |
CSF1R |
1.604e-02 | -4.13 | regulation of endothelial tube morphogenesis | biological process | GO:1901509 | 6 | 1 | 18204 | 49 |
ITGAX |
1.604e-02 | -4.13 | enucleate erythrocyte development | biological process | GO:0048822 | 6 | 1 | 18204 | 49 |
RAC2 |
1.604e-02 | -4.13 | sphingomyelin catabolic process | biological process | GO:0006685 | 6 | 1 | 18204 | 49 |
SMPD4 |
1.604e-02 | -4.13 | negative regulation of amine metabolic process | biological process | GO:0033239 | 6 | 1 | 18204 | 49 |
ITGB2 |
1.604e-02 | -4.13 | positive regulation of prostaglandin biosynthetic process | biological process | GO:0031394 | 6 | 1 | 18204 | 49 |
CD74 |
1.607e-02 | -4.13 | cargo receptor activity | molecular function | GO:0038024 | 73 | 2 | 18094 | 48 |
MARCO,ITGB2 |
1.608e-02 | -4.13 | PH_BEACH | pfam domains | PF14844 | 6 | 1 | 17795 | 48 |
WDFY3 |
1.608e-02 | -4.13 | Integrin_b_cyt | pfam domains | PF08725 | 6 | 1 | 17795 | 48 |
ITGB2 |
1.608e-02 | -4.13 | ELMO_CED12 | pfam domains | PF04727 | 6 | 1 | 17795 | 48 |
ELMO1 |
1.608e-02 | -4.13 | Integrin_B_tail | pfam domains | PF07965 | 6 | 1 | 17795 | 48 |
ITGB2 |
1.609e-02 | -4.13 | Integrin_bsu_cyt_dom | interpro domains | IPR014836 | 6 | 1 | 18521 | 50 |
ITGB2 |
1.609e-02 | -4.13 | ELMO_dom | interpro domains | IPR006816 | 6 | 1 | 18521 | 50 |
ELMO1 |
1.609e-02 | -4.13 | positive regulation of chemokine production | biological process | GO:0032722 | 72 | 2 | 18204 | 49 |
CSF1R,CD74 |
1.623e-02 | -4.12 | positive regulation of cell population proliferation | biological process | GO:0008284 | 992 | 7 | 18204 | 49 |
NCKAP1L,P2RY6,CSF1R,CD74,RAC2,ITGAX,HCK |
1.627e-02 | -4.12 | protein-containing complex binding | molecular function | GO:0044877 | 1772 | 10 | 18094 | 48 |
NCKAP1L,FYB1,GCH1,MYO1F,MYO9B,CTSB,CD74,ITGB2,ITGAX,GAS7 |
1.633e-02 | -4.11 | HSD17B12 (hydroxysteroid 17-beta dehydrogenase 12) | protein interactions | 51144 | 208 | 3 | 19454 | 50 |
CTSB,UNC93B1,P2RY6 |
1.640e-02 | -4.11 | positive regulation of protein-containing complex assembly | biological process | GO:0031334 | 199 | 3 | 18204 | 49 |
NCKAP1L,PLEK,HCK |
1.648e-02 | -4.11 | endosome | cellular component | GO:0005768 | 1067 | 7 | 19108 | 48 |
ITM2B,CMTM6,ZNRF2,CTSB,CD68,CD74,UNC93B1 |
1.652e-02 | -4.10 | endothelial cell migration | biological process | GO:0043542 | 73 | 2 | 18204 | 49 |
PLXND1,GAB1 |
1.654e-02 | -4.10 | ATP1B3 (ATPase Na+/K+ transporting subunit beta 3) | protein interactions | 483 | 209 | 3 | 19454 | 50 |
P2RY6,UNC93B1,RAC2 |
1.657e-02 | -4.10 | COPA (COPI coat complex subunit alpha) | protein interactions | 1314 | 382 | 4 | 19454 | 50 |
NCF1,CD74,P2RY6,UNC93B1 |
1.676e-02 | -4.09 | ADGRL2 (adhesion G protein-coupled receptor L2) | protein interactions | 23266 | 77 | 2 | 19454 | 50 |
RAC2,UNC93B1 |
1.676e-02 | -4.09 | DYM (dymeclin) | protein interactions | 54808 | 77 | 2 | 19454 | 50 |
UNC93B1,P2RY6 |
1.676e-02 | -4.09 | TNS3 (tensin 3) | protein interactions | 64759 | 77 | 2 | 19454 | 50 |
RAC2,GAB1 |
1.676e-02 | -4.09 | PALD1 (phosphatase domain containing paladin 1) | protein interactions | 27143 | 77 | 2 | 19454 | 50 |
P2RY6,RAC2 |
1.691e-02 | -4.08 | plasma membrane protein complex | cellular component | GO:0098797 | 600 | 5 | 19108 | 48 |
CD74,ITGB2,RAC2,ITGAX,NCF1 |
1.696e-02 | -4.08 | CRKL (CRK like proto-oncogene, adaptor protein) | protein interactions | 1399 | 211 | 3 | 19454 | 50 |
HCK,ELMO1,GAB1 |
1.697e-02 | -4.08 | mantle_cell_lymphoma | COSMIC cancer mutations | mantle_cell_lymphoma | 2849 | 14 | 16828 | 46 |
MYO9B,PLEK,SPOCK3,MYO1F,WDFY3,ELMO1,TFEB,GAB1,NCAM2,GULP1,GAS7,ABR,GCH1,PREX1 |
1.703e-02 | -4.07 | immune response-regulating signaling pathway | biological process | GO:0002764 | 368 | 4 | 18204 | 49 |
HCK,FYB1,UNC93B1,NCKAP1L |
1.703e-02 | -4.07 | activation of immune response | biological process | GO:0002253 | 368 | 4 | 18204 | 49 |
FYB1,HCK,UNC93B1,NCKAP1L |
1.705e-02 | -4.07 | Phagosome | KEGG pathways | ko04145 | 152 | 3 | 7161 | 26 |
MARCO,ITGB2,NCF1 |
1.705e-02 | -4.07 | Phagosome | KEGG pathways | hsa04145 | 152 | 3 | 7161 | 26 |
NCF1,MARCO,ITGB2 |
1.706e-02 | -4.07 | regulation of protein polymerization | biological process | GO:0032271 | 202 | 3 | 18204 | 49 |
NCKAP1L,PREX1,HCK |
1.709e-02 | -4.07 | human chr12q24.12 | chromosome location | human chr12q24.12 | 9 | 1 | 26134 | 50 |
SH2B3 |
1.709e-02 | -4.07 | human chr14q22.2 | chromosome location | human chr14q22.2 | 9 | 1 | 26134 | 50 |
GCH1 |
1.718e-02 | -4.06 | OS9 (OS9 endoplasmic reticulum lectin) | protein interactions | 10956 | 212 | 3 | 19454 | 50 |
P2RY6,UNC93B1,CTSB |
1.719e-02 | -4.06 | secretory vesicle | cellular component | GO:0099503 | 1076 | 7 | 19108 | 48 |
NCKAP1L,ITGB2,CTSB,ITGAX,QSOX1,CD68,CMTM6 |
1.726e-02 | -4.06 | external side of plasma membrane | cellular component | GO:0009897 | 396 | 4 | 19108 | 48 |
CD74,ITGB2,CTSB,ITGAX |
1.728e-02 | -4.06 | negative regulation of cell-cell adhesion | biological process | GO:0022408 | 203 | 3 | 18204 | 49 |
CD74,TNFAIP8L2,SH2B3 |
1.739e-02 | -4.05 | PPP6C (protein phosphatase 6 catalytic subunit) | protein interactions | 5537 | 213 | 3 | 19454 | 50 |
ZNRF2,P2RY6,UNC93B1 |
1.747e-02 | -4.05 | small molecule binding | molecular function | GO:0036094 | 6197 | 24 | 18094 | 48 |
RAPGEF6,NDUFS2,HCK,WDFY3,CPN1,SPOCK3,DAPP1,LPP,MYO1F,RAC2,MYO9B,ZNRF2,ITGB2,GCH1,PLEK,ZFP36L1,CSF1R,NCF1,SMPD4,ENTPD1,MFNG,ITGAX,QSOX1,ITM2B |
1.759e-02 | -4.04 | CANT1 (calcium activated nucleotidase 1) | protein interactions | 124583 | 79 | 2 | 19454 | 50 |
ITM2B,MFNG |
1.759e-02 | -4.04 | ATAD1 (ATPase family AAA domain containing 1) | protein interactions | 84896 | 79 | 2 | 19454 | 50 |
RAC2,UNC93B1 |
1.761e-02 | -4.04 | NCAPD2 (non-SMC condensin I complex subunit D2) | protein interactions | 9918 | 214 | 3 | 19454 | 50 |
CD74,UNC93B1,P2RY6 |
1.782e-02 | -4.03 | XPO5 (exportin 5) | protein interactions | 57510 | 215 | 3 | 19454 | 50 |
UNC93B1,P2RY6,CTSB |
1.786e-02 | -4.03 | ZCCHC24 (zinc finger CCHC-type containing 24) | protein interactions | 219654 | 7 | 1 | 19454 | 50 |
RBM47 |
1.786e-02 | -4.03 | TLR8 (toll like receptor 8) | protein interactions | 51311 | 7 | 1 | 19454 | 50 |
UNC93B1 |
1.804e-02 | -4.01 | ATP2B1 (ATPase plasma membrane Ca2+ transporting 1) | protein interactions | 490 | 216 | 3 | 19454 | 50 |
RAC2,UNC93B1,P2RY6 |
1.811e-02 | -4.01 | - | gene3d domains | 2.40.160.110 | 6 | 1 | 14470 | 44 |
CD68 |
1.829e-02 | -4.00 | cellular process | biological process | GO:0009987 | 14996 | 46 | 18204 | 49 |
RGS19,LPP,ITGB2,CD68,MYO1F,NCKAP1L,SMPD4,ARHGAP15,CSF1R,QSOX1,GAB1,PREX1,SH2B3,GAS7,PLXND1,ENTPD1,ZFP36L1,PLEK,UNC93B1,MFNG,NCF1,WDFY3,P2RY6,SLCO2B1,GCH1,FYB1,HCK,RBM47,CMTM6,TNFAIP8L2,DAPP1,RAC2,MARCO,CD74,LRMDA,CPN1,NCAM2,CTSB,GULP1,TFEB,MYO9B,RAPGEF6,ABR,ITGAX,ELMO1,NDUFS2 |
1.835e-02 | -4.00 | PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) | protein interactions | 5295 | 394 | 4 | 19454 | 50 |
RAC2,HCK,CSF1R,GAB1 |
1.840e-02 | -4.00 | actin filament binding | molecular function | GO:0051015 | 211 | 3 | 18094 | 48 |
MYO9B,GAS7,MYO1F |
1.840e-02 | -4.00 | regulation of leukocyte activation | biological process | GO:0002694 | 572 | 5 | 18204 | 49 |
NCKAP1L,TNFAIP8L2,ZFP36L1,RAC2,CD74 |
1.843e-02 | -3.99 | sphingomyelin phosphodiesterase activity | molecular function | GO:0004767 | 7 | 1 | 18094 | 48 |
SMPD4 |
1.843e-02 | -3.99 | MHC class II protein binding | molecular function | GO:0042289 | 7 | 1 | 18094 | 48 |
CD74 |
1.843e-02 | -3.99 | CAND2 (cullin associated and neddylation dissociated 2 (putative)) | protein interactions | 23066 | 81 | 2 | 19454 | 50 |
P2RY6,UNC93B1 |
1.848e-02 | -3.99 | caveola | cellular component | GO:0005901 | 83 | 2 | 19108 | 48 |
HCK,ENTPD1 |
1.849e-02 | -3.99 | TNPO2 (transportin 2) | protein interactions | 30000 | 218 | 3 | 19454 | 50 |
UNC93B1,GCH1,CD68 |
1.850e-02 | -3.99 | Viral myocarditis | KEGG pathways | hsa05416 | 58 | 2 | 7161 | 26 |
RAC2,ITGB2 |
1.858e-02 | -3.99 | apical plasma membrane | cellular component | GO:0016324 | 405 | 4 | 19108 | 48 |
RAPGEF6,P2RY6,SLCO2B1,CTSB |
1.864e-02 | -3.98 | regulation of apoptotic process | biological process | GO:0042981 | 1518 | 9 | 18204 | 49 |
HCK,CTSB,ZFP36L1,CD74,CSF1R,GCH1,NCKAP1L,TNFAIP8L2,PLXND1 |
1.865e-02 | -3.98 | oxidoreductase activity, acting on NAD(P)H | molecular function | GO:0016651 | 79 | 2 | 18094 | 48 |
NDUFS2,NCF1 |
1.867e-02 | -3.98 | stomach-adenocarcinoma | COSMIC cancer mutations | stomach-adenocarcinoma | 4101 | 18 | 16828 | 46 |
ITGAX,GAS7,PREX1,QSOX1,SPOCK3,PLEK,P2RY6,MARCO,ITM2B,NCAM2,NCKAP1L,TFEB,ZFP36L1,GAB1,ELMO1,WDFY3,SMPD4,MYO1F |
1.869e-02 | -3.98 | response to interleukin-3 | biological process | GO:0036015 | 7 | 1 | 18204 | 49 |
SH2B3 |
1.869e-02 | -3.98 | lamellipodium morphogenesis | biological process | GO:0072673 | 7 | 1 | 18204 | 49 |
MYO9B |
1.869e-02 | -3.98 | regulation of isomerase activity | biological process | GO:0010911 | 7 | 1 | 18204 | 49 |
ITGB2 |
1.869e-02 | -3.98 | positive regulation of dendritic cell antigen processing and presentation | biological process | GO:0002606 | 7 | 1 | 18204 | 49 |
CD74 |
1.869e-02 | -3.98 | actin polymerization-dependent cell motility | biological process | GO:0070358 | 7 | 1 | 18204 | 49 |
NCKAP1L |
1.869e-02 | -3.98 | tetrahydrofolate biosynthetic process | biological process | GO:0046654 | 7 | 1 | 18204 | 49 |
GCH1 |
1.869e-02 | -3.98 | platelet degranulation | biological process | GO:0002576 | 7 | 1 | 18204 | 49 |
PLEK |
1.869e-02 | -3.98 | regulation of macrophage proliferation | biological process | GO:0120040 | 7 | 1 | 18204 | 49 |
CSF1R |
1.869e-02 | -3.98 | chorio-allantoic fusion | biological process | GO:0060710 | 7 | 1 | 18204 | 49 |
ZFP36L1 |
1.869e-02 | -3.98 | regulation of removal of superoxide radicals | biological process | GO:2000121 | 7 | 1 | 18204 | 49 |
GCH1 |
1.869e-02 | -3.98 | regulation of mast cell proliferation | biological process | GO:0070666 | 7 | 1 | 18204 | 49 |
RAC2 |
1.869e-02 | -3.98 | regulation of TORC2 signaling | biological process | GO:1903939 | 7 | 1 | 18204 | 49 |
NCKAP1L |
1.869e-02 | -3.98 | tetrahydrobiopterin biosynthetic process | biological process | GO:0006729 | 7 | 1 | 18204 | 49 |
GCH1 |
1.869e-02 | -3.98 | positive regulation of isomerase activity | biological process | GO:0010912 | 7 | 1 | 18204 | 49 |
ITGB2 |
1.869e-02 | -3.98 | cellular response to interleukin-3 | biological process | GO:0036016 | 7 | 1 | 18204 | 49 |
SH2B3 |
1.869e-02 | -3.98 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay | biological process | GO:0031086 | 7 | 1 | 18204 | 49 |
ZFP36L1 |
1.869e-02 | -3.98 | bradykinin catabolic process | biological process | GO:0010815 | 7 | 1 | 18204 | 49 |
CPN1 |
1.869e-02 | -3.98 | regulation of myosin-light-chain-phosphatase activity | biological process | GO:0035507 | 7 | 1 | 18204 | 49 |
NCKAP1L |
1.869e-02 | -3.98 | positive regulation of gamma-delta T cell differentiation | biological process | GO:0045588 | 7 | 1 | 18204 | 49 |
NCKAP1L |
1.873e-02 | -3.98 | SPARC_Ca_bdg | pfam domains | PF10591 | 7 | 1 | 17795 | 48 |
SPOCK3 |
1.875e-02 | -3.98 | Integrin_bsu_tail | interpro domains | IPR012896 | 7 | 1 | 18521 | 50 |
ITGB2 |
1.875e-02 | -3.98 | Integrin_bsu_tail_dom_sf | interpro domains | IPR036349 | 7 | 1 | 18521 | 50 |
ITGB2 |
1.875e-02 | -3.98 | SPARC/Testican_Ca-bd-dom | interpro domains | IPR019577 | 7 | 1 | 18521 | 50 |
SPOCK3 |
1.875e-02 | -3.98 | MYSc_Myo1 | interpro domains | IPR036072 | 7 | 1 | 18521 | 50 |
MYO1F |
1.882e-02 | -3.97 | MET activates PTPN11 | REACTOME pathways | R-HSA-8865999 | 5 | 1 | 10285 | 39 |
GAB1 |
1.886e-02 | -3.97 | ANKRD52 (ankyrin repeat domain 52) | protein interactions | 283373 | 82 | 2 | 19454 | 50 |
ZNRF2,ENTPD1 |
1.886e-02 | -3.97 | OSBPL9 (oxysterol binding protein like 9) | protein interactions | 114883 | 82 | 2 | 19454 | 50 |
GCH1,RAC2 |
1.893e-02 | -3.97 | SCFD1 (sec1 family domain containing 1) | protein interactions | 23256 | 220 | 3 | 19454 | 50 |
RAC2,P2RY6,UNC93B1 |
1.913e-02 | -3.96 | positive regulation of GTPase activity | biological process | GO:0043547 | 211 | 3 | 18204 | 49 |
PREX1,RAPGEF6,ABR |
1.916e-02 | -3.95 | ERLIN2 (ER lipid raft associated 2) | protein interactions | 11160 | 221 | 3 | 19454 | 50 |
UNC93B1,P2RY6,CTSB |
1.917e-02 | -3.95 | regulation of protein targeting | biological process | GO:1903533 | 79 | 2 | 18204 | 49 |
ITGB2,RAC2 |
1.929e-02 | -3.95 | localization | biological process | GO:0051179 | 4474 | 19 | 18204 | 49 |
NDUFS2,RAPGEF6,ELMO1,TFEB,CD74,NCF1,MARCO,ITGB2,CD68,GULP1,MYO1F,CMTM6,PLEK,UNC93B1,HCK,ZFP36L1,FYB1,P2RY6,SLCO2B1 |
1.939e-02 | -3.94 | PDGFRB (platelet derived growth factor receptor beta) | protein interactions | 5159 | 222 | 3 | 19454 | 50 |
GAB1,CSF1R,RAC2 |
1.939e-02 | -3.94 | YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta) | protein interactions | 10971 | 1076 | 7 | 19454 | 50 |
TFEB,ZNRF2,RAPGEF6,CD74,ZFP36L1,GAB1,NCF1 |
1.944e-02 | -3.94 | prostate-carcinoma | COSMIC cancer mutations | prostate-carcinoma | 9000 | 32 | 16828 | 46 |
SPOCK3,P2RY6,MARCO,RGS19,RBM47,CTSB,MFNG,NCAM2,GAB1,NCKAP1L,TFEB,CSF1R,SMPD4,ARHGAP15,WDFY3,ABR,RAC2,ITGAX,GAS7,LPP,RAPGEF6,SLCO2B1,GULP1,ELMO1,ZFP36L1,MYO1F,ENTPD1,ZNRF2,PLXND1,HCK,PREX1,NDUFS2 |
1.959e-02 | -3.93 | regulation of T cell activation | biological process | GO:0050863 | 384 | 4 | 18204 | 49 |
RAC2,CD74,TNFAIP8L2,NCKAP1L |
1.959e-02 | -3.93 | cytokine-mediated signaling pathway | biological process | GO:0019221 | 384 | 4 | 18204 | 49 |
HCK,CSF1R,CD74,SH2B3 |
1.959e-02 | -3.93 | regulation of leukocyte cell-cell adhesion | biological process | GO:1903037 | 384 | 4 | 18204 | 49 |
CD74,ITGB2,NCKAP1L,TNFAIP8L2 |
1.960e-02 | -3.93 | EMC2 (ER membrane protein complex subunit 2) | protein interactions | 9694 | 402 | 4 | 19454 | 50 |
P2RY6,UNC93B1,NDUFS2,RAC2 |
1.966e-02 | -3.93 | Dbl homology (DH) domain | gene3d domains | 1.20.900.10 | 71 | 2 | 14470 | 44 |
ABR,PREX1 |
1.974e-02 | -3.93 | Tyr_kinase_cat_dom | interpro domains | IPR020635 | 80 | 2 | 18521 | 50 |
CSF1R,HCK |
1.985e-02 | -3.92 | negative regulation of cell activation | biological process | GO:0050866 | 214 | 3 | 18204 | 49 |
SH2B3,TNFAIP8L2,CD74 |
1.992e-02 | -3.92 | phagolysosome | cellular component | GO:0032010 | 8 | 1 | 19108 | 48 |
NCF1 |
1.995e-02 | -3.91 | Toll-Like Receptors Cascades | REACTOME pathways | R-HSA-168898 | 153 | 3 | 10285 | 39 |
ITGB2,UNC93B1,CTSB |
2.000e-02 | -3.91 | receptor tyrosine kinase binding | molecular function | GO:0030971 | 82 | 2 | 18094 | 48 |
ITGAX,SH2B3 |
2.008e-02 | -3.91 | RINT1 (RAD50 interactor 1) | protein interactions | 60561 | 225 | 3 | 19454 | 50 |
RAC2,UNC93B1,P2RY6 |
2.018e-02 | -3.90 | ATP5ME (ATP synthase membrane subunit e) | protein interactions | 521 | 85 | 2 | 19454 | 50 |
P2RY6,UNC93B1 |
2.018e-02 | -3.90 | WSB2 (WD repeat and SOCS box containing 2) | protein interactions | 55884 | 85 | 2 | 19454 | 50 |
PREX1,SMPD4 |
2.026e-02 | -3.90 | regulation of supramolecular fiber organization | biological process | GO:1902903 | 388 | 4 | 18204 | 49 |
PLEK,NCKAP1L,PREX1,HCK |
2.032e-02 | -3.90 | AUP1 (AUP1 lipid droplet regulating VLDL assembly factor) | protein interactions | 550 | 226 | 3 | 19454 | 50 |
UNC93B1,P2RY6,RAC2 |
2.034e-02 | -3.90 | regulation of lymphocyte differentiation | biological process | GO:0045619 | 216 | 3 | 18204 | 49 |
NCKAP1L,ZFP36L1,CD74 |
2.034e-02 | -3.90 | regulation of myeloid cell differentiation | biological process | GO:0045637 | 216 | 3 | 18204 | 49 |
NCKAP1L,CD74,ZFP36L1 |
2.038e-02 | -3.89 | CALML6 (calmodulin like 6) | protein interactions | 163688 | 8 | 1 | 19454 | 50 |
GCH1 |
2.038e-02 | -3.89 | NCF1C (neutrophil cytosolic factor 1C (pseudogene)) | protein interactions | 654817 | 8 | 1 | 19454 | 50 |
NCF1 |
2.038e-02 | -3.89 | CD1D (CD1d molecule) | protein interactions | 912 | 8 | 1 | 19454 | 50 |
CD74 |
2.038e-02 | -3.89 | MGAM (maltase-glucoamylase) | protein interactions | 8972 | 8 | 1 | 19454 | 50 |
NCF1 |
2.043e-02 | -3.89 | immune effector process | biological process | GO:0002252 | 389 | 4 | 18204 | 49 |
UNC93B1,HCK,MFNG,CD74 |
2.056e-02 | -3.88 | endoderm development | biological process | GO:0007492 | 82 | 2 | 18204 | 49 |
ITGB2,ZFP36L1 |
2.057e-02 | -3.88 | ESYT1 (extended synaptotagmin 1) | protein interactions | 23344 | 408 | 4 | 19454 | 50 |
RAC2,ARHGAP15,SMPD4,P2RY6 |
2.068e-02 | -3.88 | IQ_motif_EF-hand-BS | interpro domains | IPR000048 | 82 | 2 | 18521 | 50 |
MYO9B,MYO1F |
2.068e-02 | -3.88 | Kinesin_motor_dom_sf | interpro domains | IPR036961 | 82 | 2 | 18521 | 50 |
MYO1F,MYO9B |
2.073e-02 | -3.88 | EMC1 (ER membrane protein complex subunit 1) | protein interactions | 23065 | 409 | 4 | 19454 | 50 |
UNC93B1,NDUFS2,P2RY6,RAC2 |
2.079e-02 | -3.87 | GRN (granulin precursor) | protein interactions | 2896 | 228 | 3 | 19454 | 50 |
CTSB,RAPGEF6,CD68 |
2.082e-02 | -3.87 | Integrin_b_cyt | smart domains | SM01241 | 6 | 1 | 9717 | 34 |
ITGB2 |
2.085e-02 | -3.87 | PHB1 (prohibitin 1) | protein interactions | 5245 | 1092 | 7 | 19454 | 50 |
PREX1,CD74,CTSB,UNC93B1,P2RY6,NDUFS2,RAC2 |
2.103e-02 | -3.86 | positive regulation of B cell activation | biological process | GO:0050871 | 83 | 2 | 18204 | 49 |
NCKAP1L,CD74 |
2.103e-02 | -3.86 | CD4 receptor binding | molecular function | GO:0042609 | 8 | 1 | 18094 | 48 |
CD74 |
2.103e-02 | -3.86 | Roundabout binding | molecular function | GO:0048495 | 8 | 1 | 18094 | 48 |
MYO9B |
2.103e-02 | -3.86 | breast-carcinoma-ductal_carcinoma | COSMIC cancer mutations | breast-carcinoma-ductal_carcinoma | 14824 | 45 | 16828 | 46 |
WDFY3,SMPD4,GAB1,TFEB,NCAM2,SH2B3,RGS19,MARCO,PLEK,SPOCK3,CTSB,LPP,RAC2,ABR,CD68,GULP1,DAPP1,ITM2B,MYO1F,ELMO1,CMTM6,HCK,NCF1,ENTPD1,CPN1,PLXND1,MFNG,ARHGAP15,CSF1R,NCKAP1L,P2RY6,MYO9B,GCH1,QSOX1,ITGAX,GAS7,SLCO2B1,ITGB2,ZFP36L1,CD74,TNFAIP8L2,RAPGEF6,NDUFS2,PREX1,ZNRF2 |
2.115e-02 | -3.86 | supramolecular fiber organization | biological process | GO:0097435 | 593 | 5 | 18204 | 49 |
MYO1F,GAS7,ELMO1,RAC2,PREX1 |
2.122e-02 | -3.85 | macromolecule localization | biological process | GO:0033036 | 2376 | 12 | 18204 | 49 |
FYB1,ZFP36L1,SLCO2B1,CD74,NCF1,CMTM6,PLEK,UNC93B1,ITGB2,GULP1,CD68,RAPGEF6 |
2.127e-02 | -3.85 | FFAR1 (free fatty acid receptor 1) | protein interactions | 2864 | 230 | 3 | 19454 | 50 |
WDFY3,CMTM6,UNC93B1 |
2.134e-02 | -3.85 | regulation of respiratory burst involved in inflammatory response | biological process | GO:0060264 | 8 | 1 | 18204 | 49 |
NCF1 |
2.134e-02 | -3.85 | regulation of neutrophil degranulation | biological process | GO:0043313 | 8 | 1 | 18204 | 49 |
ITGB2 |
2.134e-02 | -3.85 | negative regulation of erythrocyte differentiation | biological process | GO:0045647 | 8 | 1 | 18204 | 49 |
ZFP36L1 |
2.134e-02 | -3.85 | regulation of keratinocyte apoptotic process | biological process | GO:1902172 | 8 | 1 | 18204 | 49 |
ZFP36L1 |
2.134e-02 | -3.85 | positive regulation of unsaturated fatty acid biosynthetic process | biological process | GO:2001280 | 8 | 1 | 18204 | 49 |
CD74 |
2.134e-02 | -3.85 | dichotomous subdivision of an epithelial terminal unit | biological process | GO:0060600 | 8 | 1 | 18204 | 49 |
PLXND1 |
2.134e-02 | -3.85 | regulation of CD8-positive, alpha-beta T cell differentiation | biological process | GO:0043376 | 8 | 1 | 18204 | 49 |
NCKAP1L |
2.134e-02 | -3.85 | cellular response to macrophage colony-stimulating factor stimulus | biological process | GO:0036006 | 8 | 1 | 18204 | 49 |
CSF1R |
2.134e-02 | -3.85 | regulation of mast cell chemotaxis | biological process | GO:0060753 | 8 | 1 | 18204 | 49 |
RAC2 |
2.134e-02 | -3.85 | tetrahydrobiopterin metabolic process | biological process | GO:0046146 | 8 | 1 | 18204 | 49 |
GCH1 |
2.134e-02 | -3.85 | positive regulation of CD8-positive, alpha-beta T cell activation | biological process | GO:2001187 | 8 | 1 | 18204 | 49 |
NCKAP1L |
2.138e-02 | -3.85 | Myosin_TH1 | pfam domains | PF06017 | 8 | 1 | 17795 | 48 |
MYO1F |
2.138e-02 | -3.85 | PSI_integrin | pfam domains | PF17205 | 8 | 1 | 17795 | 48 |
ITGB2 |
2.138e-02 | -3.85 | Integrin_alpha | pfam domains | PF00357 | 8 | 1 | 17795 | 48 |
ITGAX |
2.138e-02 | -3.85 | TIG_plexin | pfam domains | PF17960 | 8 | 1 | 17795 | 48 |
PLXND1 |
2.138e-02 | -3.85 | Integrin_beta | pfam domains | PF00362 | 8 | 1 | 17795 | 48 |
ITGB2 |
2.138e-02 | -3.85 | GDA1_CD39 | pfam domains | PF01150 | 8 | 1 | 17795 | 48 |
ENTPD1 |
2.140e-02 | -3.84 | Integrin_bsu_VWA | interpro domains | IPR002369 | 8 | 1 | 18521 | 50 |
ITGB2 |
2.140e-02 | -3.84 | Integrin_beta_N | interpro domains | IPR033760 | 8 | 1 | 18521 | 50 |
ITGB2 |
2.140e-02 | -3.84 | PH-BEACH_dom | interpro domains | IPR023362 | 8 | 1 | 18521 | 50 |
WDFY3 |
2.140e-02 | -3.84 | TIG1_plexin | interpro domains | IPR041019 | 8 | 1 | 18521 | 50 |
PLXND1 |
2.140e-02 | -3.84 | Tyr_kinase_rcpt_3_CS | interpro domains | IPR001824 | 8 | 1 | 18521 | 50 |
CSF1R |
2.140e-02 | -3.84 | Myosin_TH1 | interpro domains | IPR010926 | 8 | 1 | 18521 | 50 |
MYO1F |
2.140e-02 | -3.84 | GDA1_CD39_NTPase | interpro domains | IPR000407 | 8 | 1 | 18521 | 50 |
ENTPD1 |
2.147e-02 | -3.84 | ELMO | prosite domains | PS51335 | 6 | 1 | 12186 | 44 |
ELMO1 |
2.151e-02 | -3.84 | NBPF19 (NBPF member 19) | protein interactions | 101060226 | 231 | 3 | 19454 | 50 |
P2RY6,HCK,ITGB2 |
2.153e-02 | -3.84 | TAP2 (transporter 2, ATP binding cassette subfamily B member) | protein interactions | 6891 | 88 | 2 | 19454 | 50 |
UNC93B1,P2RY6 |
2.159e-02 | -3.84 | SRC (SRC proto-oncogene, non-receptor tyrosine kinase) | protein interactions | 6714 | 624 | 5 | 19454 | 50 |
DAPP1,FYB1,HCK,CSF1R,GAB1 |
2.160e-02 | -3.84 | NRAGE signals death through JNK | REACTOME pathways | R-HSA-193648 | 60 | 2 | 10285 | 39 |
ABR,PREX1 |
2.166e-02 | -3.83 | haematopoietic_and_lymphoid_tissue-other-normal | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-other-normal | 8 | 1 | 16828 | 46 |
CSF1R |
2.196e-02 | -3.82 | specific granule membrane | cellular component | GO:0035579 | 91 | 2 | 19108 | 48 |
ITGB2,CMTM6 |
2.199e-02 | -3.82 | ACKR2 (atypical chemokine receptor 2) | protein interactions | 1238 | 89 | 2 | 19454 | 50 |
CMTM6,UNC93B1 |
2.199e-02 | -3.82 | FMNL1 (formin like 1) | protein interactions | 752 | 89 | 2 | 19454 | 50 |
GAS7,RAC2 |
2.208e-02 | -3.81 | focal adhesion | cellular component | GO:0005925 | 427 | 4 | 19108 | 48 |
LPP,ITGB2,HCK,RAC2 |
2.225e-02 | -3.81 | cell leading edge | cellular component | GO:0031252 | 428 | 4 | 19108 | 48 |
MYO9B,PLEK,PLXND1,RAC2 |
2.239e-02 | -3.80 | unconventional myosin complex | cellular component | GO:0016461 | 9 | 1 | 19108 | 48 |
MYO1F |
2.241e-02 | -3.80 | skin-trunk-malignant_melanoma-nodular | COSMIC cancer mutations | skin-trunk-malignant_melanoma-nodular | 1291 | 8 | 16828 | 46 |
RBM47,TFEB,NCKAP1L,ARHGAP15,ITGB2,SPOCK3,PLEK,TNFAIP8L2 |
2.247e-02 | -3.80 | EPO signaling pathway | Pathway Interaction DB | epopathway | 33 | 2 | 2226 | 16 |
SH2B3,GAB1 |
2.254e-02 | -3.79 | MET activates PI3K/AKT signaling | REACTOME pathways | R-HSA-8851907 | 6 | 1 | 10285 | 39 |
GAB1 |
2.262e-02 | -3.79 | regulation of programmed cell death | biological process | GO:0043067 | 1569 | 9 | 18204 | 49 |
ZFP36L1,GCH1,CSF1R,CD74,PLXND1,TNFAIP8L2,NCKAP1L,HCK,CTSB |
2.272e-02 | -3.78 | human chr4q21.23 | chromosome location | human chr4q21.23 | 12 | 1 | 26134 | 50 |
WDFY3 |
2.290e-02 | -3.78 | MCTP2 (multiple C2 and transmembrane domain containing 2) | protein interactions | 55784 | 9 | 1 | 19454 | 50 |
RAC2 |
2.290e-02 | -3.78 | RBM46 (RNA binding motif protein 46) | protein interactions | 166863 | 9 | 1 | 19454 | 50 |
RBM47 |
2.290e-02 | -3.78 | FHAD1 (forkhead associated phosphopeptide binding domain 1) | protein interactions | 114827 | 9 | 1 | 19454 | 50 |
RAC2 |
2.290e-02 | -3.78 | HLA-DMA (major histocompatibility complex, class II, DM alpha) | protein interactions | 3108 | 9 | 1 | 19454 | 50 |
CD74 |
2.292e-02 | -3.78 | APAF1 (apoptotic peptidase activating factor 1) | protein interactions | 317 | 91 | 2 | 19454 | 50 |
WDFY3,NDUFS2 |
2.292e-02 | -3.78 | PTPRJ (protein tyrosine phosphatase receptor type J) | protein interactions | 5795 | 91 | 2 | 19454 | 50 |
P2RY6,RAC2 |
2.296e-02 | -3.77 | embryonic placenta development | biological process | GO:0001892 | 87 | 2 | 18204 | 49 |
ZFP36L1,TFEB |
2.299e-02 | -3.77 | PPP6R3 (protein phosphatase 6 regulatory subunit 3) | protein interactions | 55291 | 237 | 3 | 19454 | 50 |
CD74,P2RY6,ZNRF2 |
2.300e-02 | -3.77 | lower_third | COSMIC cancer mutations | lower_third | 7961 | 29 | 16828 | 46 |
NCAM2,TFEB,NCKAP1L,ARHGAP15,WDFY3,CSF1R,MYO9B,CTSB,SPOCK3,MARCO,P2RY6,RGS19,SH2B3,GAS7,ITGAX,RAC2,ELMO1,MYO1F,ITGB2,ITM2B,DAPP1,SLCO2B1,RAPGEF6,TNFAIP8L2,PREX1,NDUFS2,PLXND1,CPN1,NCF1 |
2.303e-02 | -3.77 | axon | cellular component | GO:0030424 | 650 | 5 | 19108 | 48 |
WDFY3,PREX1,ABR,NCAM2,PLXND1 |
2.312e-02 | -3.77 | STX4 (syntaxin 4) | protein interactions | 6810 | 423 | 4 | 19454 | 50 |
ITM2B,SMPD4,GAB1,RAC2 |
2.324e-02 | -3.76 | YTHDF3 (YTH N6-methyladenosine RNA binding protein F3) | protein interactions | 253943 | 238 | 3 | 19454 | 50 |
CSF1R,RBM47,CTSB |
2.324e-02 | -3.76 | AQP3 (aquaporin 3 (Gill blood group)) | protein interactions | 360 | 238 | 3 | 19454 | 50 |
UNC93B1,SMPD4,WDFY3 |
2.339e-02 | -3.76 | WASF1 (WASP family member 1) | protein interactions | 8936 | 92 | 2 | 19454 | 50 |
NCF1,RAC2 |
2.339e-02 | -3.76 | MLEC (malectin) | protein interactions | 9761 | 92 | 2 | 19454 | 50 |
UNC93B1,P2RY6 |
2.341e-02 | -3.75 | immune response-activating cell surface receptor signaling pathway | biological process | GO:0002429 | 228 | 3 | 18204 | 49 |
NCKAP1L,FYB1,HCK |
2.344e-02 | -3.75 | RhoGEF | smart domains | SM00325 | 68 | 2 | 9717 | 34 |
PREX1,ABR |
2.348e-02 | -3.75 | RANBP9 (RAN binding protein 9) | protein interactions | 10048 | 425 | 4 | 19454 | 50 |
ENTPD1,GCH1,QSOX1,ITGB2 |
2.350e-02 | -3.75 | DNAJC10 (DnaJ heat shock protein family (Hsp40) member C10) | protein interactions | 54431 | 239 | 3 | 19454 | 50 |
UNC93B1,P2RY6,CTSB |
2.363e-02 | -3.75 | UDP phosphatase activity | molecular function | GO:0045134 | 9 | 1 | 18094 | 48 |
ENTPD1 |
2.363e-02 | -3.75 | NADH dehydrogenase activity | molecular function | GO:0003954 | 9 | 1 | 18094 | 48 |
NDUFS2 |
2.375e-02 | -3.74 | SLC1A5 (solute carrier family 1 member 5) | protein interactions | 6510 | 240 | 3 | 19454 | 50 |
RAC2,UNC93B1,P2RY6 |
2.380e-02 | -3.74 | cell-substrate junction | cellular component | GO:0030055 | 437 | 4 | 19108 | 48 |
HCK,LPP,ITGB2,RAC2 |
2.383e-02 | -3.74 | plasma membrane bounded cell projection | cellular component | GO:0120025 | 2285 | 11 | 19108 | 48 |
PLEK,NCF1,MYO1F,PLXND1,RAC2,MYO9B,NCAM2,GCH1,WDFY3,PREX1,ABR |
2.387e-02 | -3.74 | FOXG1 (forkhead box G1) | protein interactions | 2290 | 93 | 2 | 19454 | 50 |
SMPD4,MYO9B |
2.387e-02 | -3.74 | WDR75 (WD repeat domain 75) | protein interactions | 84128 | 93 | 2 | 19454 | 50 |
WDFY3,PLEK |
2.397e-02 | -3.73 | marginal zone B cell differentiation | biological process | GO:0002315 | 9 | 1 | 18204 | 49 |
MFNG |
2.397e-02 | -3.73 | negative regulation of antigen processing and presentation | biological process | GO:0002578 | 9 | 1 | 18204 | 49 |
CD68 |
2.397e-02 | -3.73 | mesendoderm development | biological process | GO:0048382 | 9 | 1 | 18204 | 49 |
ZFP36L1 |
2.397e-02 | -3.73 | positive regulation of antigen processing and presentation | biological process | GO:0002579 | 9 | 1 | 18204 | 49 |
CD74 |
2.397e-02 | -3.73 | antibacterial innate immune response | biological process | GO:0140367 | 9 | 1 | 18204 | 49 |
TFEB |
2.397e-02 | -3.73 | transepithelial chloride transport | biological process | GO:0030321 | 9 | 1 | 18204 | 49 |
P2RY6 |
2.397e-02 | -3.73 | positive regulation of gamma-delta T cell activation | biological process | GO:0046645 | 9 | 1 | 18204 | 49 |
NCKAP1L |
2.397e-02 | -3.73 | negative regulation of chemokine-mediated signaling pathway | biological process | GO:0070100 | 9 | 1 | 18204 | 49 |
SH2B3 |
2.397e-02 | -3.73 | regulation of mRNA 3'-end processing | biological process | GO:0031440 | 9 | 1 | 18204 | 49 |
ZFP36L1 |
2.397e-02 | -3.73 | toll-like receptor 9 signaling pathway | biological process | GO:0034162 | 9 | 1 | 18204 | 49 |
UNC93B1 |
2.397e-02 | -3.73 | respiratory burst involved in defense response | biological process | GO:0002679 | 9 | 1 | 18204 | 49 |
HCK |
2.397e-02 | -3.73 | macrophage proliferation | biological process | GO:0061517 | 9 | 1 | 18204 | 49 |
CSF1R |
2.397e-02 | -3.73 | microglial cell proliferation | biological process | GO:0061518 | 9 | 1 | 18204 | 49 |
CSF1R |
2.397e-02 | -3.73 | folic acid-containing compound biosynthetic process | biological process | GO:0009396 | 9 | 1 | 18204 | 49 |
GCH1 |
2.397e-02 | -3.73 | regulation of gamma-delta T cell differentiation | biological process | GO:0045586 | 9 | 1 | 18204 | 49 |
NCKAP1L |
2.397e-02 | -3.73 | dopamine biosynthetic process | biological process | GO:0042416 | 9 | 1 | 18204 | 49 |
GCH1 |
2.402e-02 | -3.73 | CCDC47 (coiled-coil domain containing 47) | protein interactions | 57003 | 428 | 4 | 19454 | 50 |
RAC2,UNC93B1,P2RY6,SMPD4 |
2.402e-02 | -3.73 | BRICHOS | pfam domains | PF04089 | 9 | 1 | 17795 | 48 |
ITM2B |
2.402e-02 | -3.73 | Beach | pfam domains | PF02138 | 9 | 1 | 17795 | 48 |
WDFY3 |
2.402e-02 | -3.73 | Plexin_RBD | pfam domains | PF20170 | 9 | 1 | 17795 | 48 |
PLXND1 |
2.402e-02 | -3.73 | Plexin_cytopl | pfam domains | PF08337 | 9 | 1 | 17795 | 48 |
PLXND1 |
2.402e-02 | -3.73 | PH_12 | pfam domains | PF16457 | 9 | 1 | 17795 | 48 |
ELMO1 |
2.404e-02 | -3.73 | BRICHOS_dom | interpro domains | IPR007084 | 9 | 1 | 18521 | 50 |
ITM2B |
2.404e-02 | -3.73 | Plexin_RBD | interpro domains | IPR046800 | 9 | 1 | 18521 | 50 |
PLXND1 |
2.404e-02 | -3.73 | Integrin_bsu | interpro domains | IPR015812 | 9 | 1 | 18521 | 50 |
ITGB2 |
2.404e-02 | -3.73 | BEACH_dom_sf | interpro domains | IPR036372 | 9 | 1 | 18521 | 50 |
WDFY3 |
2.404e-02 | -3.73 | Plexin_cytoplasmic_RasGAP_dom | interpro domains | IPR013548 | 9 | 1 | 18521 | 50 |
PLXND1 |
2.404e-02 | -3.73 | BEACH_dom | interpro domains | IPR000409 | 9 | 1 | 18521 | 50 |
WDFY3 |
2.407e-02 | -3.73 | Exopolyphosphatase. Domain 2 | gene3d domains | 3.30.420.150 | 8 | 1 | 14470 | 44 |
ENTPD1 |
2.424e-02 | -3.72 | Integrin_B_tail | smart domains | SM01242 | 7 | 1 | 9717 | 34 |
ITGB2 |
2.466e-02 | -3.70 | anchoring junction | cellular component | GO:0070161 | 902 | 6 | 19108 | 48 |
GAB1,FYB1,HCK,ITGB2,LPP,RAC2 |
2.469e-02 | -3.70 | Doxorubicin Metabolism Pathway | SMPDB pathways | SMP0000650 | 17 | 1 | 1369 | 2 |
NDUFS2 |
2.491e-02 | -3.69 | positive regulation of phosphorylation | biological process | GO:0042327 | 619 | 5 | 18204 | 49 |
CSF1R,NCF1,CD74,MARCO,NCKAP1L |
2.496e-02 | -3.69 | positive regulation of protein polymerization | biological process | GO:0032273 | 91 | 2 | 18204 | 49 |
NCKAP1L,HCK |
2.507e-02 | -3.69 | Extracellular matrix organization | REACTOME pathways | R-HSA-1474244 | 296 | 4 | 10285 | 39 |
ITGAX,CTSB,ITGB2,SPOCK3 |
2.520e-02 | -3.68 | lysosomal lumen | cellular component | GO:0043202 | 98 | 2 | 19108 | 48 |
CTSB,CD74 |
2.541e-02 | -3.67 | PGA4 (pepsinogen A4) | protein interactions | 643847 | 10 | 1 | 19454 | 50 |
CD74 |
2.541e-02 | -3.67 | ATRAID (all-trans retinoic acid induced differentiation factor) | protein interactions | 51374 | 10 | 1 | 19454 | 50 |
LPP |
2.541e-02 | -3.67 | MYO18B (myosin XVIIIB) | protein interactions | 84700 | 10 | 1 | 19454 | 50 |
RAC2 |
2.541e-02 | -3.67 | P2rx7 (purinergic receptor P2X 7) | protein interactions | 29665 | 10 | 1 | 19454 | 50 |
ITGB2 |
2.541e-02 | -3.67 | ANGPTL3 (angiopoietin like 3) | protein interactions | 27329 | 10 | 1 | 19454 | 50 |
GULP1 |
2.548e-02 | -3.67 | phenol-containing compound metabolic process | biological process | GO:0018958 | 92 | 2 | 18204 | 49 |
CTSB,GCH1 |
2.558e-02 | -3.67 | PICALM (phosphatidylinositol binding clathrin assembly protein) | protein interactions | 8301 | 247 | 3 | 19454 | 50 |
LPP,RAC2,RBM47 |
2.573e-02 | -3.66 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 3608 | 16 | 16828 | 46 |
GAS7,PLXND1,HCK,MARCO,ITM2B,SLCO2B1,GULP1,CD74,NCAM2,ELMO1,NCKAP1L,ZFP36L1,GAB1,WDFY3,ARHGAP15,SMPD4 |
2.573e-02 | -3.66 | Kinesin motor domain | gene3d domains | 3.40.850.10 | 82 | 2 | 14470 | 44 |
MYO9B,MYO1F |
2.574e-02 | -3.66 | INTEGRINB | prints domains | PR01186 | 8 | 1 | 5227 | 17 |
ITGB2 |
2.580e-02 | -3.66 | Tuberculosis | KEGG pathways | ko05152 | 178 | 3 | 7161 | 26 |
ITGB2,CD74,ITGAX |
2.580e-02 | -3.66 | Tuberculosis | KEGG pathways | hsa05152 | 178 | 3 | 7161 | 26 |
CD74,ITGAX,ITGB2 |
2.581e-02 | -3.66 | SOCS3 (suppressor of cytokine signaling 3) | protein interactions | 9021 | 97 | 2 | 19454 | 50 |
CSF1R,GAB1 |
2.581e-02 | -3.66 | ABL2 (ABL proto-oncogene 2, non-receptor tyrosine kinase) | protein interactions | 27 | 97 | 2 | 19454 | 50 |
RAC2,HCK |
2.581e-02 | -3.66 | CLPTM1L (CLPTM1 like) | protein interactions | 81037 | 97 | 2 | 19454 | 50 |
P2RY6,UNC93B1 |
2.587e-02 | -3.65 | regulation of lymphocyte proliferation | biological process | GO:0050670 | 237 | 3 | 18204 | 49 |
CD74,RAC2,NCKAP1L |
2.595e-02 | -3.65 | myelofibrosis | COSMIC cancer mutations | myelofibrosis | 413 | 4 | 16828 | 46 |
CSF1R,CD74,SH2B3,GULP1 |
2.595e-02 | -3.65 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelofibrosis | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelofibrosis | 413 | 4 | 16828 | 46 |
GULP1,SH2B3,CSF1R,CD74 |
2.598e-02 | -3.65 | regulation of protein-containing complex assembly | biological process | GO:0043254 | 419 | 4 | 18204 | 49 |
PLEK,NCKAP1L,PREX1,HCK |
2.622e-02 | -3.64 | superoxide-generating NAD(P)H oxidase activity | molecular function | GO:0016175 | 10 | 1 | 18094 | 48 |
NCF1 |
2.622e-02 | -3.64 | GDP phosphatase activity | molecular function | GO:0004382 | 10 | 1 | 18094 | 48 |
ENTPD1 |
2.622e-02 | -3.64 | superoxide-generating NADPH oxidase activator activity | molecular function | GO:0016176 | 10 | 1 | 18094 | 48 |
NCF1 |
2.631e-02 | -3.64 | PTK2B (protein tyrosine kinase 2 beta) | protein interactions | 2185 | 98 | 2 | 19454 | 50 |
ITGB2,NCF1 |
2.631e-02 | -3.64 | FRS2 (fibroblast growth factor receptor substrate 2) | protein interactions | 10818 | 98 | 2 | 19454 | 50 |
RAC2,GAB1 |
2.632e-02 | -3.64 | B cell receptor signaling pathway | KEGG pathways | hsa04662 | 70 | 2 | 7161 | 26 |
DAPP1,RAC2 |
2.632e-02 | -3.64 | B cell receptor signaling pathway | KEGG pathways | ko04662 | 70 | 2 | 7161 | 26 |
DAPP1,RAC2 |
2.635e-02 | -3.64 | DH_2 | prosite domains | PS50010 | 70 | 2 | 12186 | 44 |
PREX1,ABR |
2.647e-02 | -3.63 | Signaling events mediated by TCPTP | Pathway Interaction DB | tcptp_pathway | 36 | 2 | 2226 | 16 |
GAB1,CSF1R |
2.660e-02 | -3.63 | cellular response to testosterone stimulus | biological process | GO:0071394 | 10 | 1 | 18204 | 49 |
NCF1 |
2.660e-02 | -3.63 | cellular response to salt stress | biological process | GO:0071472 | 10 | 1 | 18204 | 49 |
ZFP36L1 |
2.660e-02 | -3.63 | thrombin-activated receptor signaling pathway | biological process | GO:0070493 | 10 | 1 | 18204 | 49 |
PLEK |
2.660e-02 | -3.63 | endothelial cell chemotaxis | biological process | GO:0035767 | 10 | 1 | 18204 | 49 |
GAB1 |
2.660e-02 | -3.63 | negative regulation of T cell mediated cytotoxicity | biological process | GO:0001915 | 10 | 1 | 18204 | 49 |
NCKAP1L |
2.660e-02 | -3.63 | aggrephagy | biological process | GO:0035973 | 10 | 1 | 18204 | 49 |
WDFY3 |
2.666e-02 | -3.62 | TGFBR1 (transforming growth factor beta receptor 1) | protein interactions | 7046 | 251 | 3 | 19454 | 50 |
PLEK,RGS19,ARHGAP15 |
2.668e-02 | -3.62 | Pept_asp_AS | interpro domains | IPR025661 | 10 | 1 | 18521 | 50 |
CTSB |
2.668e-02 | -3.62 | Plexin | interpro domains | IPR031148 | 10 | 1 | 18521 | 50 |
PLXND1 |
2.678e-02 | -3.62 | YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon) | protein interactions | 7531 | 1150 | 7 | 19454 | 50 |
TFEB,NCAM2,SH2B3,ZFP36L1,GAB1,RAPGEF6,CD74 |
2.680e-02 | -3.62 | XPO4 (exportin 4) | protein interactions | 64328 | 99 | 2 | 19454 | 50 |
P2RY6,UNC93B1 |
2.686e-02 | -3.62 | PRKDC (protein kinase, DNA-activated, catalytic subunit) | protein interactions | 5591 | 661 | 5 | 19454 | 50 |
CTSB,CPN1,UNC93B1,P2RY6,NCF1 |
2.702e-02 | -3.61 | cell motility | biological process | GO:0048870 | 1101 | 7 | 18204 | 49 |
ELMO1,HCK,GAB1,PREX1,ITGB2,PLXND1,NCKAP1L |
2.704e-02 | -3.61 | BEACH domain | gene3d domains | 1.10.1540.10 | 9 | 1 | 14470 | 44 |
WDFY3 |
2.715e-02 | -3.61 | haematopoietic_and_lymphoid_tissue | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue | 14368 | 44 | 16828 | 46 |
MFNG,NCKAP1L,ARHGAP15,CSF1R,P2RY6,MYO9B,QSOX1,GCH1,ITGAX,GAS7,SLCO2B1,CD74,ZFP36L1,ITGB2,RAPGEF6,TNFAIP8L2,NDUFS2,PREX1,ZNRF2,NCAM2,GAB1,TFEB,SMPD4,WDFY3,SPOCK3,PLEK,MARCO,SH2B3,RBM47,CTSB,ABR,RAC2,CD68,ITM2B,DAPP1,GULP1,ELMO1,MYO1F,HCK,CMTM6,CPN1,ENTPD1,NCF1,PLXND1 |
2.719e-02 | -3.60 | Tyr_kinase_AS | interpro domains | IPR008266 | 95 | 2 | 18521 | 50 |
HCK,CSF1R |
2.727e-02 | -3.60 | Semaphorin interactions | REACTOME pathways | R-HSA-373755 | 68 | 2 | 10285 | 39 |
PLXND1,RAC2 |
2.727e-02 | -3.60 | Integrin cell surface interactions | REACTOME pathways | R-HSA-216083 | 68 | 2 | 10285 | 39 |
ITGAX,ITGB2 |
2.729e-02 | -3.60 | peptidase inhibitor complex | cellular component | GO:1904090 | 11 | 1 | 19108 | 48 |
CTSB |
2.730e-02 | -3.60 | regulation of mononuclear cell proliferation | biological process | GO:0032944 | 242 | 3 | 18204 | 49 |
RAC2,CD74,NCKAP1L |
2.731e-02 | -3.60 | SKAP1 (src kinase associated phosphoprotein 1) | protein interactions | 8631 | 100 | 2 | 19454 | 50 |
MYO9B,FYB1 |
2.731e-02 | -3.60 | TTC27 (tetratricopeptide repeat domain 27) | protein interactions | 55622 | 100 | 2 | 19454 | 50 |
UNC93B1,P2RY6 |
2.731e-02 | -3.60 | OPRL1 (opioid related nociceptin receptor 1) | protein interactions | 4987 | 100 | 2 | 19454 | 50 |
RGS19,WDFY3 |
2.731e-02 | -3.60 | SYNGR1 (synaptogyrin 1) | protein interactions | 9145 | 100 | 2 | 19454 | 50 |
UNC93B1,CMTM6 |
2.766e-02 | -3.59 | INB | smart domains | SM00187 | 8 | 1 | 9717 | 34 |
ITGB2 |
2.767e-02 | -3.59 | cellular component organization | biological process | GO:0016043 | 5636 | 22 | 18204 | 49 |
GCH1,GAS7,PLXND1,NCAM2,HCK,RAC2,SMPD4,QSOX1,MARCO,CD74,TFEB,CSF1R,MYO1F,GULP1,ITGB2,NCKAP1L,PLEK,NDUFS2,PREX1,MYO9B,RAPGEF6,ELMO1 |
2.772e-02 | -3.59 | vWFA_dom_sf | interpro domains | IPR036465 | 96 | 2 | 18521 | 50 |
ITGAX,ITGB2 |
2.773e-02 | -3.59 | Leishmaniasis | KEGG pathways | ko05140 | 72 | 2 | 7161 | 26 |
NCF1,ITGB2 |
2.773e-02 | -3.59 | Leishmaniasis | KEGG pathways | hsa05140 | 72 | 2 | 7161 | 26 |
ITGB2,NCF1 |
2.780e-02 | -3.58 | cell surface receptor protein tyrosine kinase signaling pathway | biological process | GO:0007169 | 428 | 4 | 18204 | 49 |
HCK,GAB1,CSF1R,SH2B3 |
2.781e-02 | -3.58 | FAR1 (fatty acyl-CoA reductase 1) | protein interactions | 84188 | 101 | 2 | 19454 | 50 |
P2RY6,UNC93B1 |
2.781e-02 | -3.58 | CGRRF1 (cell growth regulator with ring finger domain 1) | protein interactions | 10668 | 101 | 2 | 19454 | 50 |
ITGB2,NDUFS2 |
2.781e-02 | -3.58 | NBAS (NBAS subunit of NRZ tethering complex) | protein interactions | 51594 | 101 | 2 | 19454 | 50 |
P2RY6,UNC93B1 |
2.792e-02 | -3.58 | PLEK (pleckstrin) | protein interactions | 5341 | 11 | 1 | 19454 | 50 |
PLEK |
2.792e-02 | -3.58 | LCN15 (lipocalin 15) | protein interactions | 389812 | 11 | 1 | 19454 | 50 |
MYO9B |
2.792e-02 | -3.58 | MS4A7 (membrane spanning 4-domains A7) | protein interactions | 58475 | 11 | 1 | 19454 | 50 |
ITGB2 |
2.792e-02 | -3.58 | LAT2 (linker for activation of T cells family member 2) | protein interactions | 7462 | 11 | 1 | 19454 | 50 |
GAB1 |
2.792e-02 | -3.58 | RBP7 (retinol binding protein 7) | protein interactions | 116362 | 11 | 1 | 19454 | 50 |
DAPP1 |
2.792e-02 | -3.58 | GHSR (growth hormone secretagogue receptor) | protein interactions | 2693 | 11 | 1 | 19454 | 50 |
P2RY6 |
2.792e-02 | -3.58 | SYTL1 (synaptotagmin like 1) | protein interactions | 84958 | 11 | 1 | 19454 | 50 |
NCF1 |
2.810e-02 | -3.57 | leukocyte homeostasis | biological process | GO:0001776 | 97 | 2 | 18204 | 49 |
NCKAP1L,SH2B3 |
2.825e-02 | -3.57 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | 2737 | 13 | 16828 | 46 |
SPOCK3,PLEK,MYO9B,NCAM2,GAB1,TFEB,ELMO1,WDFY3,MYO1F,ABR,GAS7,PREX1,GCH1 |
2.832e-02 | -3.56 | DOCK5 (dedicator of cytokinesis 5) | protein interactions | 80005 | 102 | 2 | 19454 | 50 |
RAC2,ELMO1 |
2.832e-02 | -3.56 | GRAP2 (GRB2 related adaptor protein 2) | protein interactions | 9402 | 102 | 2 | 19454 | 50 |
CSF1R,GAB1 |
2.832e-02 | -3.56 | TMX3 (thioredoxin related transmembrane protein 3) | protein interactions | 54495 | 102 | 2 | 19454 | 50 |
P2RY6,UNC93B1 |
2.853e-02 | -3.56 | PH_BEACH | prosite domains | PS51783 | 8 | 1 | 12186 | 44 |
WDFY3 |
2.853e-02 | -3.56 | TH1 | prosite domains | PS51757 | 8 | 1 | 12186 | 44 |
MYO1F |
2.853e-02 | -3.56 | GDA1_CD39_NTPASE | prosite domains | PS01238 | 8 | 1 | 12186 | 44 |
ENTPD1 |
2.853e-02 | -3.56 | RECEPTOR_TYR_KIN_III | prosite domains | PS00240 | 8 | 1 | 12186 | 44 |
CSF1R |
2.875e-02 | -3.55 | human chr17p13.1 | chromosome location | human chr17p13.1 | 138 | 2 | 26134 | 50 |
GAS7,CD68 |
2.877e-02 | -3.55 | regulation of leukocyte mediated immunity | biological process | GO:0002703 | 247 | 3 | 18204 | 49 |
ITGB2,NCKAP1L,RAC2 |
2.880e-02 | -3.55 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor | molecular function | GO:0016670 | 11 | 1 | 18094 | 48 |
QSOX1 |
2.880e-02 | -3.55 | complement component C3b binding | molecular function | GO:0001851 | 11 | 1 | 18094 | 48 |
ITGB2 |
2.880e-02 | -3.55 | nitric-oxide synthase binding | molecular function | GO:0050998 | 11 | 1 | 18094 | 48 |
CD74 |
2.884e-02 | -3.55 | SERPINB2 (serpin family B member 2) | protein interactions | 5055 | 103 | 2 | 19454 | 50 |
LPP,RAPGEF6 |
2.903e-02 | -3.54 | SH3DOMAIN | prints domains | PR00452 | 83 | 2 | 5227 | 17 |
HCK,MYO1F |
2.920e-02 | -3.53 | LCK (LCK proto-oncogene, Src family tyrosine kinase) | protein interactions | 3932 | 455 | 4 | 19454 | 50 |
SH2B3,GAB1,DAPP1,HCK |
2.922e-02 | -3.53 | positive regulation of chemokine (C-X-C motif) ligand 2 production | biological process | GO:2000343 | 11 | 1 | 18204 | 49 |
CD74 |
2.922e-02 | -3.53 | positive regulation of integrin activation | biological process | GO:0033625 | 11 | 1 | 18204 | 49 |
PLEK |
2.922e-02 | -3.53 | regulation of response to reactive oxygen species | biological process | GO:1901031 | 11 | 1 | 18204 | 49 |
GCH1 |
2.922e-02 | -3.53 | negative regulation of platelet aggregation | biological process | GO:0090331 | 11 | 1 | 18204 | 49 |
SH2B3 |
2.922e-02 | -3.53 | regulation of gamma-delta T cell activation | biological process | GO:0046643 | 11 | 1 | 18204 | 49 |
NCKAP1L |
2.922e-02 | -3.53 | heme catabolic process | biological process | GO:0042167 | 11 | 1 | 18204 | 49 |
SLCO2B1 |
2.922e-02 | -3.53 | leukocyte aggregation | biological process | GO:0070486 | 11 | 1 | 18204 | 49 |
RAC2 |
2.922e-02 | -3.53 | pigment catabolic process | biological process | GO:0046149 | 11 | 1 | 18204 | 49 |
SLCO2B1 |
2.928e-02 | -3.53 | OATP | pfam domains | PF03137 | 11 | 1 | 17795 | 48 |
SLCO2B1 |
2.931e-02 | -3.53 | Pept_his_AS | interpro domains | IPR025660 | 11 | 1 | 18521 | 50 |
CTSB |
2.931e-02 | -3.53 | OATP | interpro domains | IPR004156 | 11 | 1 | 18521 | 50 |
SLCO2B1 |
2.936e-02 | -3.53 | CTDSP1 (CTD small phosphatase 1) | protein interactions | 58190 | 104 | 2 | 19454 | 50 |
CSF1R,RAC2 |
2.936e-02 | -3.53 | COG4 (component of oligomeric golgi complex 4) | protein interactions | 25839 | 104 | 2 | 19454 | 50 |
UNC93B1,NDUFS2 |
2.972e-02 | -3.52 | positive regulation of interleukin-6 production | biological process | GO:0032755 | 100 | 2 | 18204 | 49 |
CD74,UNC93B1 |
2.974e-02 | -3.52 | SCAR complex | cellular component | GO:0031209 | 12 | 1 | 19108 | 48 |
NCKAP1L |
2.988e-02 | -3.51 | SLC27A4 (solute carrier family 27 member 4) | protein interactions | 10999 | 105 | 2 | 19454 | 50 |
UNC93B1,P2RY6 |
2.988e-02 | -3.51 | CIAO2B (cytosolic iron-sulfur assembly component 2B) | protein interactions | 51647 | 105 | 2 | 19454 | 50 |
P2RY6,UNC93B1 |
2.988e-02 | -3.51 | AKTIP (AKT interacting protein) | protein interactions | 64400 | 105 | 2 | 19454 | 50 |
ZNRF2,NDUFS2 |
2.995e-02 | -3.51 | Cross-presentation of particulate exogenous antigens (phagosomes) | REACTOME pathways | R-HSA-1236973 | 8 | 1 | 10285 | 39 |
NCF1 |
2.995e-02 | -3.51 | Phosphate bond hydrolysis by NTPDase proteins | REACTOME pathways | R-HSA-8850843 | 8 | 1 | 10285 | 39 |
ENTPD1 |
3.000e-02 | -3.51 | Cytochrome c1, transmembrane anchor, C-terminal | gene3d domains | 1.20.5.100 | 10 | 1 | 14470 | 44 |
ITGB2 |
3.023e-02 | -3.50 | apical part of cell | cellular component | GO:0045177 | 471 | 4 | 19108 | 48 |
CTSB,SLCO2B1,RAPGEF6,P2RY6 |
3.027e-02 | -3.50 | platelet activation | biological process | GO:0030168 | 101 | 2 | 18204 | 49 |
PLEK,ENTPD1 |
3.027e-02 | -3.50 | regulation of carbohydrate biosynthetic process | biological process | GO:0043255 | 101 | 2 | 18204 | 49 |
P2RY6,PLEK |
3.036e-02 | -3.49 | NRAS (NRAS proto-oncogene, GTPase) | protein interactions | 4893 | 683 | 5 | 19454 | 50 |
FYB1,PREX1,ITM2B,GAB1,RAPGEF6 |
3.042e-02 | -3.49 | AMPD3 (adenosine monophosphate deaminase 3) | protein interactions | 272 | 12 | 1 | 19454 | 50 |
ITGB2 |
3.042e-02 | -3.49 | Ppp2r3a (protein phosphatase 2, regulatory subunit B'', alpha) | protein interactions | 235542 | 12 | 1 | 19454 | 50 |
LPP |
3.042e-02 | -3.49 | PNMT (phenylethanolamine N-methyltransferase) | protein interactions | 5409 | 12 | 1 | 19454 | 50 |
HCK |
3.042e-02 | -3.49 | ADGRB3 (adhesion G protein-coupled receptor B3) | protein interactions | 577 | 12 | 1 | 19454 | 50 |
ELMO1 |
3.042e-02 | -3.49 | SOWAHB (sosondowah ankyrin repeat domain family member B) | protein interactions | 345079 | 12 | 1 | 19454 | 50 |
RAPGEF6 |
3.042e-02 | -3.49 | FUT4 (fucosyltransferase 4) | protein interactions | 2526 | 12 | 1 | 19454 | 50 |
ITGB2 |
3.042e-02 | -3.49 | ROPN1L (rhophilin associated tail protein 1 like) | protein interactions | 83853 | 12 | 1 | 19454 | 50 |
CD74 |
3.042e-02 | -3.49 | NCF4 (neutrophil cytosolic factor 4) | protein interactions | 4689 | 12 | 1 | 19454 | 50 |
NCF1 |
3.065e-02 | -3.49 | Bacterial invasion of epithelial cells | KEGG pathways | ko05100 | 76 | 2 | 7161 | 26 |
GAB1,ELMO1 |
3.065e-02 | -3.49 | Bacterial invasion of epithelial cells | KEGG pathways | hsa05100 | 76 | 2 | 7161 | 26 |
GAB1,ELMO1 |
3.078e-02 | -3.48 | small_intestine | COSMIC cancer mutations | small_intestine | 250 | 3 | 16828 | 46 |
PLXND1,CSF1R,PREX1 |
3.082e-02 | -3.48 | regulation of phagocytosis | biological process | GO:0050764 | 102 | 2 | 18204 | 49 |
NCKAP1L,HCK |
3.092e-02 | -3.48 | GEMIN4 (gem nuclear organelle associated protein 4) | protein interactions | 50628 | 266 | 3 | 19454 | 50 |
UNC93B1,P2RY6,CD74 |
3.093e-02 | -3.48 | IQGAP2 (IQ motif containing GTPase activating protein 2) | protein interactions | 10788 | 107 | 2 | 19454 | 50 |
UNC93B1,CD74 |
3.093e-02 | -3.48 | TPP2 (tripeptidyl peptidase 2) | protein interactions | 7174 | 107 | 2 | 19454 | 50 |
CD74,P2RY6 |
3.100e-02 | -3.47 | RHOA (ras homolog family member A) | protein interactions | 387 | 1186 | 7 | 19454 | 50 |
PREX1,GAB1,SMPD4,NDUFS2,RAC2,MYO9B,ABR |
3.107e-02 | -3.47 | BRICHOS | smart domains | SM01039 | 9 | 1 | 9717 | 34 |
ITM2B |
3.107e-02 | -3.47 | Beach | smart domains | SM01026 | 9 | 1 | 9717 | 34 |
WDFY3 |
3.109e-02 | -3.47 | electron transfer activity | molecular function | GO:0009055 | 104 | 2 | 18094 | 48 |
NCF1,NDUFS2 |
3.122e-02 | -3.47 | catabolic process | biological process | GO:0009056 | 1936 | 10 | 18204 | 49 |
ZFP36L1,ENTPD1,SMPD4,RGS19,TFEB,CPN1,SLCO2B1,WDFY3,CTSB,ZNRF2 |
3.138e-02 | -3.46 | prostaglandin transmembrane transporter activity | molecular function | GO:0015132 | 12 | 1 | 18094 | 48 |
SLCO2B1 |
3.138e-02 | -3.46 | semaphorin receptor activity | molecular function | GO:0017154 | 12 | 1 | 18094 | 48 |
PLXND1 |
3.140e-02 | -3.46 | Antigen processing and presentation | KEGG pathways | hsa04612 | 77 | 2 | 7161 | 26 |
CD74,CTSB |
3.140e-02 | -3.46 | Antigen processing and presentation | KEGG pathways | ko04612 | 77 | 2 | 7161 | 26 |
CTSB,CD74 |
3.168e-02 | -3.45 | TyrKc | smart domains | SM00219 | 80 | 2 | 9717 | 34 |
CSF1R,HCK |
3.172e-02 | -3.45 | anatomical structure morphogenesis | biological process | GO:0009653 | 2225 | 11 | 18204 | 49 |
GAB1,ITGAX,MYO9B,CSF1R,MFNG,ZFP36L1,PLXND1,UNC93B1,NCKAP1L,ITGB2,GAS7 |
3.181e-02 | -3.45 | PGRMC2 (progesterone receptor membrane component 2) | protein interactions | 10424 | 269 | 3 | 19454 | 50 |
CD74,P2RY6,RAC2 |
3.184e-02 | -3.45 | regulation of chemokine-mediated signaling pathway | biological process | GO:0070099 | 12 | 1 | 18204 | 49 |
SH2B3 |
3.184e-02 | -3.45 | positive thymic T cell selection | biological process | GO:0045059 | 12 | 1 | 18204 | 49 |
CD74 |
3.184e-02 | -3.45 | response to macrophage colony-stimulating factor | biological process | GO:0036005 | 12 | 1 | 18204 | 49 |
CSF1R |
3.184e-02 | -3.45 | cellular response to thyroid hormone stimulus | biological process | GO:0097067 | 12 | 1 | 18204 | 49 |
CTSB |
3.184e-02 | -3.45 | cytidine to uridine editing | biological process | GO:0016554 | 12 | 1 | 18204 | 49 |
RBM47 |
3.184e-02 | -3.45 | negative thymic T cell selection | biological process | GO:0045060 | 12 | 1 | 18204 | 49 |
CD74 |
3.184e-02 | -3.45 | regulation of prostaglandin biosynthetic process | biological process | GO:0031392 | 12 | 1 | 18204 | 49 |
CD74 |
3.190e-02 | -3.45 | CarboxypepD_reg | pfam domains | PF13620 | 12 | 1 | 17795 | 48 |
CPN1 |
3.194e-02 | -3.44 | epithelial cell migration | biological process | GO:0010631 | 104 | 2 | 18204 | 49 |
GAB1,PLXND1 |
3.194e-02 | -3.44 | protein polymerization | biological process | GO:0051258 | 104 | 2 | 18204 | 49 |
PREX1,GAS7 |
3.194e-02 | -3.44 | regulation of chemokine production | biological process | GO:0032642 | 104 | 2 | 18204 | 49 |
CD74,CSF1R |
3.194e-02 | -3.44 | regulation of dephosphorylation | biological process | GO:0035303 | 104 | 2 | 18204 | 49 |
PLEK,NCKAP1L |
3.200e-02 | -3.44 | COQ8B (coenzyme Q8B) | protein interactions | 79934 | 109 | 2 | 19454 | 50 |
P2RY6,UNC93B1 |
3.200e-02 | -3.44 | B4GAT1 (beta-1,4-glucuronyltransferase 1) | protein interactions | 11041 | 109 | 2 | 19454 | 50 |
UNC93B1,CMTM6 |
3.200e-02 | -3.44 | TMEM109 (transmembrane protein 109) | protein interactions | 79073 | 109 | 2 | 19454 | 50 |
RAC2,UNC93B1 |
3.204e-02 | -3.44 | BEACH | prosite domains | PS50197 | 9 | 1 | 12186 | 44 |
WDFY3 |
3.204e-02 | -3.44 | BRICHOS | prosite domains | PS50869 | 9 | 1 | 12186 | 44 |
ITM2B |
3.204e-02 | -3.44 | INTEGRIN_BETA | prosite domains | PS00243 | 9 | 1 | 12186 | 44 |
ITGB2 |
3.218e-02 | -3.44 | semaphorin receptor complex | cellular component | GO:0002116 | 13 | 1 | 19108 | 48 |
PLXND1 |
3.218e-02 | -3.44 | early phagosome | cellular component | GO:0032009 | 13 | 1 | 19108 | 48 |
UNC93B1 |
3.232e-02 | -3.43 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-angioimmunoblastic_T_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-angioimmunoblastic_T_cell_lymphoma | 12 | 1 | 16828 | 46 |
CSF1R |
3.235e-02 | -3.43 | regulation of innate immune response | biological process | GO:0045088 | 449 | 4 | 18204 | 49 |
NCF1,RBM47,HCK,UNC93B1 |
3.251e-02 | -3.43 | antigen processing and presentation | biological process | GO:0019882 | 105 | 2 | 18204 | 49 |
CD74,UNC93B1 |
3.251e-02 | -3.43 | gland morphogenesis | biological process | GO:0022612 | 105 | 2 | 18204 | 49 |
PLXND1,CSF1R |
3.254e-02 | -3.43 | DKKL1 (dickkopf like acrosomal protein 1) | protein interactions | 27120 | 110 | 2 | 19454 | 50 |
ITM2B,QSOX1 |
3.254e-02 | -3.43 | ARHGAP39 (Rho GTPase activating protein 39) | protein interactions | 80728 | 110 | 2 | 19454 | 50 |
NCAM2,RAC2 |
3.254e-02 | -3.43 | SLC27A2 (solute carrier family 27 member 2) | protein interactions | 11001 | 110 | 2 | 19454 | 50 |
P2RY6,UNC93B1 |
3.254e-02 | -3.43 | PLXNA1 (plexin A1) | protein interactions | 5361 | 110 | 2 | 19454 | 50 |
RAC2,PLXND1 |
3.271e-02 | -3.42 | RDX (radixin) | protein interactions | 5962 | 272 | 3 | 19454 | 50 |
RAC2,ITGB2,LPP |
3.291e-02 | -3.41 | CST7 (cystatin F) | protein interactions | 8530 | 13 | 1 | 19454 | 50 |
CTSB |
3.291e-02 | -3.41 | C1orf74 (chromosome 1 open reading frame 74) | protein interactions | 148304 | 13 | 1 | 19454 | 50 |
HCK |
3.291e-02 | -3.41 | SEMA4A (semaphorin 4A) | protein interactions | 64218 | 13 | 1 | 19454 | 50 |
PLXND1 |
3.291e-02 | -3.41 | SCG3 (secretogranin III) | protein interactions | 29106 | 13 | 1 | 19454 | 50 |
NCAM2 |
3.291e-02 | -3.41 | MYBPC3 (myosin binding protein C3) | protein interactions | 4607 | 13 | 1 | 19454 | 50 |
NCF1 |
3.291e-02 | -3.41 | KCNQ4 (potassium voltage-gated channel subfamily Q member 4) | protein interactions | 9132 | 13 | 1 | 19454 | 50 |
CSF1R |
3.292e-02 | -3.41 | Complement and coagulation cascades | KEGG pathways | ko04610 | 79 | 2 | 7161 | 26 |
ITGAX,ITGB2 |
3.292e-02 | -3.41 | Complement and coagulation cascades | KEGG pathways | hsa04610 | 79 | 2 | 7161 | 26 |
ITGAX,ITGB2 |
3.296e-02 | -3.41 | Carboxypeptidase-like, regulatory domain | gene3d domains | 2.60.40.1120 | 11 | 1 | 14470 | 44 |
CPN1 |
3.307e-02 | -3.41 | cellular response to ketone | biological process | GO:1901655 | 106 | 2 | 18204 | 49 |
NCF1,P2RY6 |
3.307e-02 | -3.41 | cellular response to carbohydrate stimulus | biological process | GO:0071322 | 106 | 2 | 18204 | 49 |
ZFP36L1,NCF1 |
3.309e-02 | -3.41 | GIPC1 (GIPC PDZ domain containing family member 1) | protein interactions | 10755 | 111 | 2 | 19454 | 50 |
RGS19,GULP1 |
3.341e-02 | -3.40 | immune response-regulating cell surface receptor signaling pathway | biological process | GO:0002768 | 262 | 3 | 18204 | 49 |
NCKAP1L,HCK,FYB1 |
3.347e-02 | -3.40 | plasma membrane bounded cell projection organization | biological process | GO:0120036 | 1152 | 7 | 18204 | 49 |
RAPGEF6,MYO9B,NCAM2,NCKAP1L,PLEK,GAS7,CSF1R |
3.348e-02 | -3.40 | Cell death signalling via NRAGE, NRIF and NADE | REACTOME pathways | R-HSA-204998 | 76 | 2 | 10285 | 39 |
ABR,PREX1 |
3.350e-02 | -3.40 | brainstem | COSMIC cancer mutations | brainstem | 3102 | 14 | 16828 | 46 |
CSF1R,ARHGAP15,WDFY3,SMPD4,NCAM2,GAB1,ELMO1,SLCO2B1,RBM47,SPOCK3,GCH1,PREX1,GAS7,ITGAX |
3.363e-02 | -3.39 | C10orf88 (chromosome 10 open reading frame 88) | protein interactions | 80007 | 112 | 2 | 19454 | 50 |
GULP1,RBM47 |
3.363e-02 | -3.39 | SIGLECL1 (SIGLEC family like 1) | protein interactions | 284369 | 112 | 2 | 19454 | 50 |
CMTM6,ITM2B |
3.363e-02 | -3.39 | UBE2V1 (ubiquitin conjugating enzyme E2 V1) | protein interactions | 7335 | 112 | 2 | 19454 | 50 |
P2RY6,ZNRF2 |
3.365e-02 | -3.39 | epithelium migration | biological process | GO:0090132 | 107 | 2 | 18204 | 49 |
GAB1,PLXND1 |
3.395e-02 | -3.38 | G protein-coupled purinergic nucleotide receptor activity | molecular function | GO:0045028 | 13 | 1 | 18094 | 48 |
P2RY6 |
3.395e-02 | -3.38 | icosanoid transmembrane transporter activity | molecular function | GO:0071714 | 13 | 1 | 18094 | 48 |
SLCO2B1 |
3.405e-02 | -3.38 | CANX (calnexin) | protein interactions | 821 | 1210 | 7 | 19454 | 50 |
CD74,ITM2B,SMPD4,NDUFS2,P2RY6,UNC93B1,RAC2 |
3.443e-02 | -3.37 | positive regulation of cell development | biological process | GO:0010720 | 458 | 4 | 18204 | 49 |
PLXND1,NCKAP1L,CD74,ZFP36L1 |
3.444e-02 | -3.37 | negative regulation of leukocyte degranulation | biological process | GO:0043301 | 13 | 1 | 18204 | 49 |
NCKAP1L |
3.444e-02 | -3.37 | negative T cell selection | biological process | GO:0043383 | 13 | 1 | 18204 | 49 |
CD74 |
3.444e-02 | -3.37 | positive regulation of phagocytosis, engulfment | biological process | GO:0060100 | 13 | 1 | 18204 | 49 |
NCKAP1L |
3.444e-02 | -3.37 | positive regulation of nitric-oxide synthase activity | biological process | GO:0051000 | 13 | 1 | 18204 | 49 |
GCH1 |
3.444e-02 | -3.37 | negative regulation of homotypic cell-cell adhesion | biological process | GO:0034111 | 13 | 1 | 18204 | 49 |
SH2B3 |
3.444e-02 | -3.37 | positive regulation of membrane invagination | biological process | GO:1905155 | 13 | 1 | 18204 | 49 |
NCKAP1L |
3.444e-02 | -3.37 | type II interferon-mediated signaling pathway | biological process | GO:0060333 | 13 | 1 | 18204 | 49 |
HCK |
3.444e-02 | -3.37 | tetrapyrrole catabolic process | biological process | GO:0033015 | 13 | 1 | 18204 | 49 |
SLCO2B1 |
3.444e-02 | -3.37 | positive regulation of platelet activation | biological process | GO:0010572 | 13 | 1 | 18204 | 49 |
PLEK |
3.444e-02 | -3.37 | enucleate erythrocyte differentiation | biological process | GO:0043353 | 13 | 1 | 18204 | 49 |
RAC2 |
3.444e-02 | -3.37 | G protein-coupled purinergic nucleotide receptor signaling pathway | biological process | GO:0035589 | 13 | 1 | 18204 | 49 |
P2RY6 |
3.444e-02 | -3.37 | porphyrin-containing compound catabolic process | biological process | GO:0006787 | 13 | 1 | 18204 | 49 |
SLCO2B1 |
3.444e-02 | -3.37 | positive regulation of inositol phosphate biosynthetic process | biological process | GO:0060732 | 13 | 1 | 18204 | 49 |
P2RY6 |
3.444e-02 | -3.37 | positive regulation of actin filament depolymerization | biological process | GO:0030836 | 13 | 1 | 18204 | 49 |
PLEK |
3.448e-02 | -3.37 | IQ | prosite domains | PS50096 | 81 | 2 | 12186 | 44 |
MYO9B,MYO1F |
3.452e-02 | -3.37 | Peptidase_C1 | pfam domains | PF00112 | 13 | 1 | 17795 | 48 |
CTSB |
3.454e-02 | -3.37 | Peptidase_C1A | interpro domains | IPR013128 | 13 | 1 | 18521 | 50 |
CTSB |
3.454e-02 | -3.37 | Peptidase_C1A_C | interpro domains | IPR000668 | 13 | 1 | 18521 | 50 |
CTSB |
3.457e-02 | -3.36 | TJP2 (tight junction protein 2) | protein interactions | 9414 | 278 | 3 | 19454 | 50 |
RAPGEF6,CD74,LPP |
3.481e-02 | -3.36 | reactive oxygen species metabolic process | biological process | GO:0072593 | 109 | 2 | 18204 | 49 |
PREX1,NCF1 |
3.488e-02 | -3.36 | CYB5B (cytochrome b5 type B) | protein interactions | 80777 | 279 | 3 | 19454 | 50 |
QSOX1,RAC2,P2RY6 |
3.506e-02 | -3.35 | negative regulation of apoptotic process | biological process | GO:0043066 | 914 | 6 | 18204 | 49 |
HCK,NCKAP1L,PLXND1,CD74,CSF1R,GCH1 |
3.520e-02 | -3.35 | SMC2 (structural maintenance of chromosomes 2) | protein interactions | 10592 | 280 | 3 | 19454 | 50 |
P2RY6,UNC93B1,GULP1 |
3.520e-02 | -3.35 | SNRPE (small nuclear ribonucleoprotein polypeptide E) | protein interactions | 6635 | 280 | 3 | 19454 | 50 |
CD74,P2RY6,UNC93B1 |
3.523e-02 | -3.35 | PAPAIN | prints domains | PR00705 | 11 | 1 | 5227 | 17 |
CTSB |
3.524e-02 | -3.35 | Steroid Biosynthesis | WikiPathways | WP496 | 10 | 1 | 5310 | 19 |
CPN1 |
3.537e-02 | -3.34 | protein localization to membrane | biological process | GO:0072657 | 462 | 4 | 18204 | 49 |
FYB1,NCF1,ITGB2,RAPGEF6 |
3.540e-02 | -3.34 | FFAR3 (free fatty acid receptor 3) | protein interactions | 2865 | 14 | 1 | 19454 | 50 |
UNC93B1 |
3.540e-02 | -3.34 | CYP1B1 (cytochrome P450 family 1 subfamily B member 1) | protein interactions | 1545 | 14 | 1 | 19454 | 50 |
RAC2 |
3.540e-02 | -3.34 | HHLA2 (HHLA2 member of B7 family) | protein interactions | 11148 | 14 | 1 | 19454 | 50 |
UNC93B1 |
3.540e-02 | -3.34 | TPSAB1 (tryptase alpha/beta 1) | protein interactions | 7177 | 14 | 1 | 19454 | 50 |
P2RY6 |
3.540e-02 | -3.34 | SCGB3A1 (secretoglobin family 3A member 1) | protein interactions | 92304 | 14 | 1 | 19454 | 50 |
MARCO |
3.540e-02 | -3.34 | CPN1 (carboxypeptidase N subunit 1) | protein interactions | 1369 | 14 | 1 | 19454 | 50 |
CPN1 |
3.540e-02 | -3.34 | TFEC (transcription factor EC) | protein interactions | 22797 | 14 | 1 | 19454 | 50 |
TFEB |
3.540e-02 | -3.34 | ITGAL (integrin subunit alpha L) | protein interactions | 3683 | 14 | 1 | 19454 | 50 |
ITGB2 |
3.540e-02 | -3.34 | Tecpr2 (tectonin beta-propeller repeat containing 2) | protein interactions | 104859 | 14 | 1 | 19454 | 50 |
WDFY3 |
3.546e-02 | -3.34 | diffuse_adenocarcinoma | COSMIC cancer mutations | diffuse_adenocarcinoma | 4383 | 18 | 16828 | 46 |
PLXND1,CPN1,NDUFS2,PREX1,MYO9B,RBM47,SH2B3,RAPGEF6,MARCO,P2RY6,ELMO1,NCKAP1L,NCAM2,MYO1F,ITGB2,ARHGAP15,WDFY3,MFNG |
3.546e-02 | -3.34 | stomach-carcinoma-diffuse_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-diffuse_adenocarcinoma | 4383 | 18 | 16828 | 46 |
RAPGEF6,P2RY6,MARCO,SH2B3,RBM47,MYO9B,MFNG,WDFY3,ARHGAP15,ITGB2,MYO1F,NCAM2,NCKAP1L,ELMO1,CPN1,PLXND1,PREX1,NDUFS2 |
3.554e-02 | -3.34 | THIOL_PROTEASE_ASN | prosite domains | PS00640 | 10 | 1 | 12186 | 44 |
CTSB |
3.558e-02 | -3.34 | LYN (LYN proto-oncogene, Src family tyrosine kinase) | protein interactions | 4067 | 713 | 5 | 19454 | 50 |
DAPP1,RAC2,HCK,CSF1R,GAB1 |
3.561e-02 | -3.34 | cytoskeletal motor activity | molecular function | GO:0003774 | 112 | 2 | 18094 | 48 |
MYO1F,MYO9B |
3.587e-02 | -3.33 | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | 2531 | 12 | 16828 | 46 |
SMPD4,CSF1R,WDFY3,ARHGAP15,GAB1,ELMO1,NCAM2,SLCO2B1,GCH1,PREX1,GAS7,ITGAX |
3.590e-02 | -3.33 | regulation of response to stress | biological process | GO:0080134 | 1431 | 8 | 18204 | 49 |
HCK,RBM47,NCF1,CD74,GCH1,SH2B3,UNC93B1,TNFAIP8L2 |
3.601e-02 | -3.32 | nuclear envelope | cellular component | GO:0005635 | 498 | 4 | 19108 | 48 |
WDFY3,RAC2,GCH1,SMPD4 |
3.604e-02 | -3.32 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | biological process | GO:0051896 | 270 | 3 | 18204 | 49 |
SH2B3,NCF1,CSF1R |
3.615e-02 | -3.32 | HLA-A (major histocompatibility complex, class I, A) | protein interactions | 3105 | 283 | 3 | 19454 | 50 |
ITM2B,CTSB,RAC2 |
3.619e-02 | -3.32 | signaling adaptor activity | molecular function | GO:0035591 | 113 | 2 | 18094 | 48 |
SH2B3,GAB1 |
3.619e-02 | -3.32 | cell migration | biological process | GO:0016477 | 921 | 6 | 18204 | 49 |
PREX1,GAB1,HCK,NCKAP1L,PLXND1,ITGB2 |
3.624e-02 | -3.32 | endomembrane system | cellular component | GO:0012505 | 4764 | 18 | 19108 | 48 |
CD74,ITGB2,HCK,NCKAP1L,MFNG,WDFY3,SMPD4,CTSB,CMTM6,QSOX1,RGS19,ITM2B,UNC93B1,GCH1,CD68,ZNRF2,ITGAX,RAC2 |
3.625e-02 | -3.32 | membrane raft | cellular component | GO:0045121 | 290 | 3 | 19108 | 48 |
ITGB2,ENTPD1,HCK |
3.642e-02 | -3.31 | EMC3 (ER membrane protein complex subunit 3) | protein interactions | 55831 | 117 | 2 | 19454 | 50 |
RAC2,P2RY6 |
3.652e-02 | -3.31 | metalloendopeptidase inhibitor activity | molecular function | GO:0008191 | 14 | 1 | 18094 | 48 |
SPOCK3 |
3.652e-02 | -3.31 | Toll-like receptor binding | molecular function | GO:0035325 | 14 | 1 | 18094 | 48 |
UNC93B1 |
3.670e-02 | -3.31 | phosphatidylinositol binding | molecular function | GO:0035091 | 276 | 3 | 18094 | 48 |
WDFY3,DAPP1,NCF1 |
3.670e-02 | -3.30 | cell morphogenesis | biological process | GO:0000902 | 687 | 5 | 18204 | 49 |
NCKAP1L,UNC93B1,GAS7,MYO9B,CSF1R |
3.674e-02 | -3.30 | central_nervous_system-brain-glioma-astrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_III | 1419 | 8 | 16828 | 46 |
RAC2,PLEK,QSOX1,ARHGAP15,SMPD4,CD74,NCAM2,ELMO1 |
3.680e-02 | -3.30 | CIAO1 (cytosolic iron-sulfur assembly component 1) | protein interactions | 9391 | 285 | 3 | 19454 | 50 |
SMPD4,UNC93B1,P2RY6 |
3.688e-02 | -3.30 | membrane microdomain | cellular component | GO:0098857 | 292 | 3 | 19108 | 48 |
ITGB2,HCK,ENTPD1 |
3.699e-02 | -3.30 | DNASE1L1 (deoxyribonuclease 1 like 1) | protein interactions | 1774 | 118 | 2 | 19454 | 50 |
PLXND1,QSOX1 |
3.703e-02 | -3.30 | angioimmunoblastic_T_cell_lymphoma | COSMIC cancer mutations | angioimmunoblastic_T_cell_lymphoma | 269 | 3 | 16828 | 46 |
CSF1R,SH2B3,HCK |
3.704e-02 | -3.30 | pteridine-containing compound biosynthetic process | biological process | GO:0042559 | 14 | 1 | 18204 | 49 |
GCH1 |
3.704e-02 | -3.30 | cellular response to oxidised low-density lipoprotein particle stimulus | biological process | GO:0140052 | 14 | 1 | 18204 | 49 |
CD68 |
3.704e-02 | -3.30 | positive regulation of viral entry into host cell | biological process | GO:0046598 | 14 | 1 | 18204 | 49 |
CD74 |
3.704e-02 | -3.30 | toll-like receptor 3 signaling pathway | biological process | GO:0034138 | 14 | 1 | 18204 | 49 |
UNC93B1 |
3.704e-02 | -3.30 | regulation of unsaturated fatty acid biosynthetic process | biological process | GO:2001279 | 14 | 1 | 18204 | 49 |
CD74 |
3.704e-02 | -3.30 | cellular response to purine-containing compound | biological process | GO:0071415 | 14 | 1 | 18204 | 49 |
P2RY6 |
3.704e-02 | -3.30 | positive regulation by symbiont of entry into host | biological process | GO:0075294 | 14 | 1 | 18204 | 49 |
CD74 |
3.704e-02 | -3.30 | regulation of podosome assembly | biological process | GO:0071801 | 14 | 1 | 18204 | 49 |
HCK |
3.713e-02 | -3.29 | G protein-coupled receptor signaling pathway | biological process | GO:0007186 | 1178 | 7 | 18204 | 49 |
PREX1,SH2B3,P2RY6,PLEK,RAC2,RGS19,MARCO |
3.717e-02 | -3.29 | tissue migration | biological process | GO:0090130 | 113 | 2 | 18204 | 49 |
PLXND1,GAB1 |
3.729e-02 | -3.29 | MET receptor recycling | REACTOME pathways | R-HSA-8875656 | 10 | 1 | 10285 | 39 |
GAB1 |
3.729e-02 | -3.29 | Signaling by FGFR3 fusions in cancer | REACTOME pathways | R-HSA-8853334 | 10 | 1 | 10285 | 39 |
GAB1 |
3.740e-02 | -3.29 | protein kinase binding | molecular function | GO:0019901 | 701 | 5 | 18094 | 48 |
PLEK,SH2B3,GCH1,ITGB2,ITGAX |
3.745e-02 | -3.28 | PARD3 (par-3 family cell polarity regulator) | protein interactions | 56288 | 287 | 3 | 19454 | 50 |
RAC2,GAB1,RAPGEF6 |
3.755e-02 | -3.28 | SEC62 (SEC62 homolog, preprotein translocation factor) | protein interactions | 7095 | 493 | 4 | 19454 | 50 |
SMPD4,UNC93B1,P2RY6,MFNG |
3.756e-02 | -3.28 | NOP9 (NOP9 nucleolar protein) | protein interactions | 161424 | 119 | 2 | 19454 | 50 |
P2RY6,RBM47 |
3.757e-02 | -3.28 | myelodysplastic-myeloproliferative_neoplasm-unclassifiable | COSMIC cancer mutations | myelodysplastic-myeloproliferative_neoplasm-unclassifiable | 112 | 2 | 16828 | 46 |
SH2B3,CSF1R |
3.757e-02 | -3.28 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic-myeloproliferative_neoplasm-unclassifiable | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic-myeloproliferative_neoplasm-unclassifiable | 112 | 2 | 16828 | 46 |
CSF1R,SH2B3 |
3.759e-02 | -3.28 | human chr3p22.3 | chromosome location | human chr3p22.3 | 20 | 1 | 26134 | 50 |
CMTM6 |
3.779e-02 | -3.28 | VDAC1 (voltage dependent anion channel 1) | protein interactions | 7416 | 494 | 4 | 19454 | 50 |
CD74,P2RY6,NDUFS2,UNC93B1 |
3.788e-02 | -3.27 | GP6 (glycoprotein VI platelet) | protein interactions | 51206 | 15 | 1 | 19454 | 50 |
NCF1 |
3.788e-02 | -3.27 | GLIPR1 (GLI pathogenesis related 1) | protein interactions | 11010 | 15 | 1 | 19454 | 50 |
CMTM6 |
3.788e-02 | -3.27 | GALNT3 (polypeptide N-acetylgalactosaminyltransferase 3) | protein interactions | 2591 | 15 | 1 | 19454 | 50 |
UNC93B1 |
3.788e-02 | -3.27 | PTPRCAP (protein tyrosine phosphatase receptor type C associated protein) | protein interactions | 5790 | 15 | 1 | 19454 | 50 |
CMTM6 |
3.788e-02 | -3.27 | UCP3 (uncoupling protein 3) | protein interactions | 7352 | 15 | 1 | 19454 | 50 |
RBM47 |
3.788e-02 | -3.27 | NCKAP1L (NCK associated protein 1 like) | protein interactions | 3071 | 15 | 1 | 19454 | 50 |
GAS7 |
3.788e-02 | -3.27 | AANAT (aralkylamine N-acetyltransferase) | protein interactions | 15 | 15 | 1 | 19454 | 50 |
P2RY6 |
3.814e-02 | -3.27 | CLPTM1 (CLPTM1 regulator of GABA type A receptor forward trafficking) | protein interactions | 1209 | 120 | 2 | 19454 | 50 |
MFNG,UNC93B1 |
3.814e-02 | -3.27 | ANKRD13A (ankyrin repeat domain 13A) | protein interactions | 88455 | 120 | 2 | 19454 | 50 |
UNC93B1,P2RY6 |
3.870e-02 | -3.25 | Nucleotide GPCRs | WikiPathways | WP80 | 11 | 1 | 5310 | 19 |
P2RY6 |
3.872e-02 | -3.25 | EIF3J (eukaryotic translation initiation factor 3 subunit J) | protein interactions | 8669 | 121 | 2 | 19454 | 50 |
CD74,P2RY6 |
3.883e-02 | -3.25 | - | gene3d domains | 6.20.240.20 | 13 | 1 | 14470 | 44 |
MYO9B |
3.902e-02 | -3.24 | THIOL_PROTEASE_HIS | prosite domains | PS00639 | 11 | 1 | 12186 | 44 |
CTSB |
3.908e-02 | -3.24 | 1-phosphatidylinositol binding | molecular function | GO:0005545 | 15 | 1 | 18094 | 48 |
WDFY3 |
3.908e-02 | -3.24 | quinone binding | molecular function | GO:0048038 | 15 | 1 | 18094 | 48 |
NDUFS2 |
3.913e-02 | -3.24 | positive regulation of leukocyte cell-cell adhesion | biological process | GO:1903039 | 279 | 3 | 18204 | 49 |
CD74,ITGB2,NCKAP1L |
3.925e-02 | -3.24 | NADH dehydrogenase (ubiquinone) Fe-S protein/flavoprotein complex, mitochondria | KEGG pathways | M00143 | 11 | 1 | 7161 | 26 |
NDUFS2 |
3.925e-02 | -3.24 | NADH dehydrogenase (ubiquinone) Fe-S protein/flavoprotein complex, mitochondria | KEGG pathways | hsa_M00143 | 11 | 1 | 7161 | 26 |
NDUFS2 |
3.930e-02 | -3.24 | BRK1 (BRICK1 subunit of SCAR/WAVE actin nucleating complex) | protein interactions | 55845 | 122 | 2 | 19454 | 50 |
RAC2,NCKAP1L |
3.943e-02 | -3.23 | human chr2q14.2 | chromosome location | human chr2q14.2 | 21 | 1 | 26134 | 50 |
MARCO |
3.943e-02 | -3.23 | human chr21q21.1 | chromosome location | human chr21q21.1 | 21 | 1 | 26134 | 50 |
NCAM2 |
3.943e-02 | -3.23 | human chr4q32.3 | chromosome location | human chr4q32.3 | 21 | 1 | 26134 | 50 |
SPOCK3 |
3.964e-02 | -3.23 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | biological process | GO:1902166 | 15 | 1 | 18204 | 49 |
CD74 |
3.964e-02 | -3.23 | negative regulation of B cell apoptotic process | biological process | GO:0002903 | 15 | 1 | 18204 | 49 |
CD74 |
3.964e-02 | -3.23 | negative regulation of DNA damage response, signal transduction by p53 class mediator | biological process | GO:0043518 | 15 | 1 | 18204 | 49 |
CD74 |
3.964e-02 | -3.23 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | biological process | GO:1900153 | 15 | 1 | 18204 | 49 |
ZFP36L1 |
3.964e-02 | -3.23 | p38MAPK cascade | biological process | GO:0038066 | 15 | 1 | 18204 | 49 |
ZFP36L1 |
3.964e-02 | -3.23 | sodium-independent organic anion transport | biological process | GO:0043252 | 15 | 1 | 18204 | 49 |
SLCO2B1 |
3.964e-02 | -3.23 | regulation of phagocytosis, engulfment | biological process | GO:0060099 | 15 | 1 | 18204 | 49 |
NCKAP1L |
3.964e-02 | -3.23 | regulation of membrane invagination | biological process | GO:1905153 | 15 | 1 | 18204 | 49 |
NCKAP1L |
3.964e-02 | -3.23 | establishment of endothelial intestinal barrier | biological process | GO:0090557 | 15 | 1 | 18204 | 49 |
RAPGEF6 |
4.018e-02 | -3.21 | homeostasis of number of cells | biological process | GO:0048872 | 282 | 3 | 18204 | 49 |
SH2B3,NCKAP1L,RAC2 |
4.021e-02 | -3.21 | multicellular organismal process | biological process | GO:0032501 | 6177 | 23 | 18204 | 49 |
SLCO2B1,GCH1,PREX1,GAB1,TNFAIP8L2,NCKAP1L,ITM2B,ITGB2,CSF1R,CD74,MARCO,RAC2,CTSB,NCAM2,PLXND1,SH2B3,GAS7,ZFP36L1,ENTPD1,NDUFS2,PLEK,TFEB,MFNG |
4.035e-02 | -3.21 | SLCO3A1 (solute carrier organic anion transporter family member 3A1) | protein interactions | 28232 | 16 | 1 | 19454 | 50 |
RAC2 |
4.035e-02 | -3.21 | GPNMB (glycoprotein nmb) | protein interactions | 10457 | 16 | 1 | 19454 | 50 |
TFEB |
4.035e-02 | -3.21 | REN (renin) | protein interactions | 5972 | 16 | 1 | 19454 | 50 |
CTSB |
4.035e-02 | -3.21 | IL1RL2 (interleukin 1 receptor like 2) | protein interactions | 8808 | 16 | 1 | 19454 | 50 |
MYO1F |
4.035e-02 | -3.21 | APOA5 (apolipoprotein A5) | protein interactions | 116519 | 16 | 1 | 19454 | 50 |
CMTM6 |
4.035e-02 | -3.21 | ZSCAN4 (zinc finger and SCAN domain containing 4) | protein interactions | 201516 | 16 | 1 | 19454 | 50 |
HCK |
4.035e-02 | -3.21 | BGLAP (bone gamma-carboxyglutamate protein) | protein interactions | 632 | 16 | 1 | 19454 | 50 |
CTSB |
4.035e-02 | -3.21 | ESM1 (endothelial cell specific molecule 1) | protein interactions | 11082 | 16 | 1 | 19454 | 50 |
ITGB2 |
4.035e-02 | -3.21 | BEST2 (bestrophin 2) | protein interactions | 54831 | 16 | 1 | 19454 | 50 |
UNC93B1 |
4.043e-02 | -3.21 | negative regulation of programmed cell death | biological process | GO:0043069 | 946 | 6 | 18204 | 49 |
PLXND1,NCKAP1L,CSF1R,GCH1,CD74,HCK |
4.047e-02 | -3.21 | ERLEC1 (endoplasmic reticulum lectin 1) | protein interactions | 27248 | 124 | 2 | 19454 | 50 |
UNC93B1,P2RY6 |
4.055e-02 | -3.21 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | 476 | 4 | 16828 | 46 |
NCAM2,WDFY3,SPOCK3,GULP1 |
4.074e-02 | -3.20 | thyroid-carcinoma | COSMIC cancer mutations | thyroid-carcinoma | 4126 | 17 | 16828 | 46 |
SH2B3,RAPGEF6,PLEK,SPOCK3,MYO9B,RBM47,GULP1,SLCO2B1,WDFY3,NCKAP1L,ELMO1,CD74,NCAM2,ITGAX,ABR,PLXND1,PREX1 |
4.092e-02 | -3.20 | regulation of signaling | biological process | GO:0023051 | 3534 | 15 | 18204 | 49 |
RGS19,SH2B3,P2RY6,RBM47,NCF1,MARCO,CD74,CSF1R,ARHGAP15,MFNG,PLEK,NCKAP1L,PREX1,ABR,MYO9B |
4.095e-02 | -3.20 | Signaling by FGFR4 in disease | REACTOME pathways | R-HSA-5655291 | 11 | 1 | 10285 | 39 |
GAB1 |
4.095e-02 | -3.20 | MET activates RAP1 and RAC1 | REACTOME pathways | R-HSA-8875555 | 11 | 1 | 10285 | 39 |
GAB1 |
4.106e-02 | -3.19 | FAM234A (family with sequence similarity 234 member A) | protein interactions | 83986 | 125 | 2 | 19454 | 50 |
RAC2,WDFY3 |
4.112e-02 | -3.19 | T-Cell antigen Receptor (TCR) Signaling Pathway | WikiPathways | WP69 | 91 | 2 | 5310 | 19 |
FYB1,SH2B3 |
4.113e-02 | -3.19 | ALDH3A2 (aldehyde dehydrogenase 3 family member A2) | protein interactions | 224 | 298 | 3 | 19454 | 50 |
P2RY6,UNC93B1,RAC2 |
4.127e-02 | -3.19 | human chr4q23 | chromosome location | human chr4q23 | 22 | 1 | 26134 | 50 |
DAPP1 |
4.138e-02 | -3.18 | positive regulation of cell adhesion | biological process | GO:0045785 | 486 | 4 | 18204 | 49 |
ITGB2,NCKAP1L,CD74,PREX1 |
4.156e-02 | -3.18 | cellular component organization or biogenesis | biological process | GO:0071840 | 5850 | 22 | 18204 | 49 |
MARCO,CD74,QSOX1,CSF1R,RAC2,SMPD4,NCKAP1L,MYO1F,ITGB2,PREX1,GCH1,HCK,TFEB,PLEK,GULP1,NDUFS2,ELMO1,MYO9B,RAPGEF6,PLXND1,GAS7,NCAM2 |
4.156e-02 | -3.18 | regulation of cell communication | biological process | GO:0010646 | 3541 | 15 | 18204 | 49 |
CSF1R,ARHGAP15,NCF1,MARCO,CD74,MFNG,NCKAP1L,PLEK,PREX1,ABR,MYO9B,RGS19,P2RY6,SH2B3,RBM47 |
4.158e-02 | -3.18 | SH3 domain binding | molecular function | GO:0017124 | 122 | 2 | 18094 | 48 |
NCF1,ELMO1 |
4.163e-02 | -3.18 | sodium-independent organic anion transmembrane transporter activity | molecular function | GO:0015347 | 16 | 1 | 18094 | 48 |
SLCO2B1 |
4.163e-02 | -3.18 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | molecular function | GO:0050664 | 16 | 1 | 18094 | 48 |
NCF1 |
4.171e-02 | -3.18 | Regulation of RhoA activity | Pathway Interaction DB | rhoa_reg_pathway | 46 | 2 | 2226 | 16 |
ABR,MYO9B |
4.182e-02 | -3.17 | PPM1G (protein phosphatase, Mg2+/Mn2+ dependent 1G) | protein interactions | 5496 | 300 | 3 | 19454 | 50 |
TFEB,P2RY6,MYO9B |
4.187e-02 | -3.17 | MHC class II protein complex | cellular component | GO:0042613 | 17 | 1 | 19108 | 48 |
CD74 |
4.207e-02 | -3.17 | positive regulation of T cell differentiation | biological process | GO:0045582 | 121 | 2 | 18204 | 49 |
CD74,NCKAP1L |
4.215e-02 | -3.17 | RalA downstream regulated genes | WikiPathways | WP2290 | 12 | 1 | 5310 | 19 |
RAC2 |
4.219e-02 | -3.17 | KPNB1 (karyopherin subunit beta 1) | protein interactions | 3837 | 512 | 4 | 19454 | 50 |
SMPD4,UNC93B1,P2RY6,CD74 |
4.223e-02 | -3.16 | thyroid hormone generation | biological process | GO:0006590 | 16 | 1 | 18204 | 49 |
CTSB |
4.223e-02 | -3.16 | positive regulation of B cell differentiation | biological process | GO:0045579 | 16 | 1 | 18204 | 49 |
NCKAP1L |
4.223e-02 | -3.16 | cellular response to prostaglandin E stimulus | biological process | GO:0071380 | 16 | 1 | 18204 | 49 |
P2RY6 |
4.223e-02 | -3.16 | reactive oxygen species biosynthetic process | biological process | GO:1903409 | 16 | 1 | 18204 | 49 |
NCF1 |
4.223e-02 | -3.16 | neuron cell-cell adhesion | biological process | GO:0007158 | 16 | 1 | 18204 | 49 |
NCAM2 |
4.223e-02 | -3.16 | prostaglandin transport | biological process | GO:0015732 | 16 | 1 | 18204 | 49 |
SLCO2B1 |
4.223e-02 | -3.16 | branching involved in salivary gland morphogenesis | biological process | GO:0060445 | 16 | 1 | 18204 | 49 |
PLXND1 |
4.223e-02 | -3.16 | neutrophil homeostasis | biological process | GO:0001780 | 16 | 1 | 18204 | 49 |
SH2B3 |
4.226e-02 | -3.16 | RRM1 (ribonucleotide reductase catalytic subunit M1) | protein interactions | 6240 | 127 | 2 | 19454 | 50 |
GCH1,NCF1 |
4.226e-02 | -3.16 | GOLPH3 (golgi phosphoprotein 3) | protein interactions | 64083 | 127 | 2 | 19454 | 50 |
P2RY6,UNC93B1 |
4.231e-02 | -3.16 | Integrin_A_Ig_1 | pfam domains | PF08441 | 16 | 1 | 17795 | 48 |
ITGAX |
4.234e-02 | -3.16 | positive regulation of innate immune response | biological process | GO:0045089 | 288 | 3 | 18204 | 49 |
UNC93B1,HCK,RBM47 |
4.235e-02 | -3.16 | Integrin_alpha_Ig-like_1 | interpro domains | IPR013649 | 16 | 1 | 18521 | 50 |
ITGAX |
4.235e-02 | -3.16 | Integrin_alpha_C_CS | interpro domains | IPR018184 | 16 | 1 | 18521 | 50 |
ITGAX |
4.235e-02 | -3.16 | CarboxyPept-like_regulatory | interpro domains | IPR008969 | 16 | 1 | 18521 | 50 |
CPN1 |
4.248e-02 | -3.16 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 15 | 16828 | 46 |
MYO9B,RBM47,SPOCK3,WDFY3,TFEB,ZFP36L1,NCKAP1L,NCAM2,CD74,SLCO2B1,GULP1,GAS7,NCF1,ABR,HCK |
4.248e-02 | -3.16 | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 15 | 16828 | 46 |
HCK,GAS7,NCF1,ABR,WDFY3,NCKAP1L,ZFP36L1,TFEB,NCAM2,CD74,GULP1,SLCO2B1,MYO9B,RBM47,SPOCK3 |
4.270e-02 | -3.15 | plasma membrane bounded cell projection morphogenesis | biological process | GO:0120039 | 491 | 4 | 18204 | 49 |
CSF1R,NCKAP1L,MYO9B,GAS7 |
4.282e-02 | -3.15 | TMEM95 (transmembrane protein 95) | protein interactions | 339168 | 17 | 1 | 19454 | 50 |
CMTM6 |
4.282e-02 | -3.15 | Lrr1 (leucine rich repeat protein 1) | protein interactions | 69706 | 17 | 1 | 19454 | 50 |
WDFY3 |
4.282e-02 | -3.15 | MRAS (muscle RAS oncogene homolog) | protein interactions | 22808 | 17 | 1 | 19454 | 50 |
RAPGEF6 |
4.282e-02 | -3.15 | PSD4 (pleckstrin and Sec7 domain containing 4) | protein interactions | 23550 | 17 | 1 | 19454 | 50 |
GULP1 |
4.282e-02 | -3.15 | ARL4A (ADP ribosylation factor like GTPase 4A) | protein interactions | 10124 | 17 | 1 | 19454 | 50 |
ELMO1 |
4.282e-02 | -3.15 | SMIM11 (small integral membrane protein 11) | protein interactions | 54065 | 17 | 1 | 19454 | 50 |
UNC93B1 |
4.282e-02 | -3.15 | SYNDIG1 (synapse differentiation inducing 1) | protein interactions | 79953 | 17 | 1 | 19454 | 50 |
UNC93B1 |
4.286e-02 | -3.15 | RAB18 (RAB18, member RAS oncogene family) | protein interactions | 22931 | 128 | 2 | 19454 | 50 |
P2RY6,UNC93B1 |
4.286e-02 | -3.15 | FARP1 (FERM, ARH/RhoGEF and pleckstrin domain protein 1) | protein interactions | 10160 | 128 | 2 | 19454 | 50 |
RAC2,RBM47 |
4.286e-02 | -3.15 | ASPH (aspartate beta-hydroxylase) | protein interactions | 444 | 303 | 3 | 19454 | 50 |
UNC93B1,CMTM6,P2RY6 |
4.287e-02 | -3.15 | normal | COSMIC cancer mutations | normal | 16 | 1 | 16828 | 46 |
CSF1R |
4.293e-02 | -3.15 | diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | diffuse_large_B_cell_lymphoma | 4151 | 17 | 16828 | 46 |
MARCO,SMPD4,ARHGAP15,WDFY3,GAB1,ELMO1,ZFP36L1,NCKAP1L,CD74,NCAM2,SLCO2B1,GULP1,ITM2B,PLXND1,GAS7,CPN1,HCK |
4.297e-02 | -3.15 | RAC1 (Rac family small GTPase 1) | protein interactions | 5879 | 1005 | 6 | 19454 | 50 |
NCF1,GAB1,PREX1,ARHGAP15,NDUFS2,RAC2 |
4.311e-02 | -3.14 | human chr14q24.1 | chromosome location | human chr14q24.1 | 23 | 1 | 26134 | 50 |
ZFP36L1 |
4.345e-02 | -3.14 | protein tyrosine kinase binding | molecular function | GO:1990782 | 125 | 2 | 18094 | 48 |
SH2B3,ITGAX |
4.346e-02 | -3.14 | SCD (stearoyl-CoA desaturase) | protein interactions | 6319 | 129 | 2 | 19454 | 50 |
RAC2,ARHGAP15 |
4.348e-02 | -3.14 | molecular function regulator activity | molecular function | GO:0098772 | 2079 | 10 | 18094 | 48 |
ARHGAP15,RAC2,NCKAP1L,SPOCK3,PREX1,ABR,RAPGEF6,MYO9B,ELMO1,NCF1 |
4.404e-02 | -3.12 | cell projection morphogenesis | biological process | GO:0048858 | 496 | 4 | 18204 | 49 |
NCKAP1L,MYO9B,GAS7,CSF1R |
4.407e-02 | -3.12 | ABCC1 (ATP binding cassette subfamily C member 1 (ABCC1 blood group)) | protein interactions | 4363 | 130 | 2 | 19454 | 50 |
UNC93B1,RAC2 |
4.415e-02 | -3.12 | establishment of localization | biological process | GO:0051234 | 3887 | 16 | 18204 | 49 |
P2RY6,SLCO2B1,ZFP36L1,HCK,CMTM6,PLEK,UNC93B1,ITGB2,GULP1,MYO1F,CD68,MARCO,CD74,NCF1,ELMO1,NDUFS2 |
4.417e-02 | -3.12 | transmembrane receptor protein tyrosine kinase adaptor activity | molecular function | GO:0005068 | 17 | 1 | 18094 | 48 |
SH2B3 |
4.417e-02 | -3.12 | nucleoside diphosphate phosphatase activity | molecular function | GO:0017110 | 17 | 1 | 18094 | 48 |
ENTPD1 |
4.418e-02 | -3.12 | nuclear membrane | cellular component | GO:0031965 | 314 | 3 | 19108 | 48 |
GCH1,WDFY3,SMPD4 |
4.457e-02 | -3.11 | Pept_C1 | smart domains | SM00645 | 13 | 1 | 9717 | 34 |
CTSB |
4.459e-02 | -3.11 | Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | REACTOME pathways | R-HSA-1474151 | 12 | 1 | 10285 | 39 |
GCH1 |
4.459e-02 | -3.11 | Transport of organic anions | REACTOME pathways | R-HSA-879518 | 12 | 1 | 10285 | 39 |
SLCO2B1 |
4.459e-02 | -3.11 | P2Y receptors | REACTOME pathways | R-HSA-417957 | 12 | 1 | 10285 | 39 |
P2RY6 |
4.459e-02 | -3.11 | ribonucleoside triphosphate phosphatase activity | molecular function | GO:0017111 | 736 | 5 | 18094 | 48 |
ENTPD1,RGS19,MYO9B,GCH1,RAC2 |
4.468e-02 | -3.11 | ATP6V1H (ATPase H+ transporting V1 subunit H) | protein interactions | 51606 | 131 | 2 | 19454 | 50 |
P2RY6,UNC93B1 |
4.468e-02 | -3.11 | EIF2B1 (eukaryotic translation initiation factor 2B subunit alpha) | protein interactions | 1967 | 131 | 2 | 19454 | 50 |
UNC93B1,RBM47 |
4.481e-02 | -3.11 | monocyte differentiation | biological process | GO:0030224 | 17 | 1 | 18204 | 49 |
CSF1R |
4.481e-02 | -3.11 | protein trimerization | biological process | GO:0070206 | 17 | 1 | 18204 | 49 |
CD74 |
4.481e-02 | -3.11 | microvillus assembly | biological process | GO:0030033 | 17 | 1 | 18204 | 49 |
RAPGEF6 |
4.481e-02 | -3.11 | protein kinase C signaling | biological process | GO:0070528 | 17 | 1 | 18204 | 49 |
PLEK |
4.481e-02 | -3.11 | response to hepatocyte growth factor | biological process | GO:0035728 | 17 | 1 | 18204 | 49 |
GAB1 |
4.481e-02 | -3.11 | regulation of integrin activation | biological process | GO:0033623 | 17 | 1 | 18204 | 49 |
PLEK |
4.481e-02 | -3.11 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | biological process | GO:1902165 | 17 | 1 | 18204 | 49 |
CD74 |
4.493e-02 | -3.10 | RGS_subdom1/3 | interpro domains | IPR024066 | 17 | 1 | 18521 | 50 |
RGS19 |
4.509e-02 | -3.10 | amb2 Integrin signaling | Pathway Interaction DB | amb2_neutrophils_pathway | 48 | 2 | 2226 | 16 |
ITGB2,HCK |
4.514e-02 | -3.10 | positive regulation of cytokine production | biological process | GO:0001819 | 500 | 4 | 18204 | 49 |
UNC93B1,CSF1R,CD74,RBM47 |
4.517e-02 | -3.10 | PROTEIN_KINASE_TYR | prosite domains | PS00109 | 94 | 2 | 12186 | 44 |
CSF1R,HCK |
4.524e-02 | -3.10 | RPN2 (ribophorin II) | protein interactions | 6185 | 762 | 5 | 19454 | 50 |
CTSB,RAC2,SMPD4,P2RY6,UNC93B1 |
4.529e-02 | -3.09 | PMF1-BGLAP (PMF1-BGLAP readthrough) | protein interactions | 100527963 | 18 | 1 | 19454 | 50 |
CMTM6 |
4.529e-02 | -3.09 | NAALADL2 (N-acetylated alpha-linked acidic dipeptidase like 2) | protein interactions | 254827 | 18 | 1 | 19454 | 50 |
ITM2B |
4.529e-02 | -3.09 | SLC2A14 (solute carrier family 2 member 14) | protein interactions | 144195 | 18 | 1 | 19454 | 50 |
RAC2 |
4.529e-02 | -3.09 | PDE8A (phosphodiesterase 8A) | protein interactions | 5151 | 18 | 1 | 19454 | 50 |
RAC2 |
4.529e-02 | -3.09 | SECTM1 (secreted and transmembrane 1) | protein interactions | 6398 | 18 | 1 | 19454 | 50 |
GCH1 |
4.529e-02 | -3.09 | DCAF17 (DDB1 and CUL4 associated factor 17) | protein interactions | 80067 | 18 | 1 | 19454 | 50 |
PREX1 |
4.529e-02 | -3.09 | TM4SF20 (transmembrane 4 L six family member 20) | protein interactions | 79853 | 18 | 1 | 19454 | 50 |
CD74 |
4.529e-02 | -3.09 | FKBP8 (FKBP prolyl isomerase 8) | protein interactions | 23770 | 524 | 4 | 19454 | 50 |
CD74,SMPD4,P2RY6,RAC2 |
4.530e-02 | -3.09 | TINF2 (TERF1 interacting nuclear factor 2) | protein interactions | 26277 | 132 | 2 | 19454 | 50 |
ZFP36L1,LPP |
4.530e-02 | -3.09 | TXNDC12 (thioredoxin domain containing 12) | protein interactions | 51060 | 132 | 2 | 19454 | 50 |
CTSB,HCK |
4.531e-02 | -3.09 | ovary-other-neoplasm | COSMIC cancer mutations | ovary-other-neoplasm | 12717 | 40 | 16828 | 46 |
RAPGEF6,ELMO1,ZFP36L1,CD74,ITGB2,MYO1F,ITM2B,GULP1,SLCO2B1,PLXND1,CPN1,ZNRF2,NCF1,NDUFS2,PREX1,HCK,CMTM6,MYO9B,RBM47,PLEK,SH2B3,RGS19,P2RY6,MARCO,NCKAP1L,GAB1,TFEB,NCAM2,ARHGAP15,CSF1R,SMPD4,WDFY3,MFNG,GAS7,ABR,RAC2,ITGAX,GCH1,QSOX1,LPP |
4.549e-02 | -3.09 | chronic_eosinophilic_leukaemia-hypereosinophilic_syndrome | COSMIC cancer mutations | chronic_eosinophilic_leukaemia-hypereosinophilic_syndrome | 17 | 1 | 16828 | 46 |
SH2B3 |
4.549e-02 | -3.09 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-chronic_eosinophilic_leukaemia-hypereosinophilic_syndrome | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-chronic_eosinophilic_leukaemia-hypereosinophilic_syndrome | 17 | 1 | 16828 | 46 |
SH2B3 |
4.590e-02 | -3.08 | regulation of myeloid leukocyte differentiation | biological process | GO:0002761 | 127 | 2 | 18204 | 49 |
ZFP36L1,CD74 |
4.591e-02 | -3.08 | PIGS (phosphatidylinositol glycan anchor biosynthesis class S) | protein interactions | 94005 | 133 | 2 | 19454 | 50 |
RAC2,UNC93B1 |
4.591e-02 | -3.08 | PLAUR (plasminogen activator, urokinase receptor) | protein interactions | 5329 | 133 | 2 | 19454 | 50 |
HCK,ITGB2 |
4.596e-02 | -3.08 | CARBOXYPEPT_ZN_2 | prosite domains | PS00133 | 13 | 1 | 12186 | 44 |
CPN1 |
4.596e-02 | -3.08 | CARBOXYPEPT_ZN_1 | prosite domains | PS00132 | 13 | 1 | 12186 | 44 |
CPN1 |
4.597e-02 | -3.08 | positive regulation of organelle organization | biological process | GO:0010638 | 503 | 4 | 18204 | 49 |
HCK,GCH1,NCKAP1L,PLEK |
4.624e-02 | -3.07 | cellular response to hormone stimulus | biological process | GO:0032870 | 504 | 4 | 18204 | 49 |
P2RY6,CTSB,GAB1,ZFP36L1 |
4.653e-02 | -3.07 | GIT2 (GIT ArfGAP 2) | protein interactions | 9815 | 134 | 2 | 19454 | 50 |
RAC2,GCH1 |
4.653e-02 | -3.07 | FDFT1 (farnesyl-diphosphate farnesyltransferase 1) | protein interactions | 2222 | 134 | 2 | 19454 | 50 |
UNC93B1,CD74 |
4.673e-02 | -3.06 | trunk | COSMIC cancer mutations | trunk | 3554 | 15 | 16828 | 46 |
TNFAIP8L2,PLEK,SPOCK3,RBM47,ITGB2,MYO1F,ARHGAP15,WDFY3,SMPD4,NCKAP1L,TFEB,ITGAX,ABR,HCK,QSOX1 |
4.674e-02 | -3.06 | GRB2 (growth factor receptor bound protein 2) | protein interactions | 2885 | 769 | 5 | 19454 | 50 |
GAB1,NCF1,WDFY3,SH2B3,CSF1R |
4.680e-02 | -3.06 | ATP5PO (ATP synthase peripheral stalk subunit OSCP) | protein interactions | 539 | 314 | 3 | 19454 | 50 |
P2RY6,PREX1,UNC93B1 |
4.716e-02 | -3.05 | neuron projection | cellular component | GO:0043005 | 1331 | 7 | 19108 | 48 |
PLXND1,NCF1,GCH1,NCAM2,ABR,PREX1,WDFY3 |
4.717e-02 | -3.05 | VDAC3 (voltage dependent anion channel 3) | protein interactions | 7419 | 315 | 3 | 19454 | 50 |
UNC93B1,P2RY6,NDUFS2 |
4.720e-02 | -3.05 | response to organophosphorus | biological process | GO:0046683 | 129 | 2 | 18204 | 49 |
ZFP36L1,P2RY6 |
4.721e-02 | -3.05 | regulation of cell population proliferation | biological process | GO:0042127 | 1790 | 9 | 18204 | 49 |
ITGAX,HCK,SH2B3,P2RY6,NCKAP1L,RAC2,ZFP36L1,CD74,CSF1R |
4.728e-02 | -3.05 | Ras signaling pathway | KEGG pathways | hsa04014 | 226 | 3 | 7161 | 26 |
GAB1,RAC2,CSF1R |
4.738e-02 | -3.05 | maintenance of cell polarity | biological process | GO:0030011 | 18 | 1 | 18204 | 49 |
NCKAP1L |
4.738e-02 | -3.05 | cell-cell junction maintenance | biological process | GO:0045217 | 18 | 1 | 18204 | 49 |
CSF1R |
4.738e-02 | -3.05 | positive regulation of myelination | biological process | GO:0031643 | 18 | 1 | 18204 | 49 |
ITGAX |
4.738e-02 | -3.05 | positive regulation of superoxide anion generation | biological process | GO:0032930 | 18 | 1 | 18204 | 49 |
ITGB2 |
4.738e-02 | -3.05 | negative regulation of platelet activation | biological process | GO:0010544 | 18 | 1 | 18204 | 49 |
SH2B3 |
4.738e-02 | -3.05 | regulation of dopamine metabolic process | biological process | GO:0042053 | 18 | 1 | 18204 | 49 |
ITGB2 |
4.738e-02 | -3.05 | positive regulation of type 2 immune response | biological process | GO:0002830 | 18 | 1 | 18204 | 49 |
CD74 |
4.738e-02 | -3.05 | tetrahydrofolate metabolic process | biological process | GO:0046653 | 18 | 1 | 18204 | 49 |
GCH1 |
4.738e-02 | -3.05 | regulation of catecholamine metabolic process | biological process | GO:0042069 | 18 | 1 | 18204 | 49 |
ITGB2 |
4.738e-02 | -3.05 | regulation of epidermal growth factor-activated receptor activity | biological process | GO:0007176 | 18 | 1 | 18204 | 49 |
NCF1 |
4.738e-02 | -3.05 | regulation of hydrogen peroxide metabolic process | biological process | GO:0010310 | 18 | 1 | 18204 | 49 |
RAC2 |
4.748e-02 | -3.05 | SRCR | pfam domains | PF00530 | 18 | 1 | 17795 | 48 |
MARCO |
4.748e-02 | -3.05 | Integrin_A_Ig_2 | pfam domains | PF20805 | 18 | 1 | 17795 | 48 |
ITGAX |
4.752e-02 | -3.05 | Integrin_alpha | interpro domains | IPR000413 | 18 | 1 | 18521 | 50 |
ITGAX |
4.752e-02 | -3.05 | Integrin_alpha_Ig-like_2 | interpro domains | IPR048285 | 18 | 1 | 18521 | 50 |
ITGAX |
4.760e-02 | -3.04 | positive regulation of kinase activity | biological process | GO:0033674 | 302 | 3 | 18204 | 49 |
CD74,NCF1,CSF1R |
4.774e-02 | -3.04 | RAB26 (RAB26, member RAS oncogene family) | protein interactions | 25837 | 19 | 1 | 19454 | 50 |
GCH1 |
4.774e-02 | -3.04 | CABLES2 (Cdk5 and Abl enzyme substrate 2) | protein interactions | 81928 | 19 | 1 | 19454 | 50 |
GCH1 |
4.774e-02 | -3.04 | GCHFR (GTP cyclohydrolase I feedback regulator) | protein interactions | 2644 | 19 | 1 | 19454 | 50 |
GCH1 |
4.774e-02 | -3.04 | CSF1 (colony stimulating factor 1) | protein interactions | 1435 | 19 | 1 | 19454 | 50 |
CSF1R |
4.774e-02 | -3.04 | SPOCK2 (SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2) | protein interactions | 9806 | 19 | 1 | 19454 | 50 |
SPOCK3 |
4.786e-02 | -3.04 | negative regulation of T cell activation | biological process | GO:0050868 | 130 | 2 | 18204 | 49 |
CD74,TNFAIP8L2 |
4.802e-02 | -3.04 | PK_Tyr_Ser-Thr | pfam domains | PF07714 | 130 | 2 | 17795 | 48 |
CSF1R,HCK |
4.822e-02 | -3.03 | FCGR activation | REACTOME pathways | R-HSA-2029481 | 13 | 1 | 10285 | 39 |
HCK |
4.822e-02 | -3.03 | Signal regulatory protein (SIRP) family interactions | REACTOME pathways | R-HSA-391160 | 13 | 1 | 10285 | 39 |
FYB1 |
4.828e-02 | -3.03 | ATP5PB (ATP synthase peripheral stalk-membrane subunit b) | protein interactions | 515 | 318 | 3 | 19454 | 50 |
P2RY6,NDUFS2,UNC93B1 |
4.842e-02 | -3.03 | TNFRSF10A (TNF receptor superfamily member 10a) | protein interactions | 8797 | 137 | 2 | 19454 | 50 |
NDUFS2,RAC2 |
4.842e-02 | -3.03 | SPINT2 (serine peptidase inhibitor, Kunitz type 2) | protein interactions | 10653 | 137 | 2 | 19454 | 50 |
CMTM6,CTSB |
4.852e-02 | -3.03 | mesoderm development | biological process | GO:0007498 | 131 | 2 | 18204 | 49 |
HCK,ZFP36L1 |
4.856e-02 | -3.03 | Signaling events mediated by PTP1B | Pathway Interaction DB | ptp1bpathway | 50 | 2 | 2226 | 16 |
CSF1R,HCK |
4.871e-02 | -3.02 | RPN1 (ribophorin I) | protein interactions | 6184 | 778 | 5 | 19454 | 50 |
SMPD4,P2RY6,UNC93B1,CTSB,RAC2 |
4.881e-02 | -3.02 | cytoskeleton organization | biological process | GO:0007010 | 1251 | 7 | 18204 | 49 |
RAC2,PREX1,MYO1F,GAS7,ELMO1,NCKAP1L,PLEK |
4.905e-02 | -3.01 | AKAP12 (A-kinase anchoring protein 12) | protein interactions | 9590 | 138 | 2 | 19454 | 50 |
HCK,RAC2 |
4.905e-02 | -3.01 | ZW10 (zw10 kinetochore protein) | protein interactions | 9183 | 138 | 2 | 19454 | 50 |
UNC93B1,RAC2 |
4.918e-02 | -3.01 | regulation of mRNA processing | biological process | GO:0050684 | 132 | 2 | 18204 | 49 |
RBM47,ZFP36L1 |
4.937e-02 | -3.01 | positive regulation of cellular component biogenesis | biological process | GO:0044089 | 515 | 4 | 18204 | 49 |
PLEK,NCKAP1L,RAC2,HCK |
4.943e-02 | -3.01 | regulation of phosphorylation | biological process | GO:0042325 | 994 | 6 | 18204 | 49 |
ITGB2,NCKAP1L,CSF1R,MARCO,NCF1,CD74 |
4.966e-02 | -3.00 | regulation of vesicle-mediated transport | biological process | GO:0060627 | 516 | 4 | 18204 | 49 |
NCKAP1L,ITGB2,HCK,RAC2 |
4.968e-02 | -3.00 | MON2 (MON2 homolog, regulator of endosome-to-Golgi trafficking) | protein interactions | 23041 | 139 | 2 | 19454 | 50 |
UNC93B1,P2RY6 |
4.974e-02 | -3.00 | nucleotide binding | molecular function | GO:0000166 | 2128 | 10 | 18094 | 48 |
QSOX1,ITM2B,GCH1,MYO1F,RAC2,ENTPD1,MYO9B,CSF1R,HCK,NDUFS2 |
4.988e-02 | -3.00 | nucleoside phosphate binding | molecular function | GO:1901265 | 2129 | 10 | 18094 | 48 |
QSOX1,ITM2B,GCH1,RAC2,MYO1F,ENTPD1,CSF1R,MYO9B,NDUFS2,HCK |
4.991e-02 | -3.00 | lung-carcinoma-small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-small_cell_carcinoma | 9908 | 33 | 16828 | 46 |
PREX1,HCK,PLXND1,ZNRF2,CPN1,MYO1F,ITGB2,ELMO1,SLCO2B1,GULP1,RAPGEF6,QSOX1,LPP,GAS7,ITGAX,RAC2,ABR,CSF1R,SMPD4,ARHGAP15,WDFY3,NCAM2,GAB1,TFEB,NCKAP1L,MFNG,RBM47,MYO9B,P2RY6,MARCO,SH2B3,RGS19,SPOCK3 |
4.995e-02 | -3.00 | positive regulation of macrophage chemotaxis | biological process | GO:0010759 | 19 | 1 | 18204 | 49 |
CSF1R |
4.995e-02 | -3.00 | catechol-containing compound biosynthetic process | biological process | GO:0009713 | 19 | 1 | 18204 | 49 |
GCH1 |
4.995e-02 | -3.00 | 3'-UTR-mediated mRNA destabilization | biological process | GO:0061158 | 19 | 1 | 18204 | 49 |
ZFP36L1 |
4.995e-02 | -3.00 | microvillus organization | biological process | GO:0032528 | 19 | 1 | 18204 | 49 |
RAPGEF6 |
4.995e-02 | -3.00 | positive regulation of protein depolymerization | biological process | GO:1901881 | 19 | 1 | 18204 | 49 |
PLEK |
4.995e-02 | -3.00 | negative regulation of amyloid precursor protein biosynthetic process | biological process | GO:0042985 | 19 | 1 | 18204 | 49 |
ITM2B |
4.995e-02 | -3.00 | negative regulation of alcohol biosynthetic process | biological process | GO:1902931 | 19 | 1 | 18204 | 49 |
PLEK |
4.995e-02 | -3.00 | regulation of B cell apoptotic process | biological process | GO:0002902 | 19 | 1 | 18204 | 49 |
CD74 |
4.995e-02 | -3.00 | catecholamine biosynthetic process | biological process | GO:0042423 | 19 | 1 | 18204 | 49 |
GCH1 |
4.995e-02 | -3.00 | sphingomyelin metabolic process | biological process | GO:0006684 | 19 | 1 | 18204 | 49 |
SMPD4 |
4.995e-02 | -3.00 | neuromuscular process controlling posture | biological process | GO:0050884 | 19 | 1 | 18204 | 49 |
GCH1 |
4.995e-02 | -3.00 | base conversion or substitution editing | biological process | GO:0016553 | 19 | 1 | 18204 | 49 |
RBM47 |